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SUMMARY 
 Natural product research gained importance as it discovered 
chemicals of diverse structural classes with potential pharmacological 
actions. Among various natural sources, plants and their guest 
endophytic fungi are two potential pools for the discovery of new leads. 
In the present work, I investigated two medicinal plants: Seriphidium 
quettense, Vincetoxicum stocksii and an endophytic fungus 
Cryptosporiopsis sp. to explore for their bioactive secondary 
metabolites. The whole dissertation has been divided into five chapters. 
Chapter 1 offers comprehensive overview of role of natural products in 
human health and also provides a mini review of important bioactive 
secondary metabolites and drugs derived from different natural 
sources. In Chapter 2 a brief phytochemical survey of various species 
of the genus Vincetoxicum has been incorporated, besides, isolation and 
characterization the secondary metabolites of Vincetoxicum stocksii 
have also been discussed in this chapter. Chromatographic purification 
of ethyl acetate soluble frcation of methanolic extract of this plant 
yielded four new; vincetolate (69), vincetoside (70), vincetetrol (71) and 
vincetomine (72) along with sixteen known compounds; apocynin (73), 
4-hydroxy-3-methoxyphenyl-1-(9-hydroxy-propan-7-none) (74), 1-(4-
hydroxy-3-methoxyphenyl)-1,2,3,-propanetriol (75), feruloyl-6-O--D-
glucopyranoside (76), 7-megastigmene-3,5,6,9-tetrol (77), 4-
hydroxyphenylacetic acid (78), 4-hydroxy-3,5-dimethoxybenzoic acid 
(79), 4'-methoxy-kaempferol-3-O--D-glucopyranoside (80), 4'-methoxy-
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kaempferol-3-O--L-rhamnopyranoside (81), qurcetain-3-O--L-
rahmnopyranoside (82), 4'-methoxy-qurcetin-3-O--L-
rehmnopyranoside (83), qurcetin-3-O--D-glucopyranoside (84), 
qurcetin-3-O--D- galactopyranoside (85), 7-hydroxy-3',4',5-
trimethoxyflavone (86), β-sitosterol (87), and ß-sitosterol-3-O-D-
glucopyranoside (88), which have been identified due to a combination 
of 1D, 2D NMR and HREIMS and HRFABMS techniques and in 
comparison with the literature. Among these isolates, compounds 73, 
75, 76, 79 and 84 were screened for NO inhibition scavenging 
potential. These compounds exhibited significant inhibition with IC50 
values of 80.17±0.33, 150±0.5, 64.1±0.09, 56.42±0.04, 89.33±0.1 
µg/ml respectively and compounds 69, 70, 75, 77, 79, 80 and 84 were 
also evaluated for antiurease activity, which showed moderate to 
significant inhibition with IC50 values of 85.8±0.01, 105.47±0.01, 
22.1±0.43, 74.8±0.04, 93.4±0.01, 23.9±0.51 and 88.6±0.01 µg/ml 
respectively. 
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Chapter 3 deals with the botanical description and literature survey of 
the genus Seriphidium, which revealed that Seriphidium sp. are mostly 
producing flavonoids. In the present work, Seriphidium quettense was 
investigated for its bioactive phytochemicals and as a result The ethyl 
acetate fraction of methonalic extract yielded seriphilidine (136) as a 
new compound along with seven known compounds; 6-hydroxy-8(10)-
oplopen-14-one (137), salvigenin (138), cirsumaritin (139), p-coumaric 
acid (140), β-sitosterol (87), β-sitosterol-3-O-D-glucopyranoside (88) 
and oleanolic acid (141). The discussion on their structure elucidation 
has been provided in Chapter 4, which covres the detail of their 
purification process and spectroscopic techniques.  
OH3CO
H3C
CH3H3C
CH3
OH
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2
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6
7
8
9
10
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1314
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136  
Other part of my research work deals with the purification and 
characterization of secondary metabolites from endophytic fungus 
cryptosporiopsis Sp., which has been described in chapter 5. However, 
the same chapter also describes the biodiversity of fungal endophytes, 
its advantages in drug discovery and some details of bioactive 
compounds from endophytic fungi. The characterization of novel 
bioactive polyketide 192 was accompalished due to 1D, 2D NMR 
spectroscopy and high resolution mass spectrometry. The absolute 
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stereochemistry of 192 was fully established through electronic circular 
dichroism (CD). This compound was published in a peer-reviewed 
journal [1], whereas, re-culturing and investigation of the fungal extract 
resulted in the isolation of two derivatives; 193 and 194 of polyketide 
192. Compounds 192-194 were tested against four enzymes 
acetylcholinesterase, butyrylcholinesterase, -Glucosidase and 
lipoxygenase and compound 192 was found significantly active against 
the enzyme lipoxygenase with an IC50 value of 49.15±0.17 M and 
enzyme -glucosidase with an IC50 value of 50.59±0.28 M, whereas it 
was inactive against other two enzymes and it also showed anti-Bacillus 
megaterium activity. Compounds 193 and 194 showed moderate 
activity against -glucosidase (IC50 = 44.93±0.26 and 41.42±0.14 
respectively) and lipoxygenase (IC50 = 134.38±1.65 and 149.62±1.53 
respectively), whereas, remained inactive against other two enzymes. 
The latter derivatives 193 and 194 have been published in another 
peer-reviewed journal [2]. 
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1.1. NATURAL PRODUCTS AND EVOLUTION OF MODERN 
MEDICINE SYSTEM  
Natural products are bio-chemical substances obtained from 
natural sources like plants, animals, microorganisms and usually have 
a pharmacological or biological activity. In natural product chemistry, 
we study the structure, uses and purposes of these bio-chemical 
substances for the benefit of human. Natural products are secondary 
metabolites, including terpenoids, flavonoids, alkaloids, steroids, 
polyketides and other compounds of diverse structure. These chemicals 
are produced due to the environmental stress and other challenges 
faced by organisms for survival. Keeping in view this idea scientists 
study plants and other organisms for their important metabolites that 
may also help human to survive against environmental and other 
challenges (Townsend, C. A. and Ebizuka, Y. 1999).  
Health is the prime priority of man, who spends most of his 
sources to save it from environmental dangers. His search for new and 
novel source of medicine is ever growing. In this way, he explored 
natural sources for their bioactive chemicals. His search of medicine is 
a continuous process and nature is one who acts as guide in this 
process (Bungihan et al., 2011).  
In the past, man depended upon the local flora for his existence. 
There are countless documentary proofs which confirmed that different 
countries, culture and civilization from all over the world were familiar 
with natural sources, for their uses as medicine. Archeological evidence 
showed that Shanidar (in Iraq) were using plants (holly- hock, yarrow, 
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grape hyacinth) for healing purposes. The first documentary proof with 
respect to the history of medicine was found in Egyptian dynasties was, 
“Papyri” a book of medicine (De Pasquale 1984). The “Papyri” first time 
appeared in 1873 offered by G. Ebers, but in fact it was sold by Arab to 
G. Ebers and was discovered in 1862 in Thebes. It was titled by 
following word "Here begins the book on preparation of medicines for all 
parts of human body”. Approximately 160 vegetable drugs were listed 
in this book, which were used for the treatment of digestive disorder 
and ulcer. In 1493 B.C Queen Hatchepsut of 18th dynasties, during her 
period a plant Ammi mujus, its roots were eaten by Caravaneers to 
protect themselves from sun burning. It was discovered later that it 
contains 8-methoxypsoralen which stimulates pigment formation and 
produced an artificial Suntan (De Pasquale 1984). Trade was carried 
out between Egypt and India in 3rd millennium B.C either by the 
mountain of Elbuz in North of Iran or from the South of Baluchistan, 
Pakistan. In this way, the exchange of knowledge and drugs was taken 
place between various regions (Thorwald 1962). In Europe, the Greek, 
Roman and Hippocrates were most representative figure in field of 
medicinal plants. The “Pendanius Dicscorides” a great Greek physician 
and pharmacologist described about 500 drugs of vegetable origin and 
106 drugs of animal origin. In Asia, “Serapione the young and Ibn 
Baithar” in 13 century described about 1400 drugs of vegetable origin. 
At that time Arab schools were the active center of learning for 
scientific knowledge. In China (1122-221 B.C), the Chou period was 
known for medical therapy. They used “Ephedria Sinica” for asthma 
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and pulmonary diseases and “Dichroa Febrifuga, against malaria. The 
use of the phytotherapy was more prominent in India and China and 
both were the leading countries for phytotherapy in Asia because this 
region was blessed with many important medicinal plants. Some rural 
regions still have no access to modern facilities and dependent on the 
Ayurvedic medicines. Therefore, Indian Ayurvedic medicines are still 
famous all over the world (Anderson 1977; Farnsworth 1979; Stone 
1962; De Pasquale 1984). 
A Swiss physician, Paracelsus at the start of 17th century, 
introduced the process of extraction of drugs from plants for the first 
time. Meanwhile, the invention of printing press also favored the 
spreading of knowledge all over the world. The new exotic drugs made 
their appearance in Europe and starting point of investigation was 
plant extracts. The precious work of using plant parts as medicine was 
started but no defined chemical was isolated from plant till the end of 
18th century and knowledge of active principle of bio-chemicals was not 
studied properly. The scientists were not familiar with extraction of 
chemical substance until Carl Wilhelm Scheele separated the organic 
acids (Shellard 1980-1981; De Pasquale 1984). At the beginning of the 
19th century William Withering published his work on Digitalis 
purpurea plant and extracted the cardiotonic foxglove, use for the 
treatment of heart patients (Aronson 1985). Further, work on this plant 
led to the discovery of digoxin, a drug marketed as Lanoxin 
(GlaxoSmithKline, Research Triangle Park, North Carolina) for heart 
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patients (Smith 1930). After that Freidrich Serturne isolated morphine 
in 1806 and Charles Derosne isolated narcotine in 1803 (Schmitz 
1985). Pelletier and Caventou isolated strychnine in 1818 from the 
seeds of the Strychnos vomica a woody tree found in South America 
(Woodward et al., 1954). Quinine from cinchona was isolated in 1820. 
Pierre-Jean Robiquet (1780-1840), a French pharmacist, made an 
important contribution and isolated the cantharidin from cantharides, 
caffeine from coffee and amygdalin from bitter almonds. Nativelle 
(1868), crystallized digitalin from foxglove (Warolin 1999). The isolation 
of salicylic acid from willow bark and synthesis of aspirin from salicylic 
acid was another breakthrough (Vane 1992) in natural drug discovery 
field. 
The above overview revealed that progress in natural product 
chemistry played major role as a contributor in the development of 
biological lead and their derivative into drugs. Knowledge of active 
principle led to the discovery of life saving drugs from medicinal plants. 
In this way natural product research began its contribution in human 
welfare. 
1.2. NATURAL PRODUCT RESEARCH ON MEDICINAL PLANTS; 
PAST, PRESENT AND FUTURE 
The discovery of active compounds from the crude extract or 
crude drugs of plant origin are major focus in this field. Scientists are 
interested in study of active principles of these sources and their use as 
medicine. Research on medicinal plants began all over the world to 
discover the active leads of biological interest, with their all-possible 
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derivatives and try to find out their structure-activity relationship, to 
increase their activity, lower the side effect and toxicity (Robbers and 
Tyler 1999). 
These facts demand the enhancement of natural product 
research on promising medicinal plants towards the development of 
new drugs. Therefore, presently many research groups from all over the 
world are working on the isolation of bioactive compounds from 
different natural sources. They study antimicrobial, antioxidant, anti-
inflammatory and other activities of plants extracts, isolation of their 
active components and their use in drug discovery. These research 
groups have different criteria for their studies like; some groups study 
selected plants of medicinal importance as per reported from different 
region of the world, some groups select plants according to their 
geographical occurrence and climate habitat, whereas, some groups 
use to select the plants on the basis of information from folk and 
traditional medicine system (Keen et al., 2005). 
With respect to future research on medicinal plant activities, 
whether new results or known, the most important thing is the 
reproducibility of results to evaluate the quality of products and their 
use in human health care. Obviously, this type of study is of immense 
interest for the future use of plants and crude extracts in medicine 
(Cordell et al., 1993). New improved drugs are needed because 
appearance of life threatening diseases and emergence of bacteria that 
have developed resistance to antimicrobial drugs, for example, US 
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Center for Disease Control and Prevention has reported a strain of 
Mycobacterium tuberculosis that was resistant to all approved drugs to 
date (Morbidity and Mortality, Weekly Report 2006). Therefore 
tremendous increase in bacterial, fungal and viral infections all over 
the world has been observed.  
On the other hand, nature is beautiful source to answer his own 
problems. The hub of the diseases that endanger the human health, 
their best solution is also given by nature. These entire human health 
problems are needed to be addressed but how? Therefore, a question 
arises; where do drug come from? The answer came from the fact that 
“natural products were the origin of all the medicine with 80% of 
medicinal compounds came from natural material” (Sneader 1996). 
Nearly 83% of the chemical scaffolds used for drug development come 
from natural sources while 17% come from synthesis (figure 1.1). 
 
Figure. 1.1: Graphical representation of chemical scaffolds obtained from 
different source  
animals
microbes
synthesis
mineral
plants
Chapter 1                                                                                       Introduction of Natural Product                                                                                 
 
8 
 
 The natural product contribution in drug development over 
period of 1981-2010 (figure 1.2) was mile stone. (Newman and Cragg 
2012).  
 
Figure. 1.2: Percentage of natural product and natural product derivatives by 
year wise contribution in drug discovery from 1981-2010. 
 According to the data above, 1355 drugs were introduced in the 
market during a period 1981-2010, in which 41% were of natural origin 
while 20% were synthetic derivatives of natural product. The figure 1.3 
shows the percentage of all approved drugs during 1981-2010. 
 
 Figure. 1.3: All new approved drugs by source from 1981 to 2010.  
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During the period of 1940-2012, natural products contribution in 
the development of cancer therapeutic drugs was of great significance 
(figure 1.4). Out of total 206 anticancer drugs marketed during this 
period, 85 came from natural product and 121 drugs were contributed 
from all other sources (Newman and Cragg 2012). 
 
 Figure. 1.4: All anticancer drugs 1940s-2010 by source. 
Anti-infective drugs like antibacterial, antifungal, antiparasitic 
and antiviral are mostly small molecules of natural origin and their 
derivatives. The total number of anti-infective drugs approved till 2012 
are given in the table 1.1. 
Table. 1.1: All anti-infective drugs from 1981 to 2012 from source. 
Indication Total N ND S S/NM V 
Antibacterial  118 10 67 26 1 14 
Antifungal  29 1 3 22 3 - 
Antiparasitic  14 2 5 6 - 1 
Antiviral 109 14 4 32 12 47 
Total  270 27 79 86 16 62 
Percentage  100 4.4 29.3 31.9 5.8 23 
N= Natural product 
ND= Natural product derivate  
S= synthetic  
S/NM= Synthetic of natural product minic 
V= Vaccine  
NP ND S S/ND V B
28
57
44 46
5
26
13
28
21 23
2
13
All anticancer drugs 1940s to 2010 by source
No. of anti cancer drug by source %  of anti cancer drug by source
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The above data revealed that the role of natural product in drug 
discovery is a continuous process and natural products are the only 
source, which provide a bulk of leads to scientific community 
continuously that will be used in drug designing process. 
1.3. ADVANTAGES OF NATURAL PRODUCT RESEARCH  
 The advantage of natural product over the synthetic chemistry is 
its ability to produce the novel structure of diverse classes. The 
published data revealed that 40% of the chemical skeleton came from 
natural product research were not present in the synthetic library. 
Thus the natural product isolation is successful process in the 
screening of new compounds of novel skeleton (Henkel et al., 1999). 
The main advantages are discussed briefly. 
 Natural products produce chemicals of diverse structural classes 
and are excellent source of biologically active metabolites 
(Verdine 1996). 
 Natural products are produced due to adverse effect of nature so 
they have specific biological interactions between organism and 
environment, that’s why they have drug like properties (Nisbet 
and Moore 1997). 
 Natural product resources are largely unexplored and are the 
main source of pharmacophores (Bram et al., 1993). 
 Natural product leads are complementary to synthetic and 
combinatorial libraries (Henkel et al., 1999). 
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 Natural product led to discovery of active principle and novel 
mechanisms of action (Urizar et al., 2002). 
 Natural products act as pathfinder for molecular biology (Hung et 
al., 1996). 
 Synthesis of compounds were designed with help of natural 
product guide lines (Breinbauer et al., 2002). 
1.4. BIOLOGICALLY ACTIVE NATURAL PRODUCTS  
 According to a review published in 2012, approximately 500,000 
compounds have been isolated from natural sources with about 70,000 
metabolites from microbial sources. With respect to biological 
properties, 16500 bioactive compounds were reported as antimicrobial 
agents isolated from all natural sources. Table 1.2 describes the total 
number of important antimicrobial natural products along with other 
chemotherapeutic agents (Berdy 2005; Berdy 2012). 
Table. 1.2: Bioactive compounds isolated from different source. 
Antibacterial compounds Antifungal Compounds 
G. positive 11000-12000 Yeasts 3000-3500 
G. negative 5000-5500 phytopathogenic 1600-1800 
Mycobacteria 800-1000 Other fungi 3800-4000 
Antitumor 5000-5500 Antiviral 1500-1600 
Enzyme inhibitor 3000-3200 Immunological 800≈ 
Biochemical 1000≈ Anti-inflammatory 2000-2500 
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1.5. SOURCES OF NATURAL PRODUCTS  
 There are mainly four types of natural product sources: 
1. Plant source  
2. Animal source 
3. Microbial source 
4. Marine source 
1.5.1. Natural Products from Plant Sources 
Plants are known as a primary source of medicines. They provide 
active ingredients of medicines. There is no exact figure about the total 
number of medicinal plants present on earth and their percentage as 
their number vary from region to region depending upon the climate 
condition (Schippmann 2001). It was estimated that 35000-40000 
medicinal plants species are present worldwide (Schippmann et al., 
2002; Shiva 1996). According to scholarly medical systems relatively 
few medicinal plants (500–600) are being used in Traditional Chinese 
Medicine, with a total estimated number worldwide as 6000.  
Active ingredients from medicinal plants that are used in Western 
medicine are even fewer. An article published in 1991 shows that 121 
plant-based drugs were used in America (Farnsworth and Soejarto 
1991). However, in current scenario, medicinal herbs are grown on 
large scale in U.S.A, U.K. Canada, France and Turkey and are being 
marketed to earn foreign exchange. It was estimated that 200 tons per 
annum of herbs were used only in Indian region. About 188 tons are 
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used for culinary purposes and nearly 12 tons are consumed for 
medicinal and cosmetic preparations. The largest global markets for 
medicinal plants are China, France, Germany, Italy, Japan, Spain, UK 
and US. Japan has the highest per capital consumption of botanical 
medicines in the world. The plant base drugs of early time are aspirin 
(1), digitoxin (2), morphine (3), quinine (4) and pilocarpine (5). 
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An antimalarial drug approved as arteether (6) was derivative of 
natural lead artemisinin (7) and was marketed by Artecef BV (Central 
Drug Institute) (Graul 2001). Alzheimer’s disease drug galantamine (8), 
manufacture by Johnson & Johnson was isolated from plant Galanthus 
spp. (Heinrich and Teoh 2004). Miglustat (9) drug for type 1 Gaucher 
disease and lead compound 1-deoxynojirimycin (10) was isolated from 
Streptomyces trehalosaticus. 
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M6G (11, morphine-6-glucuronide) is a pain killer and was 
introduced in market by CeNeS. Exatecan (12), an anticancer synthetic 
drug was derived from camptothecin (13), which was isolated from the 
plant Camptotheca acuminate. Sativex a mixture of dronabinol (14) and 
cannabidol (15) was introduced by G. W. Pharmaceuticals derived from 
the Cannabis plant for neuropathic pain relief in multiple sclerosis 
(Wade et al., 2003; Nurmikko et al., 2007). Rubitecan (16) an 
anticancer isolated from the plant Camptotheca acuminate introduced 
by SuperGe.  
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 Vinflunine (17) and vinorelbine (19) is also an anticancer semi 
synthetic drug derived from vinblastine (18), which was originally 
isolated from the plant Catharanthus roseus (Butler 2004). 
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1.5.2. Natural Products Isolated from Microbial Sources 
Over 50,000 secondary metabolites have been reported from 
microbial sources, with 22000 to 23000 are bioactive compounds. 
Approximately 17,000 are antibiotic; unfortunately, very small 
percentage from them has been further processed as natural product 
drug (Berdy 2005; Knight et al., 2003).  
The discovery of penicillin by Alexander Fleming in 1928 and its 
development by Chain and Florey in the 1940s was a gateway to the 
isolation of several bioactive compounds from microbes. Streptomycin 
(20), chloramphenicol (21), chlortetracycline (22), cephalosporin C (23), 
Pestacin (24) and vancomycin (25) are other common examples 
(Newman et al., 2000). 
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 Another milestone in the history of medicine was development of 
the immunosuppressant drugs cyclosporine A (26) and rapamycin (27) 
from microbial metabolites (Demain 1998).  
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 Anti-hyperlipidemics lovastatin (28) and guggulsterone (29) are 
other good examples of microbial natural products (Urizar et al., 2002). 
Fumagillin (30) lunched by Sanoﬁ-Aventis as an antimicrobial lead is 
capable of inhibiting the proliferation of endothelial cells. It was 
isolated from Aspergillus fumigates (Mccowen et al., 1951). 
Pleuromutilin (31) is an antibacterial agent that exhibits antibacterial 
activity by inhibiting protein synthesis in bacteria (Daum et al., 2007). 
Retapamulin (32) developed by GlaxoSmithKline, use in impetigo 
caused by Gram-positive Staphylococcus aureus or Streptococcus 
pyogenes. Lisdexamfetamine (33) was designed by New River 
Pharmaceuticals to help attention deficit hyperactivity disorder (ADHD). 
It consists of dextroamphetamine coupled with the essential amino acid 
L-lysine (Popovic et al., 2009). 
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1.5.3. Natural Products Isolated from Animal Sources 
 The natural products of animal origin are of great importance. 
The antihypertensive agents; captopril (34), ramipril (35) and quinapril 
(36) are derived from the snake venom peptide teprotide. Ilepatril (37) is 
also under clinical evaluation (Davidson et al., 2007).  
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 An important metabolite trodusquemine (38) is a sulfated 
aminosterol isolated from the dogfish shark (Rao et al., 2000). 
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Epibatidine (39), obtained from the skin of an Ecuadorian poisonous 
frog, is ten time more potent than morphine (Spande et al., 1992). 
Ziconotide (40) is an N-type voltage sensitive calciumchannel blocker 
which was isolated from the toxin of Conus magus, is a synthetic form 
of the peptide -conotoxin (Mcgivern 2007). Exenatide (41) was isolated 
from the oral secretions of the poisonous lizard Heloderma suspectum. 
It was marketed by Amylin Pharmaceuticals and can mimic the 
antidiabetic or glucose-lowering properties of incretins (Bunck et al., 
2009). 
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1.5.4. Natural Products Isolated from Marine Sources 
 Natural products from marine derived fungi show promising 
biological and pharmaceutical properties. Saleem et al, in a review 
article, described 103 marine secondary metabolites of biological 
importance during the period of 2000-2006, whereas, only 15 
secondary metabolites isolated from marine sources are in clinical trials 
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(Saleem et al., 2007). In another review published in November 2010 by 
Mostafa E. Rateb describes 690 secondary metabolites of biological 
importance covering period of 2006 to mid-2010 which shows the 
marine source contribution in drug discovery or its role in finding the 
new lead structure for drug development (Ratebab and Ebel 2011).  
The important secondary metabolites isolated from marine 
sources are, the epicoccone (42) was isolated from marine brown alga 
Fucus Vesiculosus and was found potentially active, showing radical 
scavenging effect at 25 g/ml (Abdel-lateff etal., 2003). Evariquinone 
(43) exhibits antiproliferative activity and was found active against KB 
and NCI-460 cells with concentration 3.16 µg/ml (Bringmann et al., 
2003). Varitriol (44) and varioxirane (45) show the potency against 
selected renal, breast cancer and CNS cell lines, whereas, virixanthone 
(46) shows activity against Gram-positive and Gram-negative bacteria 
(Malmstrom et al., 2002). Trichodermamides A (47) and B (48) having 
cyclic O-alkyl-oxime functionality show significant in vitro cytotoxicity 
against HCT-116 human colon with an IC50 value of 0.32 µg/ml (Garo 
et al., 2003).  
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 In short natural products and natural product chemistry have 
revolutionized the world of medicine with antibiotics like penicillin (49), 
tetracycline (50), erythromycin (51), antimalarials e.g. quinine (4), 
artemisinin (52), antiparasitics drugs like avermectin (53), lipid 
controlling agents like lovastatin (28) and its analogs, 
immunosuppressants for organ transplants, e.g. cyclosporine A (26), 
rapamycins (27) and anticancer drug like doxorubicin (54) etc. (Harvey 
2008). 
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 The success of natural product drug development was 
commercially excellent. Out of 20 best-selling non-protein drugs in 
2000, nine were natural products or either derived from them. Their 
combined annual sales were over US$16 billion. Many new 
developments from natural products are in pipeline (Landry and Gies 
2008; Harvey 2001). 
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RESEARCH QUESTION AND AIM OF THE PRESENT STUDY 
 About 500 medicinal plant species out of a total 5700 are 
estimated to exist in Pakistan, whereas, it is estimated that 80% of the 
rural population of Pakistan depends on traditional medicines for their 
primary healthcare needs. Despite of the facts that Pakistan is blessed 
with large number of medicinal plants, about 90% of the country’s 
medicinal herbs are imported (Saqib and Sultan 2005). Therefore, there 
is a crucial need to investigate local flora for their medicinal potential 
and to provide a systematic data base to the community to use these 
plants and their extracts as medicine. These facts motivated us to 
investigate Pakistani indigenous medicinal plants to discover novel 
compounds of pharmaceutical importance and to establish a scientific 
data base of the local treasure. Therefore, for the present study, I 
selected two unexplored plants: Seriphidium quettense and 
Vincetoxicum stocksii to investigate them for their bioactive secondary 
metabolites.  
 On the other hand, the discovery of new drug candidates from 
endophytic fungi is relatively a new and attractive area of drug 
development. Unfortunately, this modern and important area of drug 
discovery has been totally ignored in Pakistan. Therefore, as an 
initiative, and in cooperation with German scientists, I included 
investigation on an endophytic fungus Cryptosporiosis sp. in my plan of 
Ph.D. research. 
  
Research Problem and hypothesis  
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HYPOTHESIS OF THE RESEARCH 
 Due to their use in folk medicine system and previous study on 
the related plants, it was hypothesized that Seriphidium quettense and 
Vincetoxicum stocksii must be synthesizing bioactive secondary 
metabolites, which can be lead for drug development, while various 
species of the endophytic fungi of the genus Cryptosporiopsis have been 
reported to produce potent antibacterial, antifungal and insecticides; 
therefore, the species isolated from Vibrum tanus must also be 
producing novel bioactive compounds.  
 
 
Chapter 2                                   Characterization of the Compounds Isolated from V. stocksii                                                                                  
 
25 
 
 
 
 
 
 
CHAPTER 2  
 
 
 
RESULTS AND DISCUSSION: PREVIOUS RESEARCH ON 
THE VINCETOXICUM GENUS AND ISOLATION OF 
SECONDARY METABOLITES FROM VINCETOXICUM 
STOCKSII 
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2.1. THE GENUS VINCETOXICUM 
 The genus Vincetoxicum is among various genera of plant family 
Asclepiadaceae. It is a small genus of 10-20 species, mainly distributed 
in Europe and Asia. In Pakistan, it is represented by only six species 
including V. arnottianum, V. canescens, V. cardiostephanum, V. 
hirundinaria, V. sakesarense and V. stocksii (Ali et al., 1982). 
2.2. PREVIOUS PHYTOCHEMICAL INVESTIGATION OF THE GENUS  
VINCETOXICUM  
 Literature search revealed that a very little phytochemical work 
has been done on the species of this genus. Fewer reports were 
published in literature. Lavault et. al., isolated 10-(−)-antofine N-oxide 
(55), 10-(−)-antofine N-oxide (56), (−)-antofine (57), (−)-6-O-
demethylantofine (58) and (−)-14-hydroxyantofine (59) from V. 
hirundinaria (Lavault et al., 1994). 
N
OCH3
H3CO
H3CO
N
OCH3
H3CO
H3CO
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N
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H3CO
H3CO
H
O
H
N
OCH3
H3CO
HO
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55 56 57
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 The pregnane glycosides, cynatratosides E (60) and C (61), 
hirundigoside B-D (62-64) were isolated from the roots of V. 
hirundinaria (Lavault et al., 1999). 
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60   R1 = b-D-glu (1-4) a-D-ole (1-4) b-D-digit (1-4) b-D-ole; R2 = H 
61   R1= a-D-ole (1-4) b-D-digit (1-4) b-D-ole; R2 = H
62   R1= b-D-glu (1-4) a-D-ole (1-4) b-D-digit (1-4) b-D-ole; R2 = OH
63 R1= a-D-ole (1-4) b-D-digit (1-4) b-D-ole; R2 = OH
64 R1= a-D-ole (1-4) b-D-digit (1-4)
 
 The hancokinol (65) was isolated from V. officinale (Nowaka and 
Kisielb 2000), while compounds 66-68 were obtained from V. pumilum 
(Staerk et al., 2005). 
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Above are the fewer reports published on phytochemicals of the 
relatives of this genus. Among these plants, V. stocksii has never been 
explored for its secondary metabolites. Therefore, my research work, for 
the first time emphasizes on the isolation of bioactive metabolites from 
this plant. 
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2.3. VINCETOXICUM STOCKSII 
Vincetoxicum stcoksii is an important member of the genus 
Vincetoxicum. It is a perennial climbing leafy vine growing in 
Baluchistan, Pakistan. Vincetoxicum stocksii is known for its poisonous 
as well as its medicinal properties. It is used to treat the external 
cancers, wounds and injuries in man and animals (Simandi et al., 
1996). In local medicine system, this plant has been reported to 
possess antibacterial and antifungal activities. In addition, the crude 
extract of the V. stcoksii shows antidiarrheal and antispasmodic 
potential (Zaidi and Crow 2005). 
2.3.1. Classification of the Vincetoxicum Stocksii 
Family  Asclepiadaceae 
Subfamily  Periplocoideae 
Class Asclepiadeae 
Genus Vincetoxicum 
Specie  Vincetoxicum stocksii 
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2.4. RESULTS AND DISCUSSION: CHARACTERIZATION OF 
SECONDARY METABOLITES ISOLATED FROM V. STOCKSII 
 The methanolic extract of Vincetoxicum stocksii was divided into 
n-hexane, ethyl acetate and water fractions. The ethyl acetate fraction 
exhibited several biological activities (Table 2.13 and 2.14), thus it was 
proceeded for the isolation of secondary metabolites. As a result of 
chromatographic purification, four new; vincetolate (69), vincetoside 
(70), vincetetrol (71), vincetomine (72) and sixteen know compounds; 
apocynin (73), 4-hydroxy-3-methoxyphenyl-1-(9-hydroxy-propan-7-one) 
(74), 4-hydroxy-3-methoxyphenyl-7,8,9-propanetriol (75), feruloyl-6'-O-
-D-glucopyranoside (76), 7-megastigmene-2,3,5,9-tetrol (77), 4-
hydroxyphenylacetic acid (78), 4-hydroxy-3,5-dimethoxybenzoic acid 
(79), 4'-methoxy-kaempferol-3-O--D-glucopyranoside (80), 4'-methoxy-
kaempferol-3-O--L-rhamnopyranoside (81), quercetin-3-O--L-
rhamnopyranoside (82), 4'-methoxy-quercetin-3-O--L-
rhamnopyranoside (83), quercetin-3-O--D-glucopyranoside (84), 
quercetin-3-O--D- galactopyranoside (85), 7-hydroxy-3',4',5-
trimethoxyflavone (86), β-sitosterol (87) and ß-sitosterol-3-O-D-
glucopyranoside (88) were obtained. 
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2.4.1. Characterization of Vincetolate (69)  
 Compound 69 was isolated as white amorphous powder. The 
EIMS of 69 showed the 
molecular ion peak at 
m/z 364, while the 
molecular formula 
C22H36O4 with five 
double bond equivalence (DBE) was calculated through HR-EIMS which 
exhibited the molecular ion peak at m/z 364.2416. The IR spectrum 
showed diagnostic absorption bands at 3505, 1730, 1610 and 1580, for 
hydroxyl function, ester moiety and aromatic system, respectively.   
 The 1H-NMR spectrum of 69 (Table 2.1) showed two ortho-
coupled doublets at δ 7.02 (J = 8.5 Hz) and 6.73 (J = 8.5 Hz) in the 
aromatic region. The splitting pattern (A2B2) of these two doublets 
indicated the presence of a p-substituted benzene ring in 69. The 
spectrum further displayed signals for three methylenes at δ 3.49 (s), 
4.07 (t, J = 6.5 Hz) and 3.63 (t, J = 6.5 Hz). The first methylene signal 
at δ 3.49 was correlated in HSQC spectrum with the carbon at δ 41.8, 
which indicated that this methylene must be present between two sp2 
hybridized centers. The other two methylene protons at δ 4.07 and 3.63 
showed COSY correlation with a signal of four hydrogen (two 
methylene) at δ 1.58 (m) and 1.50 (m), which in turn was correlated 
with a broad singlet of several hydrogen at δ 1.40-1.22. This data 
indicated that compound 69 must have a p-hydroxy phenylethanoate 
O
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system coupled with a hydrocarbon moiety ending with a primary 
alcoholic function.  
 The 13C-NMR (Table 2.1) substantiated the above deduction as it 
displayed signals for carbonyl at δ 174.2, aromatic moiety at δ 158.4, 
131.7, 130.8 and 116.3, oxymethylenes at δ 65.8 and 64.6 and 
remaining methylenes at δ 41.8, 33.9, 26.0 with an intense signal at δ 
30.0 for several aliphatic methylenes. 
 The above discussed data led to the structure of 69 as 14-
hydroxytetradecyl-2-(4-hydroxyphenyl) acetate, which was further 
confirmed through HMBC spectral analysis (Figure 2.1), in which the 
aromatic proton at δ 7.02 was found to correlate with the carbons at δ 
158.4 (C-4), 131.7 (C-6) and 41.8 (C-7). In turn the proton resonating 
at δ 3.49 showed HMBC correlation with the carbons at δ 131.7 (C-1), 
130.8 (C-2, 6) and 174.2 (C-8), whereas, oxymethylene at δ 4.07 
showed HMBC correlation with the carbonyl carbon at δ 174.2 (C-8). All 
other important HMBC and COSY correlation are shown in figure 2.1. 
O
O
OH
OH
69
 
Figure. 2.1: 1H-1H COSY ( ) and 1H-13C HMBC ( ) interactions 
observed in the spectra of 69. 
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 On the basis of these observations compound 69 was finally 
identified as 14-hydroxytetradecyl-2-(4-hydroxyphenyl) acetate which is 
a new addition to the natural product list and is named as vincetolate. 
    Table. 2.1: 1H and 13C-NMR data of 69 (CD3OD; 500 and 125 MHz).  
Position δ H (J in Hz) δ c 
1 - 130.8 
2  7.02 (1H, d, 8.5) 131.7 
3  6.73 (1H, d, 8.5) 116.3 
4 - 158.4 
5  7.02 (1H, d, 8.5) 131.7 
6  6.73 (1H, d, 8.5) 116.3 
7  3.49 (2H, s) 41.8 
8 - 174.2 
1' 4.07 (2H, t, 6.5) 65.8 
2'  1.58 (2H, m) 26.0 
3'-12' 1.40-1.22 (20H, br., s) 30.0 
13' 1.50 (2H, m) 33.9 
14' 3.63 (1H, t, 6.5) 64.6 
14'-OH - - 
 
2.4.2. Characterization of Vincetoside (70)  
Compound 70 was obtained as white amorphous powder, whose 
FD-MS displayed the 
molecular ion at m/z 612. 
The HR-FAB-MS in 
negative mode exhibited a pseudo-molecular ion peak at m/z 611.5263 
corresponding to the molecular formula as C37H72O6 with two DBE. The 
IR spectrum displayed absorption bands at 3385 and 1655 cm-1 for 
hydroxyl and olefinic functions, respectively. An intense absorption 
band at 1300 cm-1 was attributed to a hydrocarbon chain. 
 The 1H-NMR spectrum (Table 2.2) of 70 showed two signals at δ 
5.31 (1H, br., m, W1/2 = 20.8 Hz) and 5.27 (1H, br., m, W1/2 = 20.8 Hz) 
1
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3
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due to a trans double bond. The above two protons showed COSY 
correlation with two aliphatic methylene at δ 1.92 (2H, m), 1.90 (2H, 
m), respectively. One of the methylene at δ 1.90 was further correlated 
with another methylene at δ 1.30, which in turn was correlated in the 
same spectrum with a triplet methyl at δ 0.80 (J = 6.6 Hz). These 
observations helped to fix the position of double bond. An oxymethylene 
signal resonated at δ 3.99 (t, J = 6.9 Hz), which showed COSY 
correlation with another methylene at δ 1.70 (m), which in turn was 
correlated in COSY spectrum with a broad singlet of several aliphatic 
protons δ 1.30-1.16. This data indicated a hydrocarbon chain in the 
molecule. A doublet methine proton resonating at δ 4.20 (J = 7.0 Hz) 
could be attributed to anomeric center of a sugar moiety, whereas, 
other sugar protons resonated at δ 3.66 (1H, t, J = 9.0 Hz), 3.16 (1H, 
m), 3.95 (1H, dt, J = 9.0, 6.0 Hz), 3.46 (1H, m), 3.78 (1H, dd, J = 12.0, 
2.6 Hz) and 3.76 (1H, dd, J = 12.0, 6.6 Hz). 
 The 13C-NMR spectrum (Table 2.2) of 70 was in complete 
agreement with the proton and mass data as it displayed the signals for 
hydrocarbon part at δ 130.6, 129.7, 68.6, 35.2, 34.3, 31.8, 29.6-25.8, 
22.6, 14.0 and sugar moiety at δ 102.9, 76.2, 74.3, 73.3, 72.2, 62.2. 
The anomeric proton (δ 4.20) exhibited HMBC correlation with 
oxymethylene carbon at δ 68.6 and vice versa. This observation 
established the attachment of aliphatic chain with sugar moiety. Other 
important COSY and HMBC correlations found in spectrum are shown 
in figure 2.2. 
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Figure. 2.2: 1H-1H COSY ( ) and 1H-13C HMBC ( ) interactions 
observed in the spectra of 70. 
 The above discussed data led to the structure of 70 as (E)-2-
(hentriacont-27-enyloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-
3',4',5'-triol.  
   Table. 2.2: 1H and 13C-NMR data of 70 (CD3OD; 500 and 125 MHz).  
Position δH (J in Hz) δ c 
1 3.99 (2H, t, 6.9)  68.6 
2  1.70 (2H, m) 34.3 
3-25  1.16-1.30 (46H, br., s) 29.6-25.8 
26  1.90 (2H, m) 35.2 
27 5.31 (1H, br., m, W1/2 = 20.8) 130.6 
28 5.27 (1H, br., m, W1/2 = 20.8) 129.7 
29  1.92 (2H, m) 31.8 
30  1.30 (2H, m) 22.6 
31 0.80 (3H, t, 6.6)  14.0 
1' 4.20 (1H, d, 7.0)  102.9 
2' 3.66 (1H, t, 9.0) 74.3 
3' 3.16 (1H, m) 73.3 
4' 3.95 (1H, dt, 9.0, 6.0) 72.2 
5' 3.46 (1H, m) 76.2 
6' 3.78 (1H, dd, 12, 2.6), 
3,76 (1H, dd, 12, 6.6) 
62.2 
 
The sugar could be identified as -glucose due to acid hydrolysis 
of 70 that provided two products, which were separated by solvent 
extraction. The ethyl acetate layer contains hydrocarbon portion, 
whereas, the glycone part was separated from the aqueous layer and 
puriﬁed using preparative thin-layer chromatography (TLC) using a 
solvent system of EtOAc:MeOH:H2O:AcOH (4:2:2:2) and the Rf value 
was compared with the authentic sample. It was further confirmed due 
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to the value of optical rotation []D26 +50.2 (Mukhtar et al., 2004). The 
combination of above spectroscopic data finally led to the structure of 
70 as (E)-hentriacont-4-ene-1-O-β-D-glucoside, which we reported as a 
new secondary metabolite and is named as vincetoside. 
2.4.3. Characterization of Vincetetrol (71) 
 Compound 71 was also purified as white amorphous powder, 
whose EIMS spectrum displayed molecular ion 
peak at m/z 240, whereas, the molecular 
formula C11H12O6 with six DBE was calculated 
through HR-EIMS. The IR spectrum displayed 
absorption bands at 3510 (O-H), 1760 (C=O) 
1605 and 1570 (aromatic system) cm-1. Aromatic region of the 1H-NMR 
spectrum (Table 2.3) showed signals for two singlet protons at δ 7.25 
and 6.66 due to a 1,2,4,5-tetrasubstitited benzene ring. The spectrum 
also displayed resonance due to a methoxyl proton (δ 3.84) and a 
singlet signal of six hydrogen at δ 1.90, which was attributed to two 
equivalent methyls of acetyl moieties.  
The 13C-NMR (Table 2.3) displayed resonances of two methine 
carbons at δ 105.2 and 104.5, one methoxy at δ 56.8, two methyl at δ 
23.7 and five quaternary carbon atoms at δ 171.4, 149.7, 149.4, 138.2, 
138.2. Based on the above data and HMBC correlations (Figure 2.3), 
two structures a and b (Figure 2.3) were proposed for compound 71.  
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Figure. 2.3: 1H-13C HMBC correlations observed in compound 71. 
 However, structure “a” most fitted on the data as the 13C-NMR 
experimental shifts were close to the theoretical shifts with the 
positions of various substituents as in structure “a” (Figure 2.4). 
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Figure. 2.4: Proposed structures a and b for compound 71, based on 
NMR data. 
 Combination of the experimental and theoretical observations, 
finally led to the structure of compound as 71a, which is a new 
metabolite and is named as vincetetrol. 
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2.4.4. Characterization of Vincetomine (72) 
 Compound 72 was isolated as white amorphous powder, which 
exhibited absorption bands in IR spectrum for 
primary amine at 3260, 1601 cm-1 and at 
1605 and 1570 for aromatic system. The 
EIMS spectrum showed molecular ion peak at 
m/z 213, whereas, the molecular formula 
C14H15NO with eight DBE, was established 
through HR-EIMS (m/z 213.1254).  
  The 1H-NMR spectrum (Table 2.3) of compound 72 displayed the 
most downfield signal at  8.49 (2H, s), which was attested for an 
amino group. In the aromatic region other resonances at δ 7.39 (1H, J = 
8.6 Hz), 7.32 (1H, d, J = 8.5), 7.10 (1H, d, J = 8.6 Hz) and 7.08 (1H, d, J 
= 8.5 Hz) were observed for aromatic systems. The A2B2 splitting 
pattern of these signals was attributed to two p-substituted benzene 
rings in 72. In addition, the 1H-NMR spectrum displayed a signal due 
to methylene proton at δ 3.78 (s) and methoxyl proton at δ 3.62.  
The 13C-NMR spectrum (Table 2.3) of 72 showed nine carbon 
signals, which were identified as three methine (δ 128.8, 118.2 and 
116.4), one methylene (δ 39.9), one methyl (δ 51.4) and four quaternary 
carbon atoms (δ 153.9, 137.6, 135.5, 134.8). The NMR shifts (δH 3.78 
and δC 39.9) of methylene group indicated its presence between two 
aromatic systems, which was substantiated through HMBC experiment 
(Figure 2.5), in which methylene proton exhibited HMBC correlations 
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with the aromatic carbons at  135.5 (C-1), 134.8 (C-1'), 128.8 (C-2, 6, 
3', 5'). The position of methoxyl group was fixed due to its HMBC 
correlation with the aromatic at  153.9, whereas, amino proton 
displayed its HMBC correlation with the carbon signals resonated at  
137.6 and thus was placed at C-4'.  
H3CO
NH2
72
 
Figure. 2.5: 1H-1H COSY ( ) and 1H-13H HMBC ( ) interactions 
observed in the spectra of 72. 
 Combination of the above spectroscopic data helped to establish 
structure of 72 as 4-(4-methoxybenzyl) benzenamine, which is named 
as vincetomine. 
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Table. 2.3: 1H and 13C-NMR data of 71 (CD3OD; 500 and 125 MHz) and 72 
(CD3OD; 600 and 150 MHz)  
 71 72 
Position δH (J in Hz) δC δH (J in Hz) δC 
1 - 138.2 - 135.5 
2 - 149.7 7.39 (1H, d, 8.6) 128.8 
3 7.25 (1H, s) 104.5 7.10 (1H, d, 8.6) 116.4 
4 - 138.2 - 153.9 
5 - 149.4 7.10 (1H, d, 8.6) 116.4 
6 6.66 (1H, s) 105.2 7.39 (1H, d, 8.6) 128.8 
7 - 171.4 3.78 (2H, s) 39.9 
8 - 171.4 - - 
1 - - - 134.8 
2 - - 7.08 (1H, d, 8.5) 118.2  
3 - - 7.32 (1H, d, 8.5) 128.8 
4 - - - 137.6 
5 - - 7.32 (1H, d, 8.5) 128.8  
6 - - 7.08 (1H, d, 8.5)  118.2 
14-OMe - - 3.62 (3H, s, OMe) 51.4 
1-NH2 - - 8.49 (1H, s) - 
3-OMe 3.84 (3H, s, OMe) 56.8 - - 
7, 8-Me 1.90 (3H, s, CH3) 23.7 - - 
 
2.4.5. Characterization of Apocynin (73)  
 Compound 73 was obtained as white amorphous powder, which 
showed the molecular ion peak in EIMS spectrum 
at m/z 166, whereas, the molecular formula 
C9H10O3 with five DBE was calculated through 
HR-EIMS (m/z 166.1052 [M]+). The IR spectrum 
of 73 displayed prominent absorption bands at 1705, 1590 and 1565 
cm-1 for carbonyl function and aromatic moiety respectively.  
 In the aromatic region, the 1H-NMR spectrum of 73 (Table 2.4) 
showed three resonances at δ 7.14 (1H, dd, J = 8.4, 2.0 Hz), 7.24 (1H, 
d, J = 2.0 Hz) and 6.50 (1H, d, J = 8.4 Hz). This ABX splitting pattern 
revealed a tri-substituted benzene ring in 73. In addition, signals for 
two singlet methyls appeared at δ 3.93 and 2.54. The chemical shifts of 
HO
OCH3
CH3
O
73
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these signals depicted the acetyl and methoxyl nature of the two 
methyls respectively.  
 The 13C-NMR spectrum (Table 2.4) displayed 9 carbon signals, 
which were identified as two methyl (δ 26.2, 56.0), three methine, (δ 
124.0, 113.7, 109.6) and four quaternary carbons (δ 195.0, 149.0, 
145.0, 129.0) due to DEPT experiment. This data led to the idea for the 
structure of compound 73 as derivative of acetophenone, which was 
finally confirmed through HMBC analysis of 73, in which the aromatic 
proton at δ 7.24 and 7.14 showed HMBC interaction with carbonyl 
carbon at δ 195.0) and acetyl methyl displayed HMBC correlation with 
aromatic carbon at  129.0. This information helped to fix the position 
of acetyl moiety. The methoxyl proton at δ 3.93 shows HMBC with the 
aromatic carbon at δ 145.0 and hence was placed at C-3. Combination 
of the whole spectroscopic data and comparison with the reported data 
compound 73 was identified 1-(4-hydroxy-3-methoxyphenyl) ethanone, 
which is known as apocynin, a previously reported phytochemical (Kim 
et al., 2011). 
2.4.6. Characterization of 4-Hydroxy-3-methoxyphenyl-1-(9-
hydroxy-propan-7-one) (74) 
 Compound 74 was isolated as white amorphous powder, whose 
EIMS spectrum showed the molecular ion 
peak at m/z 196, whereas, the HR-EIMS 
analysis (m/z 196.2061 [M]+) depicted the 
molecular formula C10H12O4 with five DBE. 
The IR spectrum showed absorption bands at 1700 cm-1 due to a 
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conjugated ketonic function and bands at 3460, 1610 and 1560 cm-1 
were attested for hydroxyl group and aromatic ring respectively.  
 Three proton signals in the aromatic region of the 1H-NMR 
spectrum (Table 2.4) of 74 appeared as ABX system at δ 7.58 (1H, dd, J 
= 8.0, 2.0 Hz), 7.54 (1H, d, J = 2.0 Hz) and δ 6.86 (1H, d, J = 8.0 Hz) 
and were attributed to a tri-substituted benzene ring. Further, the 
resonances due to two methylene were observed at δ 3.94 (t, J = 6.0 Hz) 
and 3.16 (t, J = 6.0 Hz) which were found to correlate with each other 
in COSY spectrum. The same spectrum also afforded signals for a 
methoxyl proton at  3.93.  
 The 13C-NMR data (Table 2.4) showed total 10 signals, three 
methine at δ 124.7, 115.7 and 111.8, two methylene at δ 58.8 and 
41.6, four quaternary carbons at δ 199.6, 153.3, 149.0 and 130.6 and 
a methoxyl carbon at  56.6.  
 Table. 2.4: 1H and 13C-NMR data of 73 and 74 (CD3OD; 500 and 125 MHz).  
 73 74 
Position  δH (J in Hz) δc δH (J in Hz) δc 
1 - 129.0 - 130.6 
2  7.24 (1H, d, 2.0) 109.6 7.54 (1H, d, 2.0) 111.8 
3 - 145.0 - 149.0 
4 - 149.0 - 153.3 
5 6.93 (1H, d, 8.4) 113.7 6.86 (1H, d, 8.0) 115.7 
6 7.14 (1H, dd, 8.4, 2.0) 124.0 7.58 (1H, dd, 8.0, 2.0) 124.7 
7 - 195.0 - 199.6 
8 - - 3.16 (2H, t, 6.0) 41.6 
9 - - 3.94 (2H, t, 6.0) 58.8 
3-OMe 3.93 (3H, s, OMe) 56.0 3.89 (3H, s, OMe) 56.6 
7-Me  2.54 (3H, s, CH3) 26.2 - - 
 
Various connectivities were established through HSQC, COSY 
and HMBC (Figure 2.6) experiments and finally compound 74 was 
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identified as 4-hydroxy-3-methoxyphenyl-1-(9-hydroxy-propan-7-one) 
which is also a known metabolite (Kim et al., 2011) but has been 
isolated for the first time from our investigated source. 
HO
OCH3
O
74
OH
 
Figure. 2.6: 1H-1H COSY ( ) and 1H-13H HMBC ( ) interactions 
observed in the spectra of 74. 
2.4.7. Characterization of 4-Hydroxy-3-methoxyphenyl-7,8,9- 
Propanetriol (75) 
 Compound 75 was also obtained as white amorphous powder 
and was found to be the derivative of 74. The EIMS spectrum of 75 
exhibited the molecular ion peak at m/z 214, 
the molecular formula C10H14O5 with four DBE 
could be determined through HR-EIMS. The IR 
spectrum missed the absorption band for a 
ketonic function as was observed in the spectrum of 74, however, the 
absorption bands for hydroxyl function and aromatic moiety were seen 
nearly at the same positions. The 1H-NMR spectrum (Table 2.5) showed 
the similar signals in aromatic region as were observed for compound 
74, with the difference that the spectrum showed two oxymethine 
signals at δ 4.51 (1H, d, J = 6.0 Hz) and δ 3.72 (1H, q, J = 5.8). Both 
the methines showed mutual correlation in the COSY spectrum, 
whereas, the oxymethine at δ 3.72 was further correlated with an 
oxymethylene at δ 3.58 (1H, dd, J = 11.4, 7.2) and 3.47 (1H, dd, J = 
OH
OH
OH
HO
OCH3
75
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11.4, 4.2). This data indicated that ketonic group in 74 has been 
reduced to an alocoholic function in 75. This deduction was 
substantiated through the 13C-NMR spectrum (Table 2.5), which 
showed five signals for methine carbons at δ 121.0, 115.8, 111.8, 77.6 
and 75.0, one signal for oxymethylene carbon at δ 64.5, three 
quaternary carbon at δ 148.8, 147.1 and 134.8 and one signal for 
methoxyl carbon at  56.6. This data confirmed that ketonic function in 
74 has been reduced to secondary alcohol in 75, whereas, one 
methylene in 74 has been oxidized to another hydroxyl function. Based 
on these observations, compound 75 was finally characterized as 4-
hydroxy-3-methoxyphenyl-7,8,9-propanetriol which is also a known 
phytochemical (Dellagreca et al., 1998; Warashina et al., 2005) but has 
been purified for the first time from Vincetoxicum stocksii. 
2.4.8. Characterization of Feruloyl-6'-O--D-glucopyranoside (76) 
 Compound 76 showed characteristic IR absorption bands at 
3442, 1710, 1655, 1608 and 1540 
for hydroxyl function, carbonyl 
group, olefinic system and aromatic 
moiety respectively. The EIMS 
spectrum of 76 showed the molecular ion peak at m/z 356, while the 
HR-EIMS analysis of the same ion peak (m/z 356.1646) depicted the 
molecular formula C16H20O9 with seven DBE.  
The 1H-NMR (Table 2.5) showed few similar signals splitted at the 
same ABX pattern in aromatic region as was observed for 74, in 
O
OCH3
HO
O
HO
HO
OH
OH
O
76
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addition two doublets resonated at δ 7.63 (1H, d, J = 16.0 Hz) and δ 
6.41 (1H, d, J = 16.0 Hz) were attested for a trans double bond. This 
observation indicated the caffeoyl-derived molecular nature of 76. The 
spectrum also displayed a doublet due to an anomeric proton at δ 5.10 
(1H, J = 7.0 Hz), which was attributed to a β-hexose moiety. The other 
signals of sugar moiety displayed their positions at δ 3.95 (1H, d, J = 
6.5), 3.74 (1H, dd, J = 13.0, 4.9 Hz), 3.66 (1H, dd, J = 13.0, 2.6 Hz), 
3.56 (1H, t, J = 7.0 Hz), 3.46 (1H, m), 3.16 (1H, m), whereas, a 
resonance due to methoxyl proton was seen at  3.89.  
The 13C-NMR spectrum (Table 2.5) showed total 16 signals which 
were distinguished as ten methine (δ 146.9, 124.5, 116.9, 115.6, 111.7, 
98.2, 78.3, 77.6, 75.5, 72.0), one methylene (δ 64.6) and four 
quaternary carbon (δ 169.1, 150.6, 147.3 and 127.7) based on the 
DEPT experiment. Various positions of functional groups were carefully 
identified and connected through HMBC and COSY correlations. The 
methylene  3.74 and 3.66 of sugar moiety showed the HMBC 
correlation with the carbonyl carbon at δ 169.1 (C-9), which confirmed 
the aglycon and glycon linkage at C-6 of sugar moiety instead of at C-1. 
This observation resolved the issue of most of the double signals in 
NMR spectra that anomerization in solution form was responsible for 
the resonances of all double signals. However, the sugar moiety was 
finally identified as glucose due to acid hydrolysis of 76 and its 
comparison with the standard sample of sugar as is described in 
compound 70. On the base of above discussion and comparison with 
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77
H3C
CH3
CH3
OH
OH
CH3
OH
HO
the reported data the compound 76 was identified as feruloyl-6-O--D-
glucopyranoside, which is a known phytochemical (Dallacqua and 
Innocenti 2004), however, has been isolated first time from our 
investigated source. 
  Table. 2.5: 1H and 13C-NMR data of 75 (CD3OD; 600 and 150 MHz) and 76 
(CD3OD; 400 and 100 MHz). 
 75 76 
Position δH (J in Hz) δc δH(J in Hz) δc 
1 - 134.8 - 127.7 
2 6.99 (1H, d, 2.0) 111.8 7.17 (1H, d, 2.0) 111.7 
3 - 148.8 - 147.3 
4 - 147.1 - 150.6 
5 6.74 (1H, d, 8.0) 115.8 6.85 (1H, d, 8.0) 116.9 
6 6.81 (1H, dd, 8.0, 2.0) 121.0 7.06 (1H, d, 8.0, 2.0) 124.5 
7 4.51 (1H, d, 6.0) 75.0 7.63 (1H, d, 16.0) 146.9 
8 3.72 (1H, q, 5.8) 77.6 6.41 (1H, d, 16.0) 115.6 
9 3.58 (1H, dd, 11.4, 7.2), 
3.47 (1H, dd, 11.4, 4.2) 
64.5 - 169.1 
3-OMe 3.89 (3H, s, OMe) 56.6 3.92 (3H, s, OMe) 56.8 
1'   5.10 (1H, d, 7.0) 98.2 
2'   3.56 (1H, t, 7.0) 75.5 
3'   3.16 (1H, m) 72.0 
4'   3.95 (1H, d, 6.5) 77.6 
5'   3.46 (1H, m) 78.3 
6'   3.74 (1H, dd, 13, 4.9), 
3.66 (1H, dd, 13, 2.6) 
64.6 
 
2.4.9. Characterization of 7-Megastigmene-2,3,5,9-tetrol (77) 
 Compound 77 was obtained as white 
amorphous solid, which exhibited diagnostic 
IR bands at 3350 and 1655 cm-1 due to 
hydroxyl function and double bond 
respectively. The EIMS spectrum showed the 
molecular ion peak at m/z 244, whereas, the molecular formula 
C13H24O4 with two DBE was calculated through HR-EIMS (m/z 
244.1742 [M]+).  
Chapter 2                                   Characterization of the Compounds Isolated from V. stocksii                                                                                  
 
46 
 
 The 1H-NMR spectrum (Table 2.6) showed the most down field 
signals at δ 6.07 (1H, d, J = 15.6 Hz) and 5.80 (1H, dd, J = 15.6, 6.4 
Hz) attested for a trans-olefin. The spectrum also showed signals for 
two oxymethine protons at δ 4.34 (1H, m), 4.07 (1H, m). The first 
oxymethine signal was correlated in COSY spectrum with two 
methylene δ 1.75 (2H, br., d) and 1.63 (1H, dd, J = 14.4, 6.0 Hz) and 
1.44 (1H, dd, J = 14.4, 3.6 Hz), whereas, other showed correlation with 
a secondary methyl at δ 1.25 (d, J = 6.6 Hz). In addition, signals for 
three tertiary methyls were see at δ 1.12, 1.21 and 0.83.  
 The 13C-NMR (Table 2.6) showed 13 signals, which were identified 
as four methine (δ 136.1, 131.2, 69.5 and 65.2), two methylene (δ 46.4 
and 45.7), four methyl (δ 27.5, 27.0, 26.2 and 24.1) and three 
quaternary carbons (δ 79.4, 78.0 and 40.0). This data led to the 
tentative structure of 77 as an ionol derivative (Murai et al., 1992; 
Otsukaa et al., 2003). However, the structure was finally confirmed 
through HMBC experiment (Figure 2.7), in which two tertiary methyls ( 
1.21 and 0.83) were correlated with each other and with other two 
common carbons ( 78.0, 65.2 and 40.0) indicating their geminal 
nature and presence at C-1. The secondary methyl was correlated in 
HMBC spectrum with the oxymethine carbon at  69.5 (C-9) and 
olefinic methine carbon at  136.1 (C-8). This observation helped to 
identify the position of double bond. The tertiary methyl ( 1.12) 
exhibited HMBC correlations with two oxygenated quaternary carbons 
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OH
O
OH
78
at  79.4 and a methylene at  45.7. This analysis fixed the position of 
two hydroxyl groups at C-2 and C-3.  
H3C
CH3
CH3
OH
OH
CH3
OH
HO
77
 
Figure. 2.7: 1H-1H COSY ( ) and 1H-13H HMBC ( ) interactions 
observed in the spectra of 77. 
 Combination of above spectroscopic data led to structure of 77 as 
7-megastigmene-2,3,5,9-tetrol, which is a known metabolite and has 
been isolated for the first time from this plant (Murai et al., 1992; 
Otsukaa et al., 2003). 
2.4.10. Characterization of 4-Hydroxyphenylacetic Acid (78)  
 Compound 78 was obtained as white crystalline 
solid, which exhibited a broad absorption band at 
2420-3410 cm-1 due to chelated hydroxyl of a 
carboxylic acid function, with carbonyl carbon 
absorbed at 1720 cm-1. The HR-EIMS spectrum showed 
the molecular ion peak at m/z 152.4216 corresponding to the 
molecular formula C8H8O3 with five DBE. 
 Aromatic region of the 1H-NMR (Table 2.6) showed two signals at 
δ 7.08 (2H, d, J = 8.4 Hz) and 6.08 (2H, d, J = 8.4 Hz), which were 
attributed to a p-substituted benzene ring. In addition, the spectrum 
displayed resonance of a singlet methylene at δ 3.47.  
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The 13C-NMR (Table 2.6) fully supported the mass and 1H-NMR 
data as it showed total 8 signals at δ 176.2, 157.4, 131.3, 126.8, 116.2 
and 41.1. The HMBC correlations (Figure 2.8) of methylene at δ 3.47 
with the carbons at δ 176.2, 131.3 and 126.8 confirmed its presence 
between aromatic system and carbonyl carbon. Also the HMBC 
interaction of an aromatic proton at δ 7.08 with the methylene carbon 
at δ 41.1 substantiated the above deduction.  
OH
O
OH
78
 
Figure. 2.8: Important 1H-13H HMBC ( ) interactions observed in 
the    spectra of 78. 
Based on the above data, the compound 78 was identified as 4-
hydroxyphenylacetic acid, which is a known metabolite (Hareland et al., 
1975) but has been isolated for the first time from this plant. 
2.4.11. Characterization of 4-Hydroxy-3,5-dimethoxybenzoic Acid 
(79)  
 The IR spectrum of 79 was also an indicative of its carboxylic 
acid nature as it showed absorption bands at 
2410-3400 and 1705 cm-1 due to carboxylic acid 
function. Other characteristic absorptions were 
observed at 1605 and 1570 cm-1 due to an 
aromatic system. The EIMS of 79 showed molecular ion peak at m/z 
OH
O
HO
H3CO
OCH3
79
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198, whereas, the HR-EIMS (m/z 198.2134) depicted the molecular 
formula as C9H10O5 with five DBE.  The 1H-NMR spectrum of 79 (Table 
2.6) displayed only two singlets at δ 7.32 and 3.88 corresponding to an 
aromatic system and methoxyl units. The 13C-NMR (Table 2.6) showed 
total seven signals appeared at δ 170.3, 148.8, 142.2, 122.4, 108.4 and 
56.8. This data indicated that compound 79 was derivative of gallic 
acid, therefore the whole data was compared with the reported values 
(Tung et al., 2007) and the compound was finally identified as 4-
hydroxy-3,5-dimethoxybenzoic acid, which has been reported for the 
first time from our investigated source.  
Table. 2.6: 1H and 13C-NMR data of 77 (CD3OD; 600 and 150 MHz), 78 (CD3OD; 
400 and 100 MHz) and 79 (CD3OD; 500 and125 MHz).  
 77 78 79 
Position δH (J in Hz) δc δH(J in Hz) δc δH(J in Hz) δc 
1 - 40.0 - 126.8 - 122.4 
2 - 78.0 7.08 (1H, d, 8.4) 131.3 7.32 (1H, s) 108.4 
3 - 79.4 6.08 (1H, d, 8.4) 116.2 - 148.8 
4 1.75 (2H, br., d) 45.7 - 157.4 - 142.2 
5 4.07 (1H, m) 65.2 6.08 (1H, d, 8.4) 116.2 - 148.8 
6 1.63 (1H, dd, 14.4, 6.0), 
1.44 (1H, dd, 14.4, 3.6) 
46.4 7.08 (1H, d, 8.4) 131.3 7.32 (1H, s) 108.4 
7 6.07 (1H, d, 15.6) 131.2 3.47 (2H, s) 41.1 - 170.3 
8 5.80 (1H, dd, 15.6, 6.4) 136.1 - 176.2   
9 4.34 (1H, m) 69.5     
10-Me 1.25 (3H, d, 6.6, CH3) 24.1     
11-Me 1.12 (3H, s, CH3) 27.0     
12-Me 1.21 (3H, s, CH3) 26.2     
13-Me 0.83 (3H, s, CH3) 27.5     
3,5-
OMe 
    3.88 (6H, s, 
2OMe) 
56.8 
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2.4.12. Characterization of 4'-Methoxy Kaempferol-3-O--D- 
glucopyranoside (80) 
 Compound 80 was obtained as yellowish amorphous powder, 
which exhibited absorption maxima 
at 236, 257, 245, 314 and 357 nm 
as a characteristic pattern of 
kaempferol or quercetin glycoside 
(Mabry et al., 1970; Saleh et al., 
1990). The IR spectral analysis revealed hydroxyl function and aromatic 
system, while the molecular formula C22H23O11 was calculated through 
HR-FAB-MS (Positive mode) due to a pseudo-molecular ion peak at m/z 
463.4123.  
 The 1H-NMR (Table 2.7) showed four signals in the aromatic 
region in which two pairs of ortho coupled protons resonated at δ 8.05 
(2H, d, J = 8.5 Hz) and 6.89 (2H, d, J = 8.5 Hz) and two pairs of meta 
coupled protons appeared at δ 6.23 (1H, d, J = 2.0 Hz) and 6.20 (1H, d, 
J = 2.0 Hz). The same spectrum also displayed resonance due to an 
anomeric proton at δ 5.25 (1H, d, J = 8.4 Hz) with other sugar protons 
displayed their positions at δ 3.60 (1H, m), 3.53 (2H, dd, J = 10.5, 4.5 
Hz), 3.41 (1H, d, J = 6.6 Hz), 3.40 (1H, m), 3.35 (1H, dd, J = 10.5, 2.9 
Hz) and 3.20 (1H, m). A signal of three hydrogen at δ 3.62 (s) was 
attributed to a methoxyl group.  
The 13C-NMR (Table 2.7) of compound 80 showed 20 carbon 
signals, which were attested for 22 carbons. Aromatic methine carbon 
O
OH
HO
O
OCH3
O
OH
OH
HO
O
OH
80
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signals were observed at δ 132.2, 116.0, 99.9 and 94.7, while the sugar 
carbons displayed their positions at δ 104.1, 78.4, 78.0, 75.7, 71.4, 
63.0. The methoxyl carbons resonated at δ 51.4. The remaining nine 
quaternary carbons displayed their positions at δ 179.1, 165.0, 162.0, 
159.8, 159.0, 158.0, 134.0, 124.0 and 105.0. This data was 
superimposable to the data reported for 4'-methoxy-kaempferol-3-O--
D-glucopyranoside, thus compound 80 was found to be the same 
(Calderón-Montañ et al., 2011). 
2.4.13. Characterization of 4'-Methoxy Kaempferol-3-O--L-
rhamnopyranoside (81) 
 The IR and UV data of compound 81 was identical to that of 
compound 80 as an indication of 
flavonoid glycoside nature of this 
compound. The molecular formula 
C23H25O10 was calculated through 
positive HR-FAB-MS, which exhibited 
pseudo-molecular ion peak at m/z 447.4308.  
 The 1H-NMR data (Table 2.7) of 81 was also identical to that of 
80 with the only difference that in compound 80, the sugar was found 
to be glucose, whereas, in 81, rhamnose was observed due to the 
resonance of a doublet methyl at δ 1.23 (J = 7.2 Hz). The anomeric 
proton appeared as a broad singlet to support -L-rhamnoside.  
 The acid hydrolysis of 81 provided two products, which were 
separated by solvent extraction. The EtOAc layer contains aglycone part 
O
OH
HO
O
OCH3
81
O
OH
OH
O
CH3
HO
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and water soluble glycone part was separated and purified by using 
preparative thin layer chromatography developing at solvent system 
EtOAc:MeOH:H2O:AcOH (4:2:2:2). It was identified as -rhamnose due 
to comparison of the retention times of their trimethylsilyl (TMS) with 
that of the standards in gas chromatography (GC) and their optical 
rotation values [α]D23 +7.7˚ (c, 0.2 in H2O) (Liocharova et al., 1989). 
Finally the data was compared with the literature values and 81 was 
identified as 4'-methoxy-kaempferol-3-O--L-rhamnopyranoside 
(Calderon-Montan et al., 2011).  
    Table. 2.7: 1H and 13C-NMR data of 80 (CD3OD; 500 and 125 MHz), 81 
(CD3OD; 600 and 150 MHz). 
 80 81 
Position δH(J in Hz) δc δH(J in Hz) δc 
1 - - - - 
2 - 158.0 - 159.1 
3 - 134.0 - 135.3 
4 - 179.1 - 179.1 
4a - 105.0 - 105.1 
5  159.8  163.2 
6 6.20 (1H, d, 2.0) 99.9 6.18 (1H, d, 2.0) 100.1 
7 - 165.0 - 165.8 
8 6.23 (1H, d, 2.0) 94.7 6.35 (1H, d, 2.0) 94.9 
8a - 159.0 - 158.2 
1' - 124.0 - 122.1 
2' 8.05 (1H, d, 8.5) 132.2 7.76 (1H, d, 8.4) 131.8 
3' 6.89 (1H, d, 8.5) 116.0 6.93 (1H, d, 8.4) 116.5 
4' - 162.0 - 162.9 
5' 6.89 (1H, d, 8.5) 116.0 6.93 (1H, d, 8.4) 116.5 
6' 8.05 (1H, d, 8.5) 132.2 7.76 (1H, d, 8.4) 131.8 
1'' 5.25 (1H, d, 8.4) 104.1 5.34 (1H, br., s) 103.5 
2'' 3.20 (1H, m) 78.4 3.31 (1H, m) 71.9 
3'' 3.40 (1H, m) 75.7 3.71 (1H, m) 72.1 
4'' 3.41 (1H, d, 6.6) 71.4 3.33(1H, m) 73.2 
5'' 3.60 (1H, m) 78.0 3.38 (1H, m) 72.0 
6'' 3.53 (1H, dd, 10.5, 4.5), 
3.35 (1H, dd, 10.5, 2.9) 
63.0 1.23 (1H, d, 7.2) 17.6 
4'-OMe 3.62 (3H, s, OMe) 51.4 3.93 (3H, s, OMe) 56.4 
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2.4.14. Characterization of Quercetin-3-O--L-rhamnopyranoside 
(82) 
 Compound 82 was also obtained as yellowish amorphous 
powder, whose molecular formula 
C22H25O11 was calculated through 
positive HR-FAB-MS (m/z 449.3816 
[M+H]+). The IR and UV data was 
identical to that of compounds 80 and 
81 telling the same nature of 82. 
 The aromatic region of the 1H-NMR spectrum (Table 2.8) of 82 
showed five signals at 7.32 (1H, d, J = 2.4 Hz), 7.30 (1H, dd, J = 8.5, 
2.4 Hz), 6.90 (1H, d, J = 8.5 Hz), 6.35 (1H, d, J = 1.8 Hz) and 6.18 (1H, 
d, J = 1.8 Hz). First three signals splitted at ABX pattern were 
attributed to ring B of flavonoid skeleton, while others were attested for 
ring A. This information revealed that compound 82 must have a 
quercetin moiety as aglycon part, whereas, the sugar was characterized 
as rhamnose due to the resonance of anomeric proton at δ 5.34 (1H, s) 
and methyl doublet at δ 0.94 (d, J = 6.8 Hz). The spectrum showed four 
signals of oxymethine were observed at δ 4.21(1H, br, s), δ 3.75 (1H, 
dd, J = 9.0, 4.5 Hz), δ 3.34 (1H, m) and a doublet was present at δ 3.41 
(1H, d, J = 6.0 Hz). The 13C-NMR spectrum (Table 2.8) supported the 
above information as it showed 23 carbon signals at δ 179.6, 165.8, 
163.2, 159.3, 158.9, 149.7, 146.4, 136.2, 123.0, 122.9, 117.0, 116.4, 
105.9, 103.5, 99.8, 94.7, 73.3, 72.1, 72.0, 71.9 and 18.2. The whole 
data was identical to that of reported for qurcetain-3-O--L-
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rhamnopyranoside (Poumale et al., 2008), therefore, compound 82 was 
found to be the same.  
2.4.15. Characterization of 4'-Methoxy Quercetin-3-O--L- 
rhamnopyranoside (83) 
 Compound 83 was found to be 4'-methoxy-derivative of 82 as it 
displayed similar signals in NMR spectra 
(Table 2.8) with the additional signal of 
methoxyl group (δH 3.92 and δC 56.3), 
which was further confirmed due to the 
determination of molecular formula as 
C22H23O11 based on the positive HR-FAB-MS, (m/z 463.4261 [M+H]+). 
 It was also a known phytochemical (Bolzani et al., 1996) but has 
been isolated for the first time from our investigated source. 
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     Table. 2.8: 1H and 13C-NMR data of 82 and 83 (CD3OD; 600 and 150 MHz).  
 82 83 
Position δH (J in Hz) δc δH (J in Hz) δc 
1 - - - - 
2 - 159.3 - 159.3 
3 - 136.2 - 136.2 
4 - 179.6 - 179.6 
4a - 105.9 - 105.9 
5  163.2 - 163.2 
6 6.18 (1H, d, 1.8) 99.8  6.19 (1H, d, 1.8) 99.8 
7 - 165.8 - 165.9 
8 6.35 (1H, d, 1.8) 94.7 6.36 (1H, d, 1.8) 94.7 
8a - 158.9 - 158.5 
1' - 123.0 - 122.9 
2' 7.32 (1H, d, 2.4) 117.0 7.33 (1H, d, 2.0) 116.9 
3' - 146.4 - 147.6 
4' - 149.7 - 151.6 
5' 6.90 (1H, d, 8.5) 116.4 6.90 (1H, d, 8.4) 116.3 
6' 7.30 (1H, dd, 8.5, 2.4) 122.9 7.30 (1H, dd, 8.4, 2.0) 122.8 
1'' 5.34 (1H, s) 103.5 5.34 (1H, s) 103.5 
2'' 4.21 (1H, br., s) 71.9 4.11 (1H, br., s) 71.9 
3'' 3.75 (1H, dd, 9.0, 4.5) 72.1 3.73 (1H, dd, 9.3, 4.2) 72.1 
4'' 3.34 (1H, m) 73.3 3.30 (1H, m) 73.2 
5'' 3.41 (1H, d, 6.0) 72.0 3.40 (1H, d, 5.8) 72.0 
6'' 0.94 (1H, d, 6.8, CH3) 18.2 0.93 (1H, d, 6.4) 17.6 
4'-OMe - - 3.92 (3H, s, OMe) 56.3 
 
2.4.16. Characterization of Quercetin-3-O--D- glucopyranoside (84) 
and Quercetin-3-O--D- galactopyranoside (85) 
 Compounds 84 and 85 were also found to be the glycosides of 
quercetin as their NMR spectra (Table 2.9) displayed identical signals to 
that of 82 and 83. The difference was that compound 84 was found to 
be quercetin-3-O-glucoside, whereas, compound 85 was characterized 
as quercetin-3-O-galactoside due to their hydrolysis and comparison of 
the physic-chemical data of sugar moieties. Both the metabolites have 
already been isolated from various natural sources (Islam et al., 2012; 
Arora et al., 2005). 
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     Table. 2.9: 1H and 13C-NMR data of 84 and 85 (CD3OD; 400 and 100 MHz).  
 84 85 
Position δH(J in Hz) δc δH(J in Hz) δc 
1 - - - - 
2 - 159.0 - 159.0 
3 - 135.6 - 135.6 
4 - 179.6 - 179.5 
4a - 105.7 - 105.4 
5  162.9  163.0 
6  6.18 (1H, d, 2.0) 99.9 6.39 (1H, d, 2.0) 99.9 
7 - 165.9 - 166.1 
8 6.37 (1H, d, 2.0) 94.7 6.20 (1H, d, 2.0) 94.7 
8a - 158.8 - 158.5 
1' - 123.2 - 122.9 
2' 7.70 (1H, d, 2.4) 117.6 7.70 (1H, d, 2.4) 117.5 
3' -  145.8 - 145.9 
4' - 149.8 - 149.8 
5' 6.86 (1H, d, 8.5) 116.0 6.87 (1H, d, 8.8) 116.0 
6' 7.57 (1H, dd, 8.5, 2.4)  122.8 7.59 (1H, dd, 8.8, 2.4) 123.1 
1''  5.23 (1H, d, 7.6) 104.3  5.14 (1H, d, 7.6) 104.3 
2'' 3.47 (1H, m) 75.1 3.47 (1H, m) 75.7 
3''  3.34 (1H, m 71.2  3.34 (1H, m) 71.2 
4''  3.40 (1H, d, 6.0) 78.1  3.41 (1H, d, 2.9) 78.1 
5''  3.33 (1H, m) 78.3  3.33 (1H, m) 78.4 
6''  3.64 (1H, dd, 12.0, 4.8) 
 3.36 (1H, dd, 12.0, 2.9) 
62.5  3.64 (1H, dd, 12.0, 4.8) 
 3.36 (1H, dd, 12.0, 2.9) 
62.5 
 
2.4.17. Characterization of 7-Hydroxy-3',4',5-trimethoxyflavone 
(86)  
 Compound 86 was also found to 
be a flavonoid as it was obtained as 
yellowish amorphous powder, which 
exhibited molecular ion peak in the 
EIMS spectrum at m/z 328. The 
O
OMe
OOMe
HO
OMe
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molecular formula C18H16O6 was calculated through HR-EIMS (m/z 
328.3257 [M]+).  
 The 1H-NMR spectrum of compound 86 (Table 2.10) showed 
similar signals in aromatic region as were observed for quercetin 
derivatives, however, an additional singlet was observed at δ 7.25 
attested for H-3 of flavones nucleus. However, sugar signals were 
missing, instead three methoxyl groups appeared at δ 4.06, 3.97 and 
3.94. The 13C-NMR spectrum (Table 2.10) substantiated the above 
information as it displayed signals for a flavone nucleus and three 
methoxyl groups. The positions of the three methoxyl groups were fixed 
due to their HMBC correlations with the quaternary carbons at δ 149.5 
(C-4'), 149.0 (C-3') of ring B and 164.0 (C-5) of ring A. Further, this 
data was closely similar to the reported data for 7-hydroxy-3',4',5-
trimethoxyflavone, which is a known phytochemical (Lu et al., 2012), 
therefore, compound 86 was found to be the same, which has been 
reported for the first time from Vincetoxicum stocksii.  
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    Table. 2.10: 1H and 13C-NMR data of 86 (CDCl3 500 and 125 MHz).  
Position δH (J in Hz) δc 
1 - - 
2 - 160.0 
3  7.25 (1H, s) 105.0 
4 - 179.8 
4a - 104.3 
5 - 164.0 
6 6.48 (1H, d, 2.0) 100.0 
7 - 166.0 
8 6.21 (1H, d, 2.0) 95.0 
8a - 159.0 
1' - 123.0 
2' 7.51 (1H, d, 2.0) 120.2 
3' - 149.0 
4' - 149.5 
5' 6.94 (1H, d, 8.5) 117.0 
6' 7.01 (1H, dd, 8.5, 2.0) 113.0 
5-OMe 4.06 (3H, s, OMe) 56.0 
4'-OMe 3.94 (3H, s, OMe) 57.1 
5'-OMe 3.97 (3H, s, OMe) 57.4 
 
2.4.18. Characterization of β-sitosterol (87) 
 Compound 87 was purified as shining needles, which exhibited 
absorption bands in IR spectrum at 
3350 and 1655 cm-1 due to hydroxyl 
function and olefinic system. The 
molecular ion peak at m/z 414 was 
observed in EIMS spectrum with other 
characteristic fragment ions at m/z 399, 396, 381,329, 275, 273 and 
255 for a ∆5-sitosterol nucleus (Kamboj and Saluja 2011). 
 The 1H-NMR spectrum (Table 2.11) of 87 showed three secondary 
methyl signals at δ 0.95 (J = 6.1 Hz, 26-Me), 0.86 (J = 6.6 Hz, 27-Me) 
and 0.91 (J = 6.0 Hz, 21-Me), two tertiary methyl singlets at δ 0.77 (18-
Me) and 0.94 (19-Me) and a primary methyl triplet at δ 0.86 (J = 7.3 Hz, 
29-Me). The spectrum also displayed an olefinic proton resonance at δ 
HO
87
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5.35 (1H, d, J = 5.0 Hz) and an oxymethine at δ 4.56 (m) as 
characteristic information for β-sitosterol.  
The 13C-NMR spectrum (Table 2.11) of 87 was in complete 
agreement with mass and 1H-NMR data. Along with this information 
and its compariative TLC with standard sample of β-sitosterol, 
compound 87 was identified as β-sitosterol (Kamboj and Saluja 2011).  
Table. 2.11: 1H and 13C-NMR data of 87 (CD3OD; 500 and 125 MHz).  
87  
Position δ H (J in Hz) δ c Position δ H (J in Hz) δ c 
1 1.26 (2H, m) 38.3 16 1.58 (2H, m) 28.4 
2 1.77 (2H, m) 32.8 17 1.51 (1H, m) 55.2 
3 4.45 (1H, m) 78.4 18 0.77 (3H, s, Me) 12.9 
4 2.40 (2H, m) 44.4 19 0.94 (3H, s, Me) 19.8 
5 - 142.2 20 0.11 (1H, m) 36.7 
6 5.35 (1H, d, 5.0) 122.1 21 0.91 (3H, d, 6.0, Me) 19.4 
7 1.91 (4H, m) 33.1 22 1.76 (2H, m) 34.5 
8 - 32.6 23 1.29 (2H, m) 29.6 
9 1.42 (1H, m) 50.4 24 1.36 (1H, m) 50.8 
10 - 37.6 25 1.66 (1H, m) 27.2 
11 1.97 (4H, m) 20.1 26 0.95 (3H, d, 6.1, Me) 18.4 
12 1.13 (2H, m) 41.3 27 0.86 (3H, d, 6.6, Me) 19.6 
13 - 43.6 28 1.17 (2H, m) 24.1 
14 1.16 (1H, m) 57.8 29 0.86 (3H, t, 7.3, Me) 12.9 
15 1.10 (2H, m) 25.3    
 
2.4.19. Characterization of ß-sitosterol-3-O-D-glucopyranoside (88) 
 Compound 88 was isolated as a white amorphous powder, whose 
EIMS showed the 
molecular ion peak [M]+ at 
m/z 576. The IR spectrum 
exhibited absorption 
bands at 3455 cm-1 (OH) 
and 1615 cm-1 (C=C).  
O
HO
HO
OH
O
OH
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 The 1H-NMR spectrum (Table 2.12) of 88 showed similar signals 
as were observed in the spectrum of 87. However, addition signals were 
seen due to a sugar moiety at δ 4.51 (1H, d, 7.8), 3.65 (1H, m, H-2'), 
3.21 (1H, m, H-3'), 3.31 (1H, m, H-4'), 3.10 (1H, d, H-5') and methylene 
at δ 3.12 (1H, m, H-6'), 3.52 (1H, m, H-6'). The 13C-NMR spectrum of 88 
showed total 35 signals (Table 2.12), which were similar to the 
spectrum observed for β-sitosterol (87). These observations and 
comparision with the published values, compound 88 was found to be 
β-sitosterol-3-O-β-D-glucopyranoside, which is a known phytochemical 
(Akhtar et al., 2010).  
Table. 2.12: 1H and 13C-NMR data of 88 (CD3OD; 500 and 125 MHz).  
88  
Position δ H (J in Hz) δ c Position δ H (J in Hz) δ c 
1 1.24 (2H, m) 37.3 19 0.95 (3H, s, Me) 19.9 
2 1.72 (2H, m) 31.8 20 0.10 (1H, m) 36.8 
3 4.56 (1H, m) 79.4 21 0.99 (3H, d, 6.0, Me) 19.6 
4 2.39 (2H, m) 44.4 22 1.73 (2H, m) 34.7 
5 - 142.4 23 1.25 (2H, m) 29.8 
6 5.35 (1H, d, 5.0) 121.6 24 1.33 (1H, m) 50.7 
7 1.89 (4H, m) 34.1 25 1.69 (1H, m) 26.9 
8 - 32.6 26 0.94 (3H, d, 6.1, Me) 18.5 
9 1.39 (1H, m) 50.6 27 0.84 (3H, d, 6.6, Me) 19.7 
10 - 37.1 28 1.16 (2H, m) 24.6 
11 1.92 (4H, m) 20.5 29 0.87 (3H, t, 7.3, Me) 13.0 
12 1.09 (2H, m) 41.6 1' 4.51 (1H, d, 7.8) 102.4 
13 - 44.6 2' 3.65 (1H, m) 76.4 
14 1.14 (1H, m) 58.8 3' 3.21 (1H, m) 73.4 
15 1.08 (2H, m) 24.9 4' 3.31 (1H, m) 71.7 
16 1.56 (2H, m) 28.6 5' 3.10 (1H, m) 76.0 
17 1.49 (1H, m) 55.4 6' 3.12 (H, m), 3.52 
(1H, m) 
62.4 
18 0.74 (3H, s, Me) 13.0    
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2.5. BIOLOGICAL STUDIES OF THE EXTRACT OF VINCETOXICUM 
STOCKSII AND THE COMPOUNDS PURIFIED FROM THE SAME 
EXTRACT 
 The hexane and ethyl acetate soluble fractions of methanolic 
extract were evaluated for antiurease, antioxidant and antimicrobial 
activity. The ethyl acetate fraction was found significantly active (Table 
2.13 and 2.14). Therefore, pure compounds isolated from ethyl acetate 
fraction were also evaluated for their antiurease, antioxidant and 
antimicrobial activities. 
In an in vitro NO inhibition scavenging bioassay, the ethyl acetate 
soluble fraction showed antioxidant and antiurease activities with IC50 
values of 41±0.04 and 29±0.03 µg/ml (Table 2.13) respectively. 
Therefore, the purified compounds which were obtained in sufficient 
amounts 73, 75, 76, 79 and 84 were screened for NO inhibition 
scavenging potential. These compounds exhibited significant inhibition 
with IC50 values of 80.17±0.33, 150±0.5, 64.1±0.09, 56.42±0.04, 
89.33±0.1 µg/ml respectively (Table 2.13). It was therefore, concluded 
that the antioxidant activity of ethyl acetate fraction could be due to the 
presence of these metabolites, especially apocynin (73), feruloyl-6-O--
D-glucopyranoside (76) and derivate of gallic acid (79), which have 
already been reported as antioxidant in literature (Dallacqua and 
Innocenti 2004; Tung et al., 2007). 
 Further, compounds 69, 70, 75, 77, 79, 80 and 84 were also 
evaluated for antiurease activity, which showed moderate to significant 
inhibition with IC50 values of 85.8±0.01, 105.47±0.01, 22.1±0.43, 
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74.8±0.04, 93.4±0.01, 23.9±0.51 and 88.6±0.01 µg/ml respectively 
(Table 2.13). Remaining compounds were not evaluated for their 
activity due to the low amount.  
 As part of Structure-Activity Relationship (SAR), it is observed 
that a catechol or resorcinol-derived nucleus is required for antioxidant 
activity. However, substitution of hydroxyl group with methoxyl moiety 
causes a decrease in the activity. On the other hand, the metabolites 
like derivatives of ferulic acid, a conjugated carboxylate function is also 
important for the activity, which otherwise may decrease, as in case of 
compounds 75 and 76. 
 For aniturease activity, an uncertain trend was observed. Among 
69, 73, 75, 76 and 79, compound 75 exhibited significant activity 
when compared to other related phenolics. This observation revealed 
that a carboxylate or keto group is not necessary for the activity. In 
case of flavonoids (80 and 84), catechol moiety seems insignificant and 
however, a p-substituted aromatic ring B may play important role in 
inhibiting the enzyme activity.  
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 Table. 2.13: Antioxidant and antiurease activity of the isolated compounds. 
Sample code Antioxidant Antiurease 
IC50 (ug/ml) IC50 (ug/ml) 
Ethyl acetate fraction 41±0.04 29±0.03 
69 Nil 85.8±0.01 
70 Nil 105.47±0.01 
73 80.17±0.33 Nil 
75 150±0.5 22.1±0.43 
76 64.1±0.09 Nil 
77 Nil 74.8±0.04 
79 56.42±0.04 93.4±0.01 
80 Nil 23.9±0.51 
84 89.33±0.1 88.6±0.01 
Vit.C* 75.01±0.05 - 
Thioure* - 23.3±0.01 
*standard drug 
All the measurements were done in triplicate and statistical analysis was performed 
by Microsoft Excel 2003.  
Results are presented as mean  sem. 
 Six of the isolated compounds; 69, 70, 73, 79, 84 and 85 were 
further screened for their antibacterial activity. These compounds 
showed weak activity (Table 2.14). When compared to the activity of the 
crude ethyl acetate extract. The other compounds were not evaluated 
for their activity because of low amount. 
Table. 2.14: Antibacterial activity of isolated compounds. 
Sample 
Code 
%age activity at 100 ug/ml 
Bacillus 
Staphlococ
cus E.coli Psedumonas shigella 
Salmonella 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
EtOAc-
fraction 
31 31 36 215 118 128 
69 -2.73+0.03 7.94+0.002 15.44+ 0.03 5.42+0.002 
9.51+0.0
05 
15.02+0.000
7 
70 1.34+0.01 2.95+0.007 8.23+0.01 7.83+0.007 
25.16+0.
01 21.76+0.03 
73 1.89+0.01 13.6+0.001 21.30+0.001 14.60+0.04 32.19+0 21.82+0.007 
79 
-
5.00+0.032 10.0+0.002 6.42+ 0.003 6.75+0.03 
10.0+70.
001 12.77+0.004 
84 
-
1.88+0.033 5.65+0.007 22.33+ 0.02 7.24+0.02 -3.76+0 9.59+0.002 
85 -7.0+0.002 
7.11+0.000
7 29.09+ 0.002 3.46+0.01 
9.96+0.0
007 12.84+0.005 
Strepto
mycin* 65+0.01 74+0.005 71+0.005 65+0.06 80+0.006 66+0.04 
* standard drug  
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2.6. EXPERIMENTAL 
2.6.1. General Experimental Procedures 
Column chromatography (CC) was performed with silica gel (230-
400 mesh, E-Merck). Various fractions obtained from CC were monitored 
through TLC on aluminum sheets precoated with silica gel 60 F254 (20×20 
cm, 0.2 mm thickness; E-Merck). Further, the fractions and pure 
compounds were also monitored under UV lamp (254 and 366 nm) and by 
spraying with ceric sulfate followed by heating.  
The optical rotation values were measured on JASCO DIP-360 
polarimeter. The UV spectra were recorded in ethanol on JASCO V-650 
spectrophotometer (max in nm). IR spectra were measured on Shimadzu 
460 spectrometer (Duisburg, Germany). The 1H and 2D NMR (HMQC, 
HMBC and COSY) spectra were measured on Bruker spectrometer of 
AMX-400, 500 and 600 instrument using TMS as an internal reference. 
13C-NMR spectra were also recorded on the same machines operating at 
100, 125 and 200 MHz frequency. The EIMS, HR-EIMS and HR-FAB-MS 
were recorded on Finnigan (Varian MAT, Waldbronn, Germany) JMS H X 
110 with a data system and JMSA 500 mass spectrometers. The GC was 
performed on a Shimadzu gas chromatograph (GC-9A; Noisiel, France). 
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2.6.2. Plant Material 
 The aerial parts (leaves and branches) of Vincetoxicum stocksii 
were collected from Ziarat, Baluchistan, in September 2011 and were 
identified by Prof. Dr. Rasool Bakhsh Tareen, Department of Botany, 
University of Baluchistan, Quetta, Pakistan. Where a voucher specimen 
(RBT-VS-11) has been deposited in the herbarium. 
2.6.3. Extraction, Isolation and Identification  
 The plant was dried under shade for two weeks and was ground to 
semi-powder (8 kg). It was then extracted by dipping (thrice 12.0 L) in 
methanol at room temperature for 7 days. The extract was concentrated 
under educed pressure to get dark brown gummy material (200 g). The 
crude extract was evaluated for antiurease, antioxidant and antimicrobial 
activity. It was then suspended in distilled water (2.0 L) and was extracted 
with hexane and ethyl acetate. The n-hexane (40 gm) and ethyl acetate 
fraction (60 gm) was evaluated for antioxidant and antiurease activity and 
ethyl acetate showed significant activity that's why it was subjected to 
column chromatography over silica gel eluting with n-hexane, n-hexane–
ethyl acetate, ethyl acetate, ethyl acetate–methanol in increasing order of 
polarity to get twelve (V1-V12) fractions based on TLC profile.  
 The first two fractions V1 and V2 mainly contained lipid material and 
were not processed further, however, fraction V3 obtained at n-
hexane:ethyl acetate (7:3) on further chromatography under same 
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conditions gave compound 73 (26 mg). Other main fraction V4 obtained at 
n-hexane:ethyl acetate (6:4) was also chromatographed on silica gel 
column eluting in increasing order of polarity to get compound 74 (15 mg) 
and 87 (25 mg). Main fraction V5 and V6 obtained at n-hexane:ethyl 
acetate (5:5) and (4:6) when further chromatographed on silica gel eluting 
at n-hexane:ethyl acetate (4:6) fraction V5 gave 75 (25 mg) and fraction V6 
give compounds 69 (25 mg) and 71 (10 mg) as yellowish spot on T.L.C 
plate after using locating reagent. Fraction V7 obtained at n-hexane:ethyl 
acetate (3:7) was further chromatographed on silica gel eluting with n-
hexane:ethyl acetate to get five fraction subfractions VR1-VR5. The 
subfraction VR4 which was obtained at n-hexane:ethyl acetate (4:6) was 
chromatographed on silica gel eluting with n-hexane:ethyl acetaye in 
increasing order of polarity to give compounds 70 (30 mg) and 72 (18 mg) 
and VR5 gave compounds 84 (25 mg) and 85 (32 mg). 
 Fraction V8 which was obtained at n-hexane:ethyl acetate (2:8) was 
chromatographed on silica gel in increasing order of polarity to get 
compounds 76 (34 mg), 88 (34 mg) and 80 (27 mg). The fraction V9 
obtained at n-hexane:ethyl acetate (1:9) was further chromatographed on 
silica gel in increasing order of polarity to get subfrctions VS1-VS3. The 
subfractions VS2 and VS3 which were obtained at n-hexane:ethyl acetate 
(3.5:6.5) and (3:7) on eluting n-hexane:ethyl acetate in increasing order of 
polarity gave subfraction VS2 gave compounds 81 (17 mg), 82 (16 mg) and 
subfraction VS3 gave compound 86 (14 mg). 
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 Main Fraction V10 eluting with ethyl acetate:methonal (9.5: 0.5) give 
two fractions VX1 and VX2 which was chromatographed on silica gel 
eluting in increasing order of polarity to get compounds 77 (25 mg), 78 
(34 mg) and V11 give 83 (20 mg) and 79 (34 mg).  
Methanolic extract of vincetoxicum stocksii
Suspended in water
Hexane partWater part
Hexane
EtOAc
EtOAc partWater part
V1-Fr. V2 -Fr.
V3 -Fr. V4-Fr.
V5 -Fr. V6-Fr.
V7 -Fr.
V8 -Fr. V9 -Fr.
V10-Fr.
V11-Fr.
V12-Fr.
73 74
75 76
69 71
70 72
VS2 VS3
84 85
76 80
VR4 VR5
82 86
VX1 VX2
77 78
83
81
87
88
79
 
Scheme. 2.1: Extraction and isolation of secondary metabolites from 
Vincetoxicum Stocksii: V1. Fraction obtained in n-hexane:ethyl acetate(9:1), V2. 
Fraction obtained in n-hexane:ethyl acetate(8:2), V3. Fraction obtained in n-
hexane:ethyl acetate(3:7), V4. Fraction obtained in n-hexane:ethyl acetate(6:4), 
V5. Fraction obtained in n-hexane:ethyl acetate(5:5), V6. Fraction obtained in n-
hexane:ethyl acetate(4:6), V7. Fraction obtained in n-hexane:ethyl acetate (3:7), 
V8. Fraction obtained in n-hexane:ethyl acetate (2:8), V9. Fraction obtained in n-
hexane:ethyl acetate (1:9), V10. Fraction obtained in ethyl acetate(100%), V11. 
Fraction obtained in ethyl acetate: MeOH (9:1), V12. Fraction obtained in ethyl 
acetate: MeOH (8:2). 
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2.6.4. Spectroscopic Data of Isolated Compounds 
2.6.4.1. Spectroscopic data of vincetolate (69): white amorphous 
powder (25 mg); IR max (KBr) cm-1: 3505, 1730, 1610-1580; 1H-NMR 
(CD3OD; 500 MHz): δ 7.02 
(1H, d, J = 8.5 H-2, 6), 
6.73 (1H, d, J = 8.5, H-3, 
5), 4.07 (2H, t, J = 6.5 Hz, 
H-1'), 3.63 (2H, t, J = 6.5 Hz, H-14'), 3.49 (2H, s, H-7), 1.58 (2H, m, H-2'), 
1.50 (2H, m, H-13'), 1.40-1.22 (20H, br., s); 13C-NMR (CD3OD;125 MHz): δ 
174.2 (C-8), 158.4 (C-4), 131.7 (C-2, 6), 130.8 (C-1), 116.3 (C-3, 5), 65.8 
(C-1'), 64.6 (C-14'), 41.8 (C-7), 33.9 (C-13'), 30.0 (C-3',12'), 26.0 (C-2'); 
EIMS: m/z 364 [M]+; HR-EIMS: m/z 364.2416 [M]+ (364.2611 calcd. for 
C22H36O4). 
2.6.4.2. Spectroscopic data of vincetoside (70): white amorphous 
powder (30 mg); IR max (KBr) cm-1: 3385, 1655, 1300; 1H-NMR (CD3OD; 
500 MHz): δ 5.31 (1H, br., m, 
W1/2 = 20.8 Hz, H-27), 5.27 
(1H, br., m, W1/2 = 20.8 Hz, H-
28), 4.20 (1H, d, J = 7.0 Hz, H-1'), 3.99 (2H, t, J = 6.9 Hz, H-1), 3.95 (1H, 
dt, J = 6.0, 9.0 Hz, H-4'), 3.78 (1H, dd, J = 12.0, 2.6 Hz, H-6'), 3.76 (1H, 
dd, J = 12.0, 6.6 Hz, H-6'), 3.66 (1H, t, J = 9.0 Hz, H-2'), 3.46 (2H, m, H-
5'), 3.16 (1H, m, H-3'), 1.92 (2H, m, H-29), 1.90 (2H, m, H-26), 1.70 (2H, 
m, H-2), 1.30 (2H, m, H-30), 1.16-1.30 (br., s, H-3-25), 0.80 (3H, t, J = 6.6 
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Hz, Me); 13C-NMR (CD3OD; 125 MHz): δ 130.6 (C-27), 129.7 (C-28), 102.9 
(C-1'), 76.2 (C-5'), 74.3 (C-2'), 73.3 (C-3'), 72.2 (C-4'), 68.6 (C-1), 62.2 (C-
6'), 34.3 (C-2), 31.8 (C-29), 29.6-25.8 (C-3 to 26), 22.6 (C-30), 14.0 (C-31); 
FD-MS: m/z 612 [M]+; HR-FAB-MS: m/z 611.5239 [M-H]+ (611.4287 
calcd. for C37H72O6). 
2.6.4.3. Spectroscopic data of vincetetrol (71): white amorphous 
powder (10 mg); IR max (KBr) cm-1: 3510, 1760, 1605-1570; 1H-NMR 
(CD3OD; 500 MHz): δ 7.25 (1H, s, H-3), 6.66 (1H, s, 
H-6), 3.84 (OMe), 1.90 (Me); 13C-NMR (CD3OD; 125 
MHz): δ 171.4 (C-7, 8), 149.7 (C-2), 149.4 (C-5), 
138.2 (C-1, 4), 105.2 (C-6), 104.5 (C-3), 56.8 (OMe), 
23.7 (CH3); EIMS: m/z 240 [M]+; HR-EIMS: m/z 240. 2134 [M]+ (240.2646 
calcd. for C11H12O6). 
2.6.4.4. Spectroscopic data of vincetomine (72): white crystalline (18 
mg); IR max (KBr) cm-1: 3260, 1605-1570, 1601; 
1H-NMR (CD3OD; 600 MHz): δ 7.39 (2H, d, J = 
8.6 Hz, H-2, 6), 7.32 (1H, d, J = 8.5 Hz, H-2', 6'), 
7.10 (2H, d, J = 8.6 Hz, H-3, 5), 7.08 (1H, d, J = 
8.5 Hz, H-3', 5') 3.78 (2H, s, H-7), 3.62 (OMe), 8.49 (NH, s); 13C-NMR 
(CD3OD; 150 MHz): δ 153.9 (C-4), 137.6 (C-4'), 135.5 (C-1), 134.8 (C-1'), 
128.8 (C-2, 6, 2', 6'), 118.2 (C-3, 5), 116.4 (C-3', 5'), 39.9 (C-7), 51.4 
72
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(OMe); EIMS: m/z 213 [M]+; HR-EIMS: m/z 213. 1254 [M]+ (213.1346 
calcd. for C14H15NO). 
2.6.4.5. Spectroscopic data of apocynin (73): white amorphorus powder 
(26 mg); IR max (KBr) cm-1: 1715, 1590-1565 cm-1; 
1H-NMR (CD3OD; 500 MHz): δ 7.24 (1H, d, J = 2.0 
Hz, H-2), δ 7.14 (1H, dd, J = 8.4, 2.0 Hz, H-6), 6.50 
(1H, d, J = 8.4 Hz, H-5), 3.93 (OMe), 2.54 (Me); 13C-
NMR (CD3OD;125 MHz): δ 195.0 (C-7), 149.0 (C-4), 145.0 (C-3), 129.0 (C-
1), 124.0 (C-6), 113.7 (C-5), 109.6 (C-2), 56.0 (OMe), δ 26.2 (Me); EIMS: 
m/z 166 [M]+; HR-EIMS: m/z 166.1052 [M]+ (m/z 166.1456 calcd. for 
C9H10O3). 
2.6.4.6. Spectroscopic data of 4-Hydroxy-3-methoxyphenyl-1-(9-
hydroxy-propan-7-one) (74): white amorphous powder (15 mg); IR max 
(KBr) cm-1: 3750, 1700, 1610-1560; 1H-NMR 
(CD3OD; 500 MHz): δ 7.58 (1H, dd, J = 8.0, 2.0 
Hz, H-6), 7.54 (1H, d, J = 2.0 Hz, H-2), 6.86 (1H, 
d, J = 8.0 H-5), 3.94 (2H, t, J = 6.0 Hz, H-8), 3.89 
(OMe), 3.16 (2H, t, J = 6.0 Hz, H-9); 13C-NMR (CD3OD;125 MHz): δ 199.6 
(C-7), 153.3 (C-4), 149.0 (C-3), 130.6 (C-1), 124.7 (C-6), 115.7 (C-5), 111.8 
(C-2), 58.8 (C-9), 41.6 (C-8), 56.6 (OMe); EIMS: m/z 196 [M]+; HR-EIMS: 
m/z 196.2061 [M]+ (calcd. for C10H12O4, 196.2042). 
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2.6.4.7. Spectroscopic data of 4-Hydroxy-3-methoxyphenyl-7,8,9-
propanetriol (75): white amorphous powder (25 mg); 1H-NMR (CD3OD; 
600 MHz): δ 6.99 (1H, d, J = 2.0 Hz, H-2), 6.81 
(1H, d, J = 8.0, 2.0 Hz, H-6), 6.74 (1H, d, J = 8.0 
Hz, H-5), 4.51 (1H, d, J = 6.0 Hz, H-7), 3.72 (1H, 
q, J = 5.8, H-8), 3.58 (1H, dd, J = 11.4, 7.2), 3.47 
(2H, dd, J = 11.4, 4.2 Hz, H-9), δ 3.89 (OMe, s); 13C-NMR (CD3OD; 150 
MHz): δ 148.8 (C-3), 147.1 (C-4), 134.8 (C-1), 121.0 (C-6), 115.8 (C-5), 
111.8 (C-2), 77.6 (C-8), 75.0 (C-7), 64.5 (C-9), 56.6 (OMe); EIMS: m/z 214 
[M]+; HR-EIMS: m/z 214. 2246 [M]+ (214.2745 calcd. for C10H14O5). 
2.6.4.8. Spectroscopic data of Feruloyl-6'-O--D-glucopyranoside (76): 
white amorphous powder (34 mg); IR 
max (KBr) cm-1: 3542, 1710, 1655, 
1608-1540; 1H-NMR (CD3OD; 400 
MHz): δ 7.63 (1H, d, J = 16.0 Hz, H-7), 
7.17 (1H, d, J = 2.0 Hz, H-2), 7.06 (1H, d, J = 8.0, 2.0 Hz, H-6), 6.85 (1H, 
d, J = 8.0 Hz, H-5), 6.41 (1H, d, J = 16.0 Hz, H-8), 5.10 (1H, d, J = 7.0 Hz. 
H-1'), 3.95 (1H, d, J = 6.5), 3.74 (1H, dd, J = 13, 4.9), 3.66 (1H, dd, J = 13, 
2.6), 3.56 (1H, t, J = 7.0), 3.46 (1H, m), 3.16 (1H, m); 13C-NMR (CD3OD; 
100 MHz): δ 169.1 (C-9), 150.6 (C-4), 147.3 (C-3), 146.9 (C-7), 127.7 (C-1), 
124.5 (C-6), 116.9 (C-5), 115.6 (C-8), 111.7 (C-2), 98.2 (C-1'), 78.3 (C-5'), 
77.6 (C-4'), 75.5 (C-2'), 72.0 (C-3'), 64.6 (C-6'). 56.8 (OMe); EIMS: m/z 356 
[M]+; HR-EIMS: m/z 356.1646 [M]+ (356.1486 calcd. for C16H20O9). 
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2.6.4.9. Spectroscopic data of 7-Megastigmene-2,3,5,9-tetrol (77): 
white amorphous powder (25 mg); IR max (KBr) 
cm-1: 3350, 1655; 1H-NMR (CD3OD; 600 MHz): δ 
6.07 (1H, d, J =15.6 Hz, H-7), 5.80 (1H, dd, J 
=15.6, 6.4 Hz, H-8), 4.34 (1H, m, H-9), 4.07 (1H, 
m, H-5), 1.75 (2H, br., d, H-4), 1.63 (1H, dd, J = 14.4, 6.0 Hz), 1.44 (1H, 
dd, 14.4, 3.6 Hz), 1.25 (3H, d, J = 6.6 Hz, CH3), 1.21(3H, s, CH3),1.12 (3H, 
s, CH3), 0.83(3H, s, CH3); 13C-NMR (CD3OD; 150 MHz): δ 136.1 (C-8), 
131.2 (C-7), 79.4 (C-3), 78.0 (C-2), 69.5 (C-9), 65.2 (C-5), 46.4 (C-6), 45.7 
(C-4), 40.0 (C-1), 27.5 (C-13 Me), 27.0 (C-11 Me), 26.2 (C-12 Me), 24.1 (C-
10 Me); EIMS: m/z 244 [M]+; HR-EIMS: m/z 244.1742 [M]+ (244.1437 
calcd. for C13H24O4). 
2.6.4.10. Spectroscopic data of 4-Hydroxyphenylacetic acid (78): 
white amorphous powder (34 mg); IR max (KBr) cm-1: 
2420-3410, 1720; 1H-NMR (CD3OD; 400 MHz): δ 7.08 (1H, 
d, J = 8.4 Hz, H-2, 6), 6.08 (1H, d, J = 8.4 Hz, H-3, 5), 3.47 
(2H, s); 13C-NMR (CD3OD;100 MHz): δ 176.2 (C-8), 157.4 
(C-4), 131.3 (C-2, 6), 126.8 (C-1), 116.2 (C-3, 5), 41.1 (C-
7); EIMS: m/z 152.4365 [M]+.  
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2.6.4.11. Spectroscopic data of 4-Hydroxy-3,5-dimethoxybenzoic acid 
(79): white amorphous powder (34 mg); IR max (KBr) 
cm-1: 2410-3400, 1705, 1605 and 1570; 1H-NMR 
(CD3OD; 500 MHz): δ 7.32 (2H, s), 3.88 (6H, s); 13C-
NMR (CD3OD; 125 MHz): δ 170.3 (C-7), 148.8 (C-3, 
5), 122.4 (C-1), 142.2 (C-4), 108.4 (C-2, 6), 56.8 (OMe); EIMS: m/z 198 
[M]+; HR-EIMS: m/z 198.2134 [M]+ (198.4261 calcd. for C9H10O5). 
2.6.4.12. Spectroscopic data of 4'-Methoxy kaempferol-3-O--D-
glucopyranoside (80): yellowish 
amorphous powder (27 mg); UV max 
(max, 6.28 mM in CH3CN) nm (104M–1cm–
1): 236, 257, 245, 314 and 357 nm; IR 
max (KBr) cm-1: 3480, 1615–1520; 1H-
NMR (CD3OD; 500 MHz): δ 8.05 (2H, d, J = 8.5 Hz, H-2',6'), 6.89 (2H, d, J 
= 8.5 Hz, H-3', 5'), 6.23 (1H, d, J = 2.0 Hz, H-8), 6.20 (1H, d, J = 2.0 Hz, H-
8), 5.25 (1H, s), 3.88 (3H, s), 3.60 (1H, m), 3.53 (2H, dd, J = 10.5, 4.5), 
3.41(1H, d, J = 6.6), 3.40 (1H, m), 3.35 (1H, dd, J = 10.5, 2.9) 3.20 (1H, 
m); 13C-NMR (CD3OD;125 MHz): δ 179.1 (C-4), 165.0 (C-7), 162.0 (C-4'), 
159.8 (C-5), 159.0 (C-8a), 158.0 (C-2), 134.0 (C-3), 124.0 (C-1'), 132.2 (C-
2', 6'), 116.0 (C-3'. 5'), 105.0 (C-4a), 104.1 (C-1''), 99.9 (C-6), 94.7 (C-8), 
78.4 (C-2''), 78.0 (C-5''), 75.7 (C-3''), 71.4 (C-4''), 63.0 (C-6''), 51.4 (OMe); 
HR-FAB-MS: m/z 463.4123 [M+H]+ (463.4986 calcd. for C22H23O11). 
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2.6.4.13. Spectroscopic data of 4'-Methoxy kaempferol-3-O--L-
rhamnopyranoside (81): yellowish 
amorphous powder (17 mg); IR max 
(KBr) cm-1: 3480, 1615–1520; 1H-NMR 
(CD3OD; 600 MHz): δ 7.76 (2H, d, J = 8.4 
Hz, H-2',6'), 6.93 (2H, d, J = 8.4 Hz, H-3', 
5'), 6.35 (1H, d, J = 2.0 Hz, H-8), 6.18 (1H, d, J = 2.0 Hz, H-8), 5.34 (1H, 
br., s), 3.93 (OMe, s), 3.31 (1H, m), 3.71(1H, m), 3.38(1H, m), 3.33 (1H, 
m), 0.91 (3H, d, J = 7.2 Hz); 13C-NMR (CD3OD; 150 MHz): δ 179.1 (C-4), 
165.8 (C-7), 163.2 (C-5), 162.9 (C-4'), 159.1 (C-2), 158.2 (C-8a), 135.3 (C-
3), 131.8 (C-2', 6'), 122.1 (C-1'), 116.5 (C-3'. 5'), 105.1 (C-4a), 103.5 (C-1''), 
100.1 (C-6), 94.9 (C-8), 73.2 (C-4''), 72.1 (C-3''), 72.0 (C-5''), 71.9 (C-2''), 
17.6 (C-6''), 56.4 (OMe); HR-FAB-MS: m/z 447.4308 [M+H]+ (447.4248 
calcd. for C23H25O10). 
2.6.4.14. Spectroscopic data of qurcetain-3-O--L-rhamnopyranoside 
(82): yellowish amorphous powder (16 mg); 1H-NMR (CD3OD; 600 MHz): δ 
7.32 (1H, d, J = 2.4 Hz, H-2'), 7.30 (1H, 
dd, J = 8.5, 2.4 Hz H-6'), 6.90 (1H, d, J = 
8.5 Hz, H-5'), 6.35 (1H, d, J = 1.8 Hz, H-
8), 6.18 (1H, d, J = 1.8 Hz H-6), 5.34 (1H, 
br., s), 4.21 (1H, br., s), 3.75 (1H, dd, J = 
9.0, 4.5 Hz), 3.34 (1H, m), 3.41 (1H, d, J = 6.0), 0.94 (1H, d, J = 6.8); 13C-
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NMR (CD3OD; 150 MHz): δ 179.6 (C-4), 165.8 (C-7), 163.2 (C-5), 159.3 (C-
2), 158.9 (C-8a), 149.7 (C-4'), 146.4 (C-3'), 136.2 (C-3), 123.0 (C-1'), 122.9 
(C-6'), 117.0 (C-2'), 116.4 (C-5'), 105.9 (C-4a), 103.5 (C-1''), 99.8 (C-6), 
94.7 (C-8), 73.3 (C-4''), 72.1 (C-3''), 72.0 (C-5''), 71.9 (C-2''), 18.2 (C-6''); 
HR-FAB-MS: m/z 449.3816 [M+H]+ (449.3765 calcd. for C22H25O11). 
2.6.4.15. Spectroscopic data of 4'-Methoxy quercetin-3-O--L-
rhamnopyranoside (83): yellowish amorphous powder (20 mg); 1H-NMR 
(CD3OD; 600 MHz): δ 7.33 (1H, d, J = 
2.0 Hz, H-2'), 7.30 (1H, dd, J = 8.4, 2.0 
Hz, H-6'), 6.90 (1H, d, J = 8.4 Hz, H-5'), 
6.36 (1H, d, J = 1.8 ), 6.19 (1H, d, J = 
1.8 Hz, H-8), 5.34 (1H, s), 3.92 (3H, s), 
4.11 (1H, br., s), 3.73 (1H, dd, 9.3, 4.2), 3.40 (1H, d, 5.8), 3.30 (1H, m), 
0.93 (3H, d, J = 6.4); 13C-NMR (CD3OD; 150 MHz): δ 179.6 (C-4), 165.9 (C-
7), 163.2 (C-5), 159.3 (C-2), 158.5 (C-8a), 151.6 (C-4'), 147.6 (C-3'), 136.2 
(C-3), 122.9 (C-1'), 122.8 (C-6'), 116.9 (C-2'), 116.3 (C-5'), 105.9 (C-4a), 
103.5 (C-1''), 99.8 (C-6), 94.7 (C-8), 73.2 (C-4''), 72.1 (C-3''), 72.0 (C-5''), 
71.9 (C-2''), 17.6 (C-6''), 56.3 (OMe); HR-FAB-MS: m/z 463.4261 [M+H]+ 
(463.2265 calcd. for C22H23O11). 
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2.6.4.16. Spectroscopic data of quercetin-3-O--D- glucopyranoside 
(84): yellowish amorphous powder (25 
mg); 1H-NMR (CD3OD; 400 MHz): δ 7.70 
(1H, d, J = 2.0 Hz, H-2'), 7.57 (1H, dd, J 
= 8.5, 2.4 Hz, H-6'), 6.86 (1H, d, J = 8.5 
Hz, H-5'), 6.37 (1H, d, J = 2.0 Hz H-8), 
6.18 (1H, d, J = 2.0 Hz, H-6), 5.23 (1H, d, J = 7.6 Hz), 3.64 (1H, dd, J = 
12.0, 4.8), 3.47 (1H, m), 3.40 (1H, d, J = 6.0), 3.36 (1H, dd, J = 12.0, 2.9), 
3.34(1H, m), 3.33 (1H, m); 13C-NMR (CD3OD; 100 MHz): δ 179.6 (C-4), 
165.9 (C-7), 162.9 (C-5), 159.0 (C-2), 158.8 (C-8a), 149.8 (C-4'), 145.8 (C-
3'), 135.6 (C-3), 123.2 (C-1'), 122.8 (C-6'), 116.0 (C-5'), 117.6 (C-2'), 105.7 
(C-4a), 104.3 (C-1''), 99.9 (C-6), 94.7 (C-8), 78.3 (C-5''), 78.1 (C-4''), 75.1 
(C-2''), 71.2 (C-3''), 62.5 (C-6''); HR-FAB-MS: m/z 463.3561 [M+H]+ 
(463.4325 calcd. for C21H26O12). 
2.6.4.17. Spectroscopic data of quercetin-3-O--D-galactopyranoside 
(85): yellowish amorphous powder (32 
mg); 1H-NMR (CD3OD; 400 MHz): δ 
7.70 (1H, d, J = 2.4 Hz, H-2'), 7.59 (1H, 
dd, J = 8.8, 2.4 Hz, H-6'), 6.87 (1H, d, J 
= 8.8 Hz, H-5'), 6.39 (1H, d, J = 2.0 Hz 
H-8), 6.20 (1H, d, J = 2.0 Hz, H-6), 5.14 (1H, d, J = 7.6 Hz), 3.64 (1H, dd, J 
= 12, 4.8), 3.47 (1H, m), 3.41 (1H, d, J = 2.9), 3.36 (1H, dd, J = 12.0, 2.9), 
3.34 (1H, m), 3.33 (1H, m); 13C-NMR (CD3OD; 100 MHz): δ 179.5 (C-4), 
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166.1 (C-7), 163.0 (C-5), 159.0 (C-2), 158.5 (C-8a), 149.8 (C-4'), 145.9 (C-
3'), 135.6 (C-3), 129.9 (C-1'), 123.1 (C-6'), 117.5 (C-2'), 116.0 (C-5'), 105.4 
(C-4a), 104.3 (C-1''), 99.9 (C-6), 94.7 (C-8), 78.4 (C-5''), 78.1 (C-4''), 75.7 
(C-2''), 71.2 (C-3''), 62.5 (C-6''); HR-FAB-MS: m/z 463.3561 [M+H]+ 
(463.4325 calcd. for C21H26O12). 
2.6.4.18. Spectroscopic data of 7-Hydroxy-3',4',5-trimethoxyflavone 
(86): yellowish amorphous powder (14 mg); 1H-NMR (CD3OD; 500 MHz): δ 
7.51 (1H, d, J = 2.0 Hz, H-2'), 7.25 (1H, s), 
7.01 (1H, dd, J = 8.5, 2.0 Hz, H-6'), 6.94 (1H, 
d, J = 8.5 Hz, H-5'), 6.48 (1H, d, J = 2.0 Hz, 
H-6), 6.21 (1H, d, J = 2.0 Hz, H-8), 4.06 (3H, 
OMe), 3.97(3H, OMe), 3.94 (3H, OMe); 13C-
NMR (CD3OD; 125 MHz): δ 179.8 (C-4), 166.0 (C-7), 160.1 (C-2), 164.0 (C-
5), 159.0 (C-8a), 149.5 (C-4'), 149.0 (C-3'), 123.0 (C-1'), 120.2 (C-2'), 117.0 
(C-5'), 113.0 (C-6'), 105.0 (C-3), 104.3 (C-4a), 100.0 (C-6), 95.0 (C-8), 56.0 
(OMe), 57.1 (OMe), 57.4 (OMe); EIMS: m/z 328 [M]+; HR-EIMS: m/z 
328.3257 [M]+ (328.4256 calcd. for C18H16O6). 
2.6.4.19 Spectroscopic data of β-sitosterol (87): white amorphous 
powder (25 mg); 1H-NMR (CD3OD; 500 
MHz): δ 5.35 (1H, d, 5.0), 4.56 (1H, m), 
2.40 (2H, m),1.97 (4H, m), 1.91 (4H, m), 
1.77 (2H, m), 1.76 (2H, m), 1.66 (1H, m), 
1
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1
2
3
4
5
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7
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9
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12
13
14
15
16
17
1'
2'
3'
4'
5'
6'
O
18
19 20
21 22
23
24
28
29
25
26
27
O
OH
OH
88
HO
HO
1.58 (2H, m), 1.51 (1H, m), 1.42 (1H, m), 1.36 (1H, m), 1.29 (2H, m), 1.26 
(2H, m), 1.17 (2H, m), 1.13 (2H, m), 1.16 (1H, m), 1.10 (2H, m), 0.95 (3H, 
d, 6.1, Me), 0.94 (3H, s, Me), 0.91 (3H, d, 6.0, Me), 0.86 (3H, d, 6.6, Me), 
0.86 (3H, t, 7.3, Me), 0.77 (3H, s, Me), 0.11 (1H, m); 13C-NMR(CD3OD; 
125 MHz): δ142.2 (C-5), 122.2 (C-6), 78.4 (C-3), 57.8 (C-14), 55.2 (C-17), 
50.4 (C-9), 50.8 (C-24), 43.6 (C-13), 44.4 (C-4), 41.3 (C-12), 38.3 (C-1), 
37.6 (C-10), 36.7 (C-20), 34.5 (C-22), 33.1 (C-7), 32.8 (C-2), 32.6 (C-8), 
29.6 (C-23), 28.4 (C-16), 27.2 (C-25), 25.3 (C-15), 24.1 (C-28), 20.1 (C-11), 
19.8 (C-19),19.6 (C-27), 19.4 (C-21), 18.4 (C-26), 12.9 (C-29) and 12.9 (C-
18); EIMS: m/z 414, 399, 396, 381, 329, 275, 273, 255 [M]+. 
2.6.4.20 Spectroscopic data of ß-sitosterol-3-O-D-glucopyranoside 
(88): white amorphous powder 
(34 mg); IR max (KBr) cm-1: 
3455, 1615; 1H-NMR (CD3OD; 
500 MHz): δ 5.35 (1H, d, 5.0), 
4.56 (1H, m), 4.51 (1H, d, 7.8), 
3.65 (1H, m), 3.52 (1H, m), 3.21 (1H, m), 3.31 (1H, m), 3.12 (H, m), 3.10 
(1H, m), 2.39 (2H, m), 1.92 (4H, m), 1.89 (4H, m), 1.73 (2H, m), 1.72 (2H, 
m), 1.69 (1H, m), 1.56 (2H, m), 1.49 (1H, m), 1.39 (1H, m), 1.33 (1H, m), 
1.25 (2H, m), 1.24 (2H, m), 1.16 (2H, m), 1.14 (1H, m), 1.09 (2H, m), 1.08 
(2H, m), 0.99 (3H, d, 6.0, Me), 0.95 (3H, s, Me), 0.94 (3H, d, 6.1, Me), 0.87 
(3H, t, 7.3, Me), 0.84 (3H, d, 6.6, Me), 0.74 (3H, s, Me), 0.10 (1H, m); 13C-
NMR (CD3OD; 125 MHz): δ 142.4 (C-5), 121.6 (C-6), 79.4 (C-3), 58.8 (C-
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14), 55.4 (C-17), 50.6 (C-9), 50.7 (C-24), 44.6 (C-13), 44.4 (C-4), 41.6 (C-
12), 37.3 (C-1), 37.1 (C-10), 36.8 (C-20), 34.7 (C-22), 34.1 (C-7), 32.6 (C-
8), 31.8 (C-2), 29.8 (C-23), 28.6 (C-16), 26.9 (C-25), 24.9 (C-15), 24.6 (C-
28), 20.5 (C-11), 19.7 (C-27), 19.9 (C-19), 19.6 (C-21), 18.5 (C-26), 13.0 
(C-29) and 13.0 (C-18), 102.4 (C-1'), 76.4 (C-2'), 73.4 (C-3'), 71.7 (C-4'), 
76.0 (C-5'), 62.4 (C-6'); EIMS: m/z 576.4 [M]+. 
2.6.5. Acid Hydrolysis  
 A solution of the compounds under investigated (6 mg each) in 
MeOH (5 ml) containing 1N HCl (5 ml) was prepared and it was refluxed 
for 4 hour. After reflux it was concentrated under reduced pressure and 
diluted with H2O (10 ml). Extraction of extract was done with EtOAc and 
the residue recovered from the organic phase was found to be aglycone 
part of compounds. The aqueous part was concentrated and purified 
using preparative TLC using the solvent system (EtOAc:MeOH:H2O:AcOH, 
4:2:2:2) and identified as D-glucose, D-galactose and L-rhamnose by the 
sign of their optical rotations [α]D26 +50.2, [α]D23 +78 and [α]D23 +7.7˚ (c, 
0.2 in H2O), respectively. These sugars were also confirmed by the 
retention time of their TMS ether (D-glucose, -anomer, 5.0 min; D-
galactose, -anomer, 3.9 min; and L-rhamnose, 8.3 min) with the 
standards. 
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2.6.6. Bioassays  
2.6.6.1. Antioxidant (NO scavenging) assay 
 The 1mg/ml sample solution was prepared. In wells of plate the 178 
ml phosphate buffer solution along with 20 ml of sodium nitroprusside 
were added. These walls of plates were incubated at 37 ºC for 2 hours. The 
20 ml Griess reagent was added in each wells of plates for color 
development and this mixture was kept at room temperature for 20 
minutes. Absorbance was measured after color development on ELISA 
reader by using Gen 5 software at 490 nm and percentage inhibition was 
calculated by using the following formulae (Garret 1964).  
Percentage Inhibition = O.D of control - O.D of sample
O.D of control
x100
 
2.6.6.2. Antiurease assay (Berthelot method)  
 The 6 ml of phosphate buffer was added in 20 ml of urease enzyme 
and were dispended in wells of plates. It was incubated for 10 minutes at 
25 ºC and 5 ml of the test compound was added in it. the mixture was 
further incubated at room temperature and after that 15 ml of 20mM Urea 
was added. It was again incubated for 10 minutes at 25 ºC and 100 ml 
RGT 2 was added. After incubation at room temperature for 25 minutes, 
absorbance was measured on ELISA reader by using Gen 5 software at 
630 nm and percentage inhibition was calculated by using the following 
formulae. 
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Percentage Inhibition = O.D of control - O.D of sample
O.D of control
x100
 
*Control: No sample was added. 
*Negative control: No urea was added 
2.6.6.3. Antibacterial assay 
 The antibacterial activity was carried out in sterile 96-wells 
microplates. The method is based on the principle that microbial cell 
number increases as the microbial growth proceeds in the log phase of 
growth which results in increased absorbance of broth medium (Kaspady 
et al., 2009; Patel et al., 2009). Six bacterial strains were included in this 
study, Bacillus, Staphlococcus, E.coli, Psedumonas, shigella and 
Salmonella. The organisms were maintained on stock culture agar. The 
test samples were dissolved in suitable solvent. The initial absorbance of 
the culture was strictly maintained between 0.12-0.19 at 540 nm. The 
total volume in each well was kept to 200 µl. The incubation was done at 
37 oC for 16-24 hours with lid on the microplate. The absorbance was 
measured at 540 nm using Synergy HT Bio-Tek, USA microplate reader, 
before and after incubation and the difference was noted as an index of 
bacterial growth. The percent inhibition was calculated using the formula: 
Inhibition (%) = 100 (X–Y)/X 
where “X” is absorbance in control with bacterial culture and Y is 
absorbance in test sample. Streptomycin were taken as standard drug.
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3.1. THE GENUS SERIPHIDIUM  
 The genus Seriphidium belongs to the plant family Asteraceae. This 
genus consists of 140 species occurring predominantly throughout 
Europe, North Africa, Temperate Asia and Western North America. 
Literature search revealed that the two genera Seriphidium and Artemisia 
have identical genetic properties, but they are isolated and consider being 
different genera of the family Asteraceae (Deng et al., 2004; Watson et al., 
2002). 
3.2. PHARMACEUTICAL IMPORTANCE OF THE SERIPHIDIUM SP. 
 Many members of the genus Seripidium are important component of 
folk medicine system. In traditional medical system they are used for 
treatment of various diseases like antihelminthics, gastrointestinal, 
disorders diabetes and high blood pressure (Hayat et al., 2009). S. annua 
and S. indica are source of artemisinin (7), an anti-malarial drug, isolated 
from the aerial parts of these plants. It was found active against all the 
drug resistant strain of malarial parasites, plasmodium. The S. dubia has 
been used as anti-ulcer and purgative agents. It is also used to cure 
asthma and skin diseases like scabies. S. absinthium L. is source of 
anthelmintic, antifungal and antimicrobial agents. S. brevifolia is widely 
used as anthelmintic agent in ethno-veterinary medicinal system of 
Pakistan (Mahmood et al., 2011). S. kurramense is commercially used for 
extraction of santonin and transported to many countries for this purpose 
(Gilani et al., 2010).  
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3.3. PREVIOUS PHYTOCHEMICAL STUDIES OF THE GENUS 
SERIPHIDIUM 
 Literature search revealed several species of this genus have been 
studied for their secondary metabolites. For example S. santolium have 
been investigated for its secondary metabolites and was found to produce 
variety of compounds like apigenin-7-O-β-D-glucopyranoside-(3'-O-7")-
quercetin-3"-methyl ether (89), apigenin (90), luteolin (91), chrysoeriol 
(92), tricin (93), hispidulin (94), pectolinarigenin (95), eupatilin (96), 5,7-
dihydroxy-6,3',4',5'-tetramethoxyflavone (97), 5,7,4'trihydroxy-6,3',5'-
trimethoxyflavone (98), 3,6-O-dimethylquercetagetin-7O-β-D-glucoside 
(99), 6-hydroxy-5,7-dimethoxy-coumarin (100), taraxerol (101), taraxeryl 
acetate (102), β-sitosterol (103), stigmasterol (104), a series of the n-alkyl 
trans-p-coumarates (105-107), series of the n-alkyl trans-ferulates (108-
110), 2-hydroxy-4, 6, di-methoxyacetophenone (111), 4-hydroxy-2,6-
dimethoxyphenol-1-O-β-Dglucopyranoside (112) and 2-hydroxycinnamoyl-
β-D-glucopyranoside (113) (Deng et al., 2004). 
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 Luteolin (91) has been reported as anti-microbial, anti-oxidant and 
anti-inflammatory agent. In traditional medicinal system it is used against 
lung cancer, gastric cancer and acute myocardial infarction (Lopez-Lazaro, 
2008). Compound 93 acts as chemo-preventive agent (Deng et al., 2004; 
Jiao, et al., 2007), while hispidulin (94) was reported as anti-inﬂammatory 
and anti-oxidant agent (He et al., 2011). Pectolinarigenin (95) exhibit anti-
inflammatory and anti-allergic effect (Lim et al., 2008), whereas, eupatilin 
(96) displayed potent cytotoxicity and antitumor activity (Shawi et al., 
2011). β-sitosterol (103) and stigmasterol (104) have been reported as 
neutralizer for viper and cobra venom (Lim et al., 2008), while 4-
hydroxy,2,6-dimethoxyphenol-1-O-ß-D-glucopyranoside (112) has been 
reported as anti-estrogenic agent (Luecha et al., 2009).  
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 Balchanin (114), hydroxy costunolide (115), costunolide (116), 
balchanolide (117), balchanolide acetate (118) and hydroxy balchanolide 
(119) were reported from S. balchanorum Krasch. This plant contains 
another important metabolite vachanic acid (120), whereas, S. fragrans 
and S. taurica produced tauremisin (121) (Geissman and Irwin). 
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 Cumambrin A (122), B (123) and deoxycumambrin (124) were 
isolated from S. tripartia and S. nova. Other Seriphidium species; S. 
tridentata, S. cana pursh, S. juncea, S. lercheana and S. leucods are known 
to produce matricarin (125), deacetylmatricarin (126) and 
deacetyloxymatricarin (127) (Geissman and Irwin).  
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 Gallic acid (128), gallic acid methyl ester (129), 1,2,4,6-O-tetra-
gallolyl-β-D-glucpyranoside (130), 1,2,3,4,6-O-penta-galloyl-β-D-
glucopyranoside (131), quecetin-3-O-β-D-(2ʺ -galloyl)-glucopyranoside 
(132), quercetin-3-O-β-D-glucopyranoside (133), quercetin-3-O- -L-
arabinopyranoside (134) and kaempferol-3-O-β-D-glucopyranoside (135) 
were isolated from S. oliverianum. Compounds 129 and 131 exhibited 
strong DPPH radical scavenging activity with IC50 values of 3.0 and 2.8 
µM, respectively (Ho et al., 2012).  
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STRUCTURE ELUCIDATION OF SECONDARY METABOLITES 
ISOLATED FROM SERIPHIDIUM QUETTENSE 
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4.1. SERIPHIDIUM QUETTENSE 
 Seriphidium quettense is a woody shrub, growing up to 40-60 cm 
high. It is found in Hazarganji, Balochistan, Pakistan (Ghafoor 2002). 
4.1.1. Classification of the Seriphidium Quettense 
Kingdom Plantae 
Phylum Tracheophyta  
Class  Magnoliopsida  
Order  Asterales  
Family  Asteraceae  
Genus  Seriphidium  
Specie  Seriphidium quettense 
4.2. RESULTS AND DISCUSSION 
 The ethyl acetate fraction of methonalic extract of Seriphidium 
quettense was subjected to column chromatography which yielded 
seriphilidine (136) as a new compound along with seven known 
compounds; 6-hydroxy-8(10)-oplopen-14-one (137), salvigenin (138), 
cirsumaritin (139), p-coumaric acid (140), β-sitosterol (87), β-sitosterol-3-
O-D-glucopyranoside (88) and oleanolic acid (141). 
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4.2.1. Characterization of Seriphilidine (136) 
 Compound 136 was isolated as white amorphous powder, whose 
EIMS spectrum showed molecular ion peak at m/z 268 and molecular 
formula C16H28O3 with three double bond equivalents (DBE) was 
calculated through HR-EIMS (m/z 268.2435). 
The IR spectrum showed characteristic 
absorption bands at 3410 and 1645 cm-1 for 
hydroxyl and olefinic functions respectively.  
 The 1H-NMR spectrum (Table 4.1) of 136 showed two signals at δ 
5.53 (1H, ddd, J = 15.5, 9.5, 1.0 Hz) and 5.45 (1H, dd, J = 15.5, 7.0 Hz). 
The larger J value of these two nuclei depicted a trans nature of the 
olefinic system. Further, resonances due to four methine protons were 
observed at δ 5.05 (t, J = 5.0 Hz), 3.41 (br., s), 2.30 (m) and 1.75 (d, J = 
9.5). These protons were correlated in HSQC spectrum with the carbons at 
δ 105.5, 83.5, 57.2 and 31.4 respectively. This data revealed that the first 
methine could be an anomeric center, whereas, the second could be part 
of furan ring system. In addition, the same spectrum displayed signals of 
six protons at δ 1.89 (1H, d, J = 5.5 Hz), 1.85 (1H, d, J = 4.5 Hz), 1.78 (2H, 
m), 1.51 (1H, d, J = 4.5 Hz) and 1.37 (1H, d, J = 5.5 Hz) attested for three 
methylenes, whereas, resonances due to four methyl groups were 
observed at δ 1.08 (s), 1.02 (s), 0.97 (d, J = 6.5 Hz) and 0.96 (d, J = 6.5 
Hz). The doublet methyls showed COSY correlation with a methine 
multiplet at δ 2.30 and were attested for an isopropyl group. Another 
OH3CO
H3C
CH3H3C
CH3
OH
1
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signal of three hydrogen appeared at δ 3.93, which was attributed to a 
methoxyl group. 
The 13C-NMR spectrum (Table 4.1) of 136 was in full agreement 
with the 1H-NMR and mass data as it showed signals for six methine δ 
142.0, 122.5, 105.5, 83.5, 57.2 and 31.4, three methylene at δ 47.8, 39.5 
and 21.6, one methoxy at δ 56.0, four methyl at δ 31.0, 22.7, 22.7 and 
15.7 and two quaternary carbons at δ 72.3 and 46.0.  
Most of the part of this molecule could be established due to several 
COSY correlations (figure 4.1), whereas, the C-H connectivities were 
accomplished due to HSQC experiment. The position of various functional 
groups were fixed through HMBC analysis, in which two methyl groups (δ 
0.97, Me-13 and 0.96, Me-14) showed the HMBC correlations with C-12 (δ 
31.4), C-11 (δ 142.0) and also with each other. This information confirmed 
the presence of an isoprene unit in 136. The HMBC correlation of 
anomeric proton at δ 5.05 with the carbon at δ 83.5 (C-9) and 46.0 (C-4) 
confirmed the furan moiety. The HMBC correlation of methyl proton at δ 
1.02 (Me-16) with the carbon at δ 83.5 (C-9), 57.2 (C-5), 46.0 (C-4) and 
47.8 (C-3) and HMBC interaction of H-5 with Me-16 (δ 15.8) and C-11 (δ 
142.0) confirmed the potion of Me-16 and isopropyl moiety at C-5 (δ 57.2). 
Other important HMBC correlations are shown in figure 4.1.  
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Figure. 4.1: COSY (─) and important HMBC ( ) correlations observed 
in compound 136. 
 The relative stereochemistry at various chiral centers was 
established by detail examination of NOESY spectrum and deriding model. 
In the NOESY spectrum, (figure 4.2) H-2 (δ 5.05) showed the correlations 
with H-9 (δ 3.41) indicated that these groups or atoms were oriented on 
same side. Accordingly, Me-15 showed NOESY correlation with H-5 (δ 
1.75), which in turn exhibited NOESY interaction with H-9 (δ 3.41) set the 
orientation of these atoms or groups on the same side of molecule. The 
combination of all spectroscopic data helped us to establish structure 136 
and was identified as new natural product to which we propose the name 
seriphilidine. 
 
 
Figure. 4.2: NOESY correlation observed in compound 136. 
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 Table. 4.1: 1H and 13C-NMR data of 136 (CD3OD; 500 and 125 MHz).  
Position 136 
δH (J in Hz) δc 
1 - - 
2 5.05 (1H, t, 5.0) 105.5 
3 1.89 (1H, d, 5.5), 1.37 (1H, d, 5.5) 47.8 
4 - 46.0 
5  1.75 (1H, d, 9.5) 57.2 
6 - 72.3 
7  1.85 (1H, d, 4.5), 1.51 (1H, d, 4.5) 39.5 
8  1.78 (2H, m) 21.6 
9 3.41 (1H, br., s) 83.5 
10 5.53 (1H, ddd, 15.5, 9.5, 1.0) 122.5 
11 5.45 (1H, dd, 15.5, 7.0) 142.0 
12 2.30 (1H, m) 31.4 
13-Me 0.97 (3H, d, 6.5) 22.7 
14-Me 0.96 (3H, d, 6.5) 22.7 
15-Me 1.08 (3H, s, CH3) 31.0 
16-Me 1.02 (3H, s, CH3) 15.8 
2-OMe 3.93 (3H, s, CH3) 56.0 
 
4.2.2. Characterization of 6-Hydroxy-8(10)-oplopen-14-one (137)  
 Compound 137 was isolated as a white 
crystalline solid, which exhibited diagnostic 
absorption bands at 1715 and 3450 cm-1 for 
ketonic and hydroxyl groups respectively (Marco et 
al., 1993; Paolini et al., 2008). The EIMS spectrum of 137 showed 
molecular ion at m/z 236, whereas, the molecular formula C15H24O2 with 
four DBE was established through HR-EIMS (m/z 236.1780 [M]+).  
The 1H-NMR spectrum (Table 4.2) of compound 137 showed two 
most downfield resonances at δ 4.68 (1H, br s) and δ 4.59 (1H, br s), 
which were correlated in HSQC spectrum with a methylene carbon at δ 
105.2 and thus were attested for an exocyclic double bond. The spectrum 
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H
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also displayed five signals for methine at δ 3.53 (dt, J = 9.5, 4.5 Hz), 2.88 
(dd, J = 12.5, 9.5 Hz), 2.02 (m), 1.70 (dd, J = 9.5, 5.0 Hz) and 1.36 (t, J = 
10.0 Hz). Further, the same spectrum displayed a signal at δ 2.17 (3H, s) 
for a methyl of acetyl group. The two doublet methyl, displayed their 
positions at δ 1.09 (J = 7.5 Hz) and 0.82 (J = 7.5 Hz), were correlated in 
COSY spectrum with a methine at δ 1.49 (m) indicating the presence of an 
isopropyl moiety in 137. This data revealed a sesquiterpenoids skeleton of 
137. 
The 13C-NMR spectrum (BB and DEPT, Table 4.2) of 137 fully 
supported the 1H-NMR data as it displayed fifteen carbon signals at δ 
213.9 (C), 148.4 (C), 105.2 (CH2), 73.6 (C-H), 56.2 (C-H), 55.8 (C-H), 52.5 
(C-H), 50.2 (C-H), 46.6 (CH2), 31.1 (C-H), 30.3 (CH2), 29.5 (CH3), 27.8 
(CH2), 23.8 (CH3) and 16.8 (CH3). This data was quite similar to the data 
reported for oplopanone type sesquiterpenoids (Marco et al., 1993). 
Further confirmation of the structure of compound 137 was achieved by 
comparison of 1H, 13C-NMR and mass spectral data with the published 
data of oplopanone (Marco et al., 1993; Paolini et al., 2008). 
 This compound was already isolated in our group (Shafiq et al., 
(2014), where its absolute stereochemistry was determined by measuring 
the electric circular dichroism spectrum of compound 137. 
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   Table. 4.2: 1H and 13C-NMR data of 137 (CD3OD; 500 and 125 MHz).  
Position 137 
δH (J in Hz) δc 
1 2.12 (1H, m), 1.57 (1H, m) 30.3 
2 1.76 (1H, m), 1.54 (1H, m) 27.8 
3 2.88 (1H, dd, 12.5, 9.5) 56.2 
4 1.70 (1H, dd, 9.5, 5.0) 50.2 
5 1.36 (1H, t, 10.0) 55.8 
6 3.53 (1H, dt, 9.5, 4.5) 73.6 
7 2.54 (1H, dd, 12.0, 4.5) 46.6 
8 - 148.4 
9 2.02 (1H, m) 52.5 
10 4.68 (1H, br., s), 4.59 (1H, br., s) 105.2 
11 1.49 (1H, m) 31.1 
12-Me 1.09 (3H, d, 7.5) 23.8 
13-Me 0.82 (3H, d, 7.5) 16.8 
14 - 213.9 
15-Me 2.17 (3H, s, CH3) 29.5 
 
4.2.3. Characterization of Salvigenin (138) 
  Compound 138 was obtained as yellowish crystalline solid, which 
exhibited UV absorption maxima at 235, 
259, 246, 315 and 356 nm, the 
characteristic pattern of kaempferol or 
quercetin glycoside (Mabry et al., 1970; 
Saleh et al., 1990). The EIMS spectrum displayed molecular ion peak at 
m/z 328, whereas, high resolution of the same ion (m/z 328.2413) 
depicted the molecular formula as C18H16O6.  
 The 1H-NMR spectrum (Table 4.3) of compound 138 showed two 
doublets at δ 7.78 (2H, J = 9.0 Hz) and 6.69 (2H, J = 9.0 Hz) indicating the 
presence of a p-substituted benzene ring system. The spectrum also 
displayed two singlets in the aromatic region at δ 6.51 (1H) and 6.48 (1H) 
which were found to be correlated with carbons at δ 104.0 and 90.5 in 
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HSQC spectrum respectively and thus were attested for H-3 of ring C and 
H-8 of ring A respectively. Three methoxyl signals were found at δ 3.92, 
3.88 and 3.85. The most down fielded signal at δ 12.73 (1H, s) was 
attributed to a chelated hydroxyl function, which confirmed its position at 
C-5. The 13C-NMR spectrum (Table 4.3) of 138 displayed total 16 signals 
in which four signals at δ 127.9, 114.4, 104.0 and 95.0 were attested for 
six methine carbons. The three methoxyl carbons resonated at δ 60.8, 
56.2 and 55.5, while nine quaternary carbon nuclei displayed their 
positions at δ 182.6, 163.9, 162.6, 158.7, 153.1, 153.0, 132.6, 123.4 and 
106.1. This data indicated a substituted flavone nucleus. The positions of 
the methoxyl groups were fixed due to HMBC correlations in which the 
methoxyl proton resonating at δ 3.85, 3.92 and 3.88 showed the HMBC 
correlation with C-4' (δ 162.6), C-5 (δ 132.6) and C-6 (δ 153.0) 
respectively. The singlet proton at δ 6.51 showed HBMC correlation with 
C-4a (δ 106.1), C-4 (δ 182.6) and C-1' (δ 123.4) and thus was assigned as 
H-3. The combination of the whole spectroscopic data and comparison 
with the reported values (Ragasa et al., 1999), compound 138 was found 
to be salvigenin which is a known metabolite but has been isolated from 
this plant for the first time.  
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4.2.4. Characterization of Cirsumaritin (139) 
 Compound 139 was also isolated as yellowish crystalline solid, 
which exhibited similar UV data as that of 
138, indicating its flavone nature. The 
EIMS showed molecular ion peak at m/z 
314, whereas, the molecular formula 
C17H14O6 was calculated through the HR-EIMS that exhibited molecular 
ion peak at m/z 314.2947.  
 Aromatic region of the 1H-NMR spectrum (Table 4.3) of compound 
139 was nearly super imposable to that of 138 that depicted a p-
substituted ring B, H-3 of ring C and H-8 of ring A. The only difference 
was the resonances of two methoxyl group at δ 4.02 and 3.89 instead of 
three. The 13C-NMR spectrum (Table 4.3) of 139 displayed 15 signals, 
which were differentiated as four methine (δ 128.3, 114.6, 103.8 and 
95.9), two methyls (δ 56.7 and 55.5) and nine quaternary carbons (δ 
180.5, 163.2, 162.4, 161.1, 157.9, 154.1, 130.6, 123.0 and 105.1), based 
on DEPT experiment. 
The methoxyl group present at δ 3.89 could be fixed at C-4' due to 
its HMBC correlation with quaternary carbon at δ 163.2 and that of H-2' 
with the same carbon. The other methoxyl group was placed at C-7 due to 
its HMBC correlation with another quaternary carbon at δ 161.1.  
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 All connectivities were confirmed through careful analysis of HSQC 
and HMBC spectra and the whole data was comparable to the reported 
data of cirsumaritin, which has already been reported from different 
biological sources like Cirsium spp., Teucrium spp. and Digitalis ferruginea, 
Drimys winteri (Imre et al., 1973; Cruz and Silva 1973). 
   Table. 4.3: 1H and 13C-NMR data of 138 and 139 (CD3OD; 500 and 125 MHz).  
 
4.2.5. Characterization of p-Coumaric Acid (140) 
 The EIMS of 140 showed the molecular ion peak at m/z 164 and the 
HR-EIMS analysis of the same ion depicted the 
molecular formula as C9H8O4 with six DBE. The 
1H-NMR spectrum of 140 (Table 4.4) displayed 
only four signals in aromatic region at δ 7.64 
(1H, d, J = 16.5 Hz), 7.40 (2H, d, J = 8.5 Hz), 6.64 (2H, d, J = 8.5 6.35 (1H, 
Position 138 139 
δH (J in Hz) δc δH (J in Hz) δc 
1 - - - - 
2 - 162.6 - 162.4 
3 6.51 (1H, s) 104.0 6.61 (1H, s) 103.8 
4 - 182.6 - 180.5 
4a - 106.1 - 105.1 
5 - 153.1 - 154.1 
6 - 132.6 - 130.6 
7 - 153.0 - 161.1 
8 6.48 (1H, s) 95.0 6.45 (1H, s) 95.9 
8a - 158.7 - 157.9 
1' - 123.4 - 123.0 
2' 7.78 (1H, d, 9.0) 127.9 7.94 (1H, d, 8.8) 128.3 
3' 6.69 (1H, d, 9.0) 114.4 7.05 (1H, d, 8.8) 114.6 
4' - 163.9 - 163.2 
5' 6.69 (1H, d, 9.0) 114.4 7.05 (1H, d, 8.8) 114.6 
6' 7.78 (1H, d, 9.0) 127.9 7.94 (1H, d, 8.8) 128.3 
6-OMe 3.92 (3H, s, OMe) 56.2 4.02 (3H, s, OMe) 56.7 
7-OMe 3.88 (3H, s, OMe) 60.8 - - 
4'-OMe 3.85 (3H, s, OMe) 55.5 3.89 (3H, s, OMe) 55.5 
OH
O
HO
140
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d, J = 16.5 Hz). The signals splitted at higher J values (J = 16.5 Hz) were 
attributed to a conjugated trans olefinic system, whereas, the other two 
signals of four hydrogen were attested for a p-substituted benzene ring. 
This data quite fitted with a p-coumaric acid structure, which was 
substantiated due to the 13C-NMR spectrum (Table 4.4), in which seven 
signals were seen as four methines (δ 142.3, 128.6, 116.4 and 114.2) and 
three quaternary carbons (δ 169.4, 158.1 and 124.1). Combination of 
above data and comparison with published literature (Ahmad et al., 2009), 
compound 140 could be confirmed as p-coumaric acid, which is an 
important known phytochemical but has been isolated for the first time 
from Seriphidium quettense. 
 Table. 4.4: 1H and 13C-NMR data of 140 (CDCl3, 400 and 100 MHz).  
Position δH (J in Hz) δc 
1 - 124.1 
2 7.40 (2H, d, 8.5) 128.6 
3 6.64 (2H, d, 8.5) 116.4 
4 - 158.1 
5 6.64 (2H, d, 8.5) 116.4 
6 7.40 (2H, d, 8.5) 128.6 
7 7.64 (1H, d, 16.5) 142.3 
8 6.35 (1H, d, 16.5) 114.2 
9 - 169.4 
 
4.2.6. Characterization of β-sitosterol (87) 
The compound 87 was isolated as a white amorphous powder and 
structure elucidation of this compound has already been discussed in 
chapter 2 section 2.4.18. (Kamboj and Saluja 2011). 
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4.2.7. Characterization of β-sitosterol-3-O-β-D-glucopyranoside (88) 
 The compound 88 was isolated as a white amorphous powder and 
structure elucidation of this compound 88 has already been discussed in 
chapter 2 section 2.4.19. (Akhtar et al., 2010).  
4.2.8. Characterization of Oleanolic Acid (141) 
  Compound 141 was isolated as white 
amorphous powder, which exhibited 
molecular ion peak in EIMS spectrum at m/z 
456, while the HR-EIMS (m/z 456.3601) 
depicted the molecular formula as C30H48O3. 
The IR spectrum of compound 141 displayed characteristic absorption 
bands at 2570-3500 and 1710 cm-1 for a carboxylic acid function. 
 The 1H-NMR spectrum (Table 4.5) displayed a triplet signal at  5.26 
(1H, J = 3.6 Hz) due to a double bond and a doublet of doublet at  3.21 
(1H, J = 11.0, 5.0 Hz) was attributed to an oxymethine. The spectrum also 
displayed seven methyl singlets at  1.14, 0.98, 0.96, 0.94, 0.86, 0.75 and 
0.74 characteristic of a pentacyclic triterpenoidal skeleton of oleanane 
series. The 13C-NMR (BB and DEPT) revealed the presence of seven 
methyls at  33.6, 29.6, 25.5, 24.1, 18.4, 16.3 and16.1, ten methylenes at 
 45.2, 37.9, 33.7, 33.4, 32.4, 27.6, 27.1, 23.7, 22.1 and 18.4, five 
methines at  122.9, 78.5, 55.5, 49.6 and 40.2 and eight quaternary 
carbons at  182.6, 142.5, 46.2, 41.3, 41.0, 38.7, 37.6 and 31.1. This data 
HO
OH
O
141
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was suggestive of oleanolic acid and its comparison with the reported data 
(Ragasa and Lim 2005) confirmed the compound 141 to be oleanolic acid, 
which is an important phytochemical and isolated first time from this 
source. 
 Table. 4.5: 1H and 13C-NMR data of 141 (CD3OD; 500 and 125 MHz). 
Position δH (J in Hz) δc Position δH (J in Hz) δc 
1 1.71 (1H, m), 0.96 (1H, m) 37.9 16 1.98 (1H, m), 1.62 (1H, m) 22.1 
2 1.61 (1H, m), 1.55 (1H, m) 27.1 17 - 46.2 
3 3.21 1H, dd, 11.0, 5.0) 78.5 18 2.79 (1H, dd, 13.6, 3.6) 40.2 
4 - 38.7 19 1.62 (1H, m), 1.14 (1H, m) 45.2 
5 0.73 (1H, t, 6.8) 55.5 20 - 31.1 
6 1.53 (1H, m), 1.36 (1H, m) 18.4 21 1.30 (1H, m), 1.20 (1H, m) 33.4 
7 1.42 (1H, m), 1.27 (1H, m) 33.7 22 1.78 (1H, m), 1.57 (1H, m) 32.4 
8 - 41.0 23 0.98 (3H, s, Me) 29.6 
9 1.51 (1H, m) 49.6 24 0.86 (3H, s, Me) 16.3 
10 - 37.6 25 0.74 (3H, s, Me) 16.1 
11 1.87 (1H, m), 0.92 (1H, m) 23.7 26 0.75 (3H, s, Me) 18.4 
12 5.26 (1H, t, 3.6) 122.9 27 1.14 (3H, s, Me) 25.5 
13 - 142.5 28 - 182.6 
14 - 41.3 29 0.94 (3H, s, Me) 33.6 
15 1.70 (1H, m), 1.11 (1H, m) 27.6 30 0.96 (3H, s, Me) 24.1 
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4.3. EXPERIMENTAL 
4.3.1. General Experimental Procedures 
Column chromatography was performed with silica gel (230-400 
mesh). The aluminum sheets precoated with silica gel 60 F254 (20×20 cm, 
0.2 mm thick; E. Merck) for thin layer chromatography. The UV lamp (254 
and 366 nm) was used to check unsaturation in compounds and ceric 
sulfate was used as locating reagent for UV inactive metabolites. The UV 
spectra were recorded in ethanol on JASCO V-650 spectrophotometer 
(max in nm). IR spectra were measured on Shimadzu 460 spectrometer 
(Duisburg, Germany). The 1D (1H NMR) and 2D NMR (HMQC, HMBC and 
COSY) spectra were measured on Bruker spectrometer of AMX-400, 500 
instrument, using TMS as an internal reference. The 13C-NMR spectra 
were also recorded on the same machines operating at 100 and 125 MHz. 
The EIMS and HR-EIMS were calculated on Finnigan (Varian MAT) JMS 
H×110 with a data system and JMSA 500 mass spectrometers.  
4.3.2. Collection and Identification of Plant Material 
 The whole plant material (stem, leaves and branches) of 
Serphidium quettense was collected from Ziarat, Baluchistan, in 
September 2011 and was identified by Prof. Dr. Rasool Bakhsh Tareen, 
Department of Botany, University of Baluchistan, Quetta, Pakistan, where 
a voucher specimen (RBT-SQ-11) has been deposited in the herbarium. 
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4.3.3. Extraction  
 The plant material was dried under shade for two weeks and was 
ground to semi-powder (5.0 kg). It was then extracted with methanol (8.0 
L) at room temperature for 6 days (twice). The combined concentrated 
extract (150 gm) was suspended in water (1.0 L) and was extracted with n-
hexane (65 gm) and ethyl acetate (40 gm). The ethyl acetate fraction 
showed significant antioxidant and antiurease activity and thus was 
subjected to purification. 
4.3.4. Isolation and Identification 
 Ethyl acetate fraction of methnolic extract was subjected to column 
chromatography (Scheme 4.1) over silica gel eluting with n-hexane, n-
hexane–chloroform, chloroform, chloroform–methanol in increasing order 
of polarity to obtain eight fractions (SQ1-SQ8) based on the TLC profiles.  
 The main fraction SQ1 and SQ2 mostly contain hydrocarbon part 
and thus were not processed. The fraction SQ3 obtained at n-
hexane:chloroform (7:3) on silica gel chromatography give two 
subfractions; S3-1 and S3-2, which on eluting with n-hexane:chlorofrom in 
increasing order of their polarity give compound 137 (30 mg). Another 
fraction SQ4 obtained at n-hexane:chlorofrom (6:4) was chromatographed 
further to get compound 87 (25 mg). Main fraction SQ5 obtained at n-
hexane:chlorofrom (4:6) when further purified on silica gel eluting with n-
hexane:chlorofrom (4.5:5.5) to get five subfractions SQ5-1-SQ5-5. The 
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subfractions SQ5-4 and SQ5-5 were further subjected to purification on 
silica gel column eluting at n-hexane:chlorofrom in increasing order of 
polarity to get compounds 141 (25 mg) and 140 (32 mg). The fraction SQ6 
obtained with n-hexane:chlorofrom (3:7) was re-chromatographed on silica 
gel column using same eluting system to get compounds 136 (20 mg) and 
88 (24 mg). Fraction SQ7 obtained at n-hexane:chlorofrom (1:9) when 
further chromatographed with n-hexane:chlorofrom (3:7) yielded three 
subfractions S7-1-S7-3. The subfractions S7-2 and S7-3 on eluting with n-
hexane:chlorofrom in increasing order of polarity through a silica gel 
column to give compounds 138 (25 mg) and 139 (23 mg). 
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Methanolic extract of Seriphidium Quettense
Suspended in water
Hexane partWater part
Hexane
EtOAc
EtOAc partWater part
SQ2 SQ3 SQ4 SQ5SQ1 SQ6 SQ7 SQ8
137 87
141 140
136 88
138 139
9:1 8:2 3:7 6:4 4:6 3:7 1:9 CHCl3
n-hexane: chloroform
 
Scheme. 4.1: Purification protocol of secondary metabolites from 
Seriphidium quettense. 
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4.3.5. Spectroscopic Data of Purified Compounds 
4.3.5.1. Spectroscopic data of seriphilidine (136): white amorphous 
powder (20 mg); IR max (KBr) cm-1: 3410, 
1645; 1H-NMR (CD3OD; 500 MHz):  5.53 (1H, 
ddd, J = 15.5, 9.5, 1.0 Hz, H-10), 5.45 (1H, dd, 
J = 15.5, 7 Hz, H-11), 5.05 (1H, t, J = 5.0 Hz, 
H-2), 3.93 (3H, s, 2-OMe), 3.41 (1H, br., d, H-
9), 2.30 (1H, m, H-12), 1.89 (1H, d, J = 5.5 Hz, H-3), 1.85 (1H, d, J = 4.5 
Hz, H-7), 1.78 (2H, m, H-8), 1.75 (1H, d, J = 9.5 Hz, H-5), 1.51 (1H, d, J = 
4.5 Hz, H-7), 1.37 (1H, d, J =5.5 Hz, H-3), 1.08 (3H, s, Me-14), 1.02 (3H, s, 
Me-16), 0.97 (3H, d, J = 6.5 Hz, Me-13) and 0.96 (3H, d, J = 6.5 Hz, Me-
14); 13C-NMR (CD3OD; 125 MHz): δ 142.0 (C-11), 122.5 (C-10), 105.5 (C-
2), 83.5 (C-9), 72.3 (C-6), 57.2 (C-5), 47.8 (C-3), 46.0 (C-4), 39.5 (C-7), 
31.4 (C-12), 31.0 (C-15), 22.7 (C-13, 14), 21.6 (C-8), 15.8 (C-16) and 56.0 
(2-OMe); EIMS: m/z 268 [M]+; HR-EIMS: m/z 268.2435 [M]+ (calcd. 
268.4375 for C16H28O3). 
4.3.5.2. Spectroscopic data of -Hydroxy-8(10)-oplopen-14-one 
(137): White crystalline solid (30 mg); IR max 
(KBr) cm-1: 3450 and 1715; 1H-NMR (CD3OD; 
500 MHz): δ 4.68 (1H, br., s, H-10), 4.59 (1H, 
br., s, H-10), 3.53 (1H, dt, J = 9.5, 4.5 Hz, H-
6), 2.88 (1H, dd, J = 12.5, 9.5 Hz, H-3), 2.54 (1H, dd, 12.0, 4.5 Hz, H-7), 
OH3CO
H3C
CH3H3C
CH3
OH
1
2
3
4
5
6
7
8
9
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2
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5
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2.17 (3H, s, Me-15), 2.12 (1H, m, H-1), 2.02 (1H, m, H-9), 1.76, 1.54 (1H, 
m, H-2), 1.70 (1H, dd, J = 9.5, 5.0 Hz, H-4), 1.57 (1H, m, H-1), 1.49 (1H, 
m, H-11), 1.36 (1H, t, J = 10.0 Hz, H-5), 1.09 (3H, d, J = 7.5 Hz, Me-12) 
and 0.82 (3H, d, J = 7.5 Hz, Me-13); 13C-NMR (CD3OD; 125 MHz): δ 213.9 
(C-14), 148.4 (C-8), 105.2 (C-10), 73.6 (C-6), 56.2 (C-3), 55.8 (C-5), 52.5 
(C-9), 50.2 (C-4), 46.6 (C-7), 31.1 (C-11), 30.3 (C-1), 29.5 (C-15), 27.8 (C-
2), 23.8 (C-12) and 16.8 (C-13); EIMS: m/z 236 [M]+; HR-EIMS: m/z 
236.1780 (calcd. 236.3548 for C16H28O3). 
4.3.5.3. Spectroscopic data of salvigenin (138): Yellowish crystalline 
solid (25 mg); UV max (max, 6.28 mM in CH3CN) nm (104M–1cm–1): 235, 
259, 246, 315 and 356; 1H-NMR (CD3OD; 
500 MHz): δ 7.78 (1H, d, J = 9.0 Hz, H-2', 
6'), 6.69 (1H, d, J = 9.0 Hz, H-3', 5'), 6.51 
(1H, s, H-3), 6.48 (1H, s, H-7), 12.73 (1H, s, 
OH), 3.92 (3H, s, OCH3), 3.88 (3H, s, OCH3) and 3.85 (3H, s, OCH3); 13C-
NMR (CD3OD; 125 MHz): δ 182.6 (C-4), 163.9 (C-4'), 162.6 (C-2), 158.7 
(C-8a), 153.1 (C-5), 153.0 (C-7), 132.6 (C-6), 106.1 (C-4a), 127.9 (C-2', 6'), 
123.4 (C-1'), 114.4 (C-3', 5'), 104.0 (C-3), 95.0 (C-8), 60.8 (OMe), 56.2 
(OMe) and 55.5 (OMe); EIMS: m/z 328 [M]+; HR-EIMS: m/z 328.2413 [M]+ 
(calcd. 328.2365 for C18H16O6). 
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4.3.5.4. Spectroscopic data of cirsumaritin (139): Yellowish crystalline 
solid (23 mg); 1H-NMR (CD3OD; 500 MHz): 
δ 7.94 (1H, d, J = 8.8 Hz, H-2', 6'), 7.05 
(1H, d, J = 8.8 Hz, H-3', 5'), 6.61 (1H, s, H-
3), 6.45 (1H, s, H-7), 4.02 (3H, s, OCH3), 
3.89 (3H, s, OCH3); 13C-NMR (CD3OD; 500 MHz): δ 180.5 (C-4), 163.2 (C-
4'), 162.4 (C-2), 161.1 (C-7), 157.9 (C-8a), 154.1 (C-5), 103.8 (C-3), 130.6 
(C-6), 128.3 (C-2', 6'), 123.0 (C-1'), 114.6 (C-3', 5'), 105.1 (C-4a), 95.9 (C-
8), 56.7 (OMe) and 55.5 (OMe); EIMS: m/z 314 [M]+; HR-EIMS: m/z 
314.2947 [M]+ (calcd. 314.2843 for C17H14O6). 
4.3.5.5. Spectroscopic data of p-Coumaric acid (140): Yellow 
amorphous powder (32 mg); 1H-NMR (CDCl3, 
400 MHz): δ 7.64 (1H, d, J = 16.5 Hz, H-7), 7.40 
(2H, d, J = 8.5 Hz, H-2, 6), 6.64 (2H, d, J = 8.5 
Hz, H-3, 5) and 6.35 (1H, d, J = 16.5 Hz, H-8); 13C-NMR (CDCl3, 100 MHz): 
δ 169.4 (C-9), 158.1 (C-4), 142.3 (C-7), 128.6 (C-2, 6), 124.1 (C-1), 116.4 
(C-3, 5), 114.2 (C-8); EIMS: m/z 164 [M]+; HR-EIMS: m/z 164.0466 [M]+ 
(calcd. 164.0473 for C9H8O4). 
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4.3.5.6. Spectroscopic data of oleanolic acid (141): White amorphous 
powder (25 mg); IR max (KBr) cm-1: 1710, 
2570-3500; 1H-NMR (CD3OD; 500 MHz): δ 
5.26 (1H, t, 3.6, H-12), 3.21 (1H, dd, 11.0, 
5.0, H-3), 2.79 (1H, dd, 13.6, 3.6, H-18), 
1.98, 1.62 (1H, m, H-22), 1.87, 0.92 (1H, m, 
H-11), 1.78, 1.57 (1H, m, H-22), 1.71, 0.96 (2H, m, H-1), 1.70, 1.11 (1H, 
m, H-15), 1.62, 1.14 (1H, m, H-19), 1.61, 1.55 (2H, m, H-2), 1.53, 1.36 
(2H, m, H-6), 1.51 (1H, m, H-9), 1.42, 1.27 (2H, m, H-7), 1.30, 1.20 (1H, 
m, H-21), 1.14 (3H, s, Me-27), 0.98 (3H, s, Me-23), 0.96 (3H, s, Me-30), 
0.94 (3H, s, Me-29), 0.86 (3H, s, Me-24), 0.75 (3H, s, Me-26), 0.74 (3H, s, 
Me-25), 0.73 (1H, t, 6.8, H-5); 13C-NMR (CD3OD; 125 MHz): δ 182.6 (C-
28), 142.5 (C-13), 122.9 (C-12), 78.5 (C-3), 55.5 (C-5), 49.6 (C-9), 46.2 (C-
17), 45.2 (C-19), 41.3 (C-14), 41.0 (C-8), 40.2 (C-18), 38.7 (C-4), 37.9 (C-
1), 37.6 (C-10), 33.7 (C-7), 33.6 (C-29), 33.4 (C-21), 32.4 (C-22), 31.1 (C-
20), 29.6 (C-23), 27.6 (C-15), 27.1 (C-2), 25.5 (C-27), 24.1 (C-30), 23.7 (C-
11), 22.1 (C-16), 18.4 (C-6), 18.4 (C-26), 16.3 (C-24), 16.1 (C-25); EIMS: 
m/z 456 [M]+; HR-EIMS: m/z 456.3601 [M]+ (calcd. 456.8473 for 
C17H14O6). 
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CHAPTER 5 
 
 
PURIFICATION AND CHARACTERIZATION OF SECONDARY 
METABOLITES FROM ENDOPHYTIC FUNGUS 
CRYPTOSPORIOPSIS SP. 
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5.1. ENDOPHYTES AND ENDOPHYTIC FUNGI  
 The term ‘endophyte’ was firstly introduced by A. De Bary in 1866 to 
describe all microorganisms including fungi, bacteria, cyanobacteria, and 
actinomycetes that are found in plant tissues (De Bary 1866). Among 
these organisms, endophytic fungi are a diverse group of microorganisms 
and found more abundant in nature then bacterial endophytes. 
Endophytic fungi have gain importance due to two reasons, firstly they are 
found in all the plants, and secondly the secondary metabolites produced 
by endophytic fungi help plants to improve their growth and resistance to 
the environmental condition (including all the biotic and abiotic factors). 
Secondary metabolites that provide resistance and survival to the plant, if 
they are isolated and characterized, may found to be potential lead for 
drug discovery. In drug discovery prospectus finding of new drugs for the 
treatment of newly appearing diseases in human, animal and plants is 
always a great aspect. In recent years, a massive investigation on 
endophytes has been done with respect to biotechnological and ecological 
aspects in recent years for the development of new source and products of 
agriculture and pharmaceutical importance (Strobel et al., 2004; Chagas 
et al., 2013). 
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5.2. BIODIVERSITY OF FUNGAL ENDOPHYTES 
 Endophytes live in mutualistic association with plants and spend 
their whole life living in plant tissues causing no damage to the host. 
Fungal endophytes are the more diverse group of microorganisms that 
they have been found everywhere, like in geothermal soils, deserts, 
oceans, rainforests and coastal forests. They are important component of 
microbial biodiversity. In green land plants, where they help the host to 
develop offence against threats and other environmental circumstances, 
which make their ability to produce fascinating and structurally complex 
natural products (Debbab et al., 2010). Endophytic fungi are hosted by 
algae, bryophytes, pteridophytes, gymnosperms and angiosperms. They 
have been isolated from the shoot, root and leaves including all aerial 
parts in every plant studied to date (Kharwar et al., 2011). 
5.3. ADVANTAGE OF MICROBIAL STUDIES IN DRUG DISCOVERY  
 There are many advantages of microbial studies in drug discovery 
process. Fungi and bacteria are existing on earth from million of year, as 
they have adopted unique biosynthetic pathways and mechanism to 
synthesis the secondary metabolites of diverse structural classes. These 
secondary metabolites interact with different enzymes and help the 
organism to survive in harsh weather conditions and other challenges. 
Secondly the yield of different bioactive compounds can be increased in 
certain organism, if culture conditions are optimized. The required 
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microorganism can be stored for infinite time period, which ensure the 
availability of the target product at any time. 
 There is a problem associated with plant derived drug that potent 
metabolites are produced in very low amount, for example plant Taxus 
contain only 0.01-0.03% of paclitaxel by dry phloem weight. In case of 
microorganisms, this problem can be solved by culturing of the organisms 
at any scale (Kharwar et al., 2011). 
5.4. BIOACTIVE COMPOUNDS FROM ENDOPHYTIC FUNGI 
 Endophytes have represented a promising source of bioactive 
compounds and their production can be increased at lower cost by large 
scale fermentation and cultivation of the organisms. A bulk of leads has 
been isolated and characterized from endophytes, which includes anti-
bacterial, anticancer, antifungals, antivirals and immunosuppressants. 
5.4.1. Antibacterial Agents from Endophytic Fungi 
 About 25 years before, the antibiotic cephalosporin C (142) was 
introduced in the pharmaceutical market as antibacterial drug (Newton 
and Abraham 1955). Guanacastepenes A (143), obtained from 
unidentified endophytic fungus was active against drug-resistant strains 
of Enterococcus faecium and Staphylococcus aureus (Brady et al., 2001). 
Chaetoglobosin A (144) was isolated from endophytic Chaetomium 
globosum and rhizotonic acid (145) obtained from Rhizoctonia sp., both 
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the compounds showed potent activity against Helicobacter pylori a 
bacterium involved in the gastric ulcer (Tikoo et al., 2000; Ma et al., 2004). 
Altersetin (146) isolated from Alternaria sp. was found active against 
Gram-positive bacteria (Hellwig et al., 2002).  
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 Marinopyrroles A (147) and B (148) were found active against 
methicillin-resistant S. aureus (Hughes et al., 2008). Ascochytatin (149), a 
marine-derived fungal metabolite isolated from Ascochyta sp. NGB4, has 
been reported to kill Gram-positive bacteria and yeast C. albicans (Kanoh 
et al., 2008). Lynamicins B (150) and C (151) are two halogenated bis-
indole derivatives, which have reported to be active against S. aureus 
(MSSA, MRSA: methicillin resistant), Staphylococcus epidermidis and 
Enterococcus faecalis (Mcarthur et al., 2008). 
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 Bionectins A-C (152-154), verticillin D (155) and G (156) exhibited 
antibacterial activity against S. aureus, methicillin-resistant S. aureus 
(MRSA) and quinolone-resistant S. aureus (QRSA). These compounds were 
isolated from the fungus Bionectra byssicola F120 (Donnell and Gibbons 
2007; Zheng et al., 2006; Zheng et al., 2007). 
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5.4.2. Anti-Cancer Agents from Endophytic Fungi 
 Compound 149 showed cytotoxicity as it inhibited the growth of 
A549 (human lung carcinoma cell line) cell lines with EC values of 4.8 and 
Jurkat cells (human leukaemia cell line) with EC values of 6.3 µM (Kanoh 
et al., 2008). Camptothecin (157) and its analogues, 9-
methoxycamptothecin (158) and 10-hydroxycamptothecin (159), were 
potentially active against human cancer cell lines A549 (lung cancer), 
HEP-2 (liver cancer). These compounds were isolated from an endophytic 
fungus Fusarium solani (Kusari et al., 2009). 
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 Cytoglobosins C (160) and D (161), two novel alkaloids, were 
isolated from Chaetomium globosum which showed cytotoxicity with IC50 
values of 2.26 and 2.55 µM against the tumor cell line (A549) (Cui et al., 
2010). 
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 Chaetominine (162) another alkaloid, obtained from endophytic 
fungus Chaetomium sp. IFB-E015, was found active against the human 
leukemia K562 and colon cancer cell lines SW1116 with IC50 values of 
21.0 and 28.0 µM (Jiao et al., 2006). Brefeldin A (163) was isolated from 
Acremonium, and has been reported potentially active against epidermoid 
cancer of the mouth KB, small-cell lung cancer NCI-H187 and breast 
cancer cell line BC-1 with IC50 values of 0.18, 0.11 and 0.04 µM, 
respectively (Chinworrungsee et al., 2008). Radicicol (164) was purified 
from Chaetomium chiversii, which inhibited MCF-7 cell lines (breast cancer 
cell line) with an IC50 value of 0.03 µM (Turbyville et al., 2006). 
Chaetoglobosin U (165) is known as the metabolite of the endophytic 
fungus Chaetomium globosum IFB-E019. It showed potent cytotoxic 
activity against the human nasopharyngeal epidermoid tumor KB cell line 
with an IC50 value of 16.0 µM (Ding et al., 2006). 
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5.4.3. Anti-Fungal Agents from Endophytic Fungi 
  The first antifungal drug from filamentous fungus isolated was 
griseofulvin (166) (Grove et al., 1952), afterwards, several new metabolites 
were isolated from fungal sources. For example, anidulafungin marketd 
with name of Eraxis, (167) and caspofungin lunched as Cancidas (168) 
are two antifungal drugs obtained from Aspergillus rugulovalvus and 
Glarlozoyensis (Butler 2004). Ambuic acid, (169), an antifungal 
metabolite, was isolated from Pestalotiopsis microspora. It is a highly 
functionalized cyclohexenone-derived natural product (Harper et al., 2001; 
Harper et al., 2003; Harper et al., 2003). Cryptocin (170) is another 
antifungal compound isolated from Cryptosporiopsis quercina. It has a 
tetramic acid skeleton that possesses potent activity against Pyricularia 
oryzae (Li et al., 2000). Oocydin A (171), a chlorinated macrocyclic lactone 
was a potent antifungal compound, isolated from Serratia marcescens 
(Strobel and Daisy 2003).  
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(172) an antifungal lead isolated from fungus Aspergillus sydowii, is a 
derivative of deoxymulundocandin (173) (Keating and Figgitt 2003; 
Igarashi et al., 1956).  
HO
OH
NH
O
HO
H3C
N
O
H3C
HO
NH
O
HO OH
NH
O
HN
O
N
CH3
OH
H
N
O
OH
O
H3C
H3C
173
HO
OH
NH
O
HO
H3C
N
O
H3C
HO
NH
O
HO NH
NH
O
HN
O
N
CH3
OH
H
N
O
OH
O
O
H3C
NH2
172
 
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
122 
 
 A fungal polyketide metabolite chaetocyclinones A (174) was 
isolated from cultures of Chaetomium sp. This compound was found active 
against Phytophthora Infestans (Losgen et al., 2007). Antifungal partricin A 
(175) is a 38-membered heptaene polyene and its derivative (176) is also a 
new antifungal agent. PLD-118 (BAY-10-8888) (177) is a cyclic -amino 
acid and other compound cispentacin (178); both the compounds are in 
clinical trial for the development of antifungal agent (Butler 2005).  
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5.4.4. Anti-Viral Agents from Endophytic Fungi 
 Cytonic acids A (179) and B (180) were isolated from the endophytic 
fungus Cytonaema sp. and were reported as human cytomegalovirus 
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
123 
 
protease inhibitors (Guo et al., 2000). Xanthoviridicatins E (181) and F 
(182) obtained from endophytic Penicillium chrysogenum based on novel 
quinone-related metabolites, blocked the cleavage reaction of HIV-1 
integrase (Singh et al., 2003). 
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5.4.5. Immunosuppressant Agents from Endophytic Fungi 
 The first immunosuppressive drug cyclosporine A (26) was isolated 
from Tolypocladium inflatum and was used as immunosuppressant during 
organ transplantations (Borel and Kis 1991). Mycophenolic acid (183) is 
known as the metabolite of the fungi Penicillium, Aspergillus, 
Byssochlamys and Septoria species (Larsen et al., 2005). It is a potential 
immunosuppressive drug that is used during the organ transplantations. 
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
124 
 
Subglutinol A (184) another immunosuppressant, was isolated from an 
endophytic Fusarium subglutinans (Lee et al., 1995a). 
CH3
CH3
H3CO
CH3
HOOC
O
O
O
CH3
CH3
OHO
H
O
O
CH3
H
H3C
H
H
H
CH3
CH3
184183
 
5.5. TAXONOMY OF THE ENDOPHYTIC FUNGUS CRYPTOSPORIOPSIS 
Kingdom: Fungi 
Phylum: Ascomycota 
Class: Leotiomycetes 
Subclass: Leotiomycetidae 
Order: Helotiales 
Family: Dermateaceae 
Genus: Cryptosporiopsis  
  
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
125 
 
5.6. LITERATURE SURVEY ON THE GENUS CRYPTOSPORIOPSIS  
5.6.1. Previous Investigation of Cryptosporiopsis Sp. 
Cryptosporiopsis is known to produce a unique lipopeptide cryptocandin 
(185), which is a potent antimycotic agent. This compound was first time 
isolated and reported from Cryptosporiopsis cf. quercina. The most 
impressive antifungal activity of 185 was against Candida albicans with 
MIC value 0.03 g/ml, Candida parapsilosis with MIC value of 2.5 g/ml 
and Histoplasma capsulatum with MIC value of 0.01 g/ml (Strobel et al., 
1999). Another antimycotic agent cryptocin (170) isolated from the same 
endophytic fungus bears a unique tetramic acid structure was found 
active against many fungal strains, Pythium ultimum, Phytophthora 
cinnamoni, Phytophthora citrophthora, Sclerotinia sclerotiorum, Pyricularia 
oryzae, Rhizoctonia solani, Geotrichum candidum and Fusarium oxysporum 
with MIC (g/ml) value 0.78, 0.78, 1.56, 0.78, 0.39, 6.25, 1.56 and 1.56 
respectively (Li et al., 2000). In recent study two important polyketides, 
cryptosporiopsin A (186) and hydroxypropan-2',3'-diol orsellinate (187), a 
cyclic pentapeptide (188) and several other compounds (189-191) have 
been isolated from Cryptosporiopsis sp., associated with the leaves and 
branches of Zanthoxylum leprieurii (Rutaceae). These metabolites were 
found active against zoospores of pathogen Plasmopara viticola with MIC 
value 10-25 g/ml. They displayed potent inhibitory activity against 
Pythium ultimum, Aphanomyces cochlioides and a fungus Rhizoctonia 
solani (Talontsi et al., 2012). 
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5.7. RESULTS AND DISCUSSION 
5.7.1. Structure Elucidation of the Isolated Compounds from 
Endophytic Fungus Cryptosporiopsis Sp. 
 The culture media of the fungus Cryptosporiopsis sp was extracted 
with ethyl acetate, which on chromatographic purification yielded three 
novel bioactive polyketide, cryptosporioptide (192), cryptosporioptide A 
(193) and cryptosporioptide B (194), which were characterized due to 
several spectroscopic analyses analysis including 1D (1H, 13C), 2D NMR 
(HSQC, HMBC, COSY) techniques and mass spectrometry (FABMS, 
HRFABMS). 
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5.7.1.1. Characterization of cryptosporioptide (192) 
Cryptosporioptide (192) was isolated as yellow amorphous powder, 
whose molecular formula (C19H19NO10) with eleven double bond 
equivalents (DBE) was established due 
to (+ve) HR-FABMS (m/z 444.0781, 
[M+Na]+). The IR spectrum displayed 
absorption bands at 3465 for hydroxyl 
group, 3105, 2945 (C-H), 1732, 1695-
1680 (broad for carbonyl group) and 1590-1565 (for double bond) cm-1. 
The 1H NMR spectrum of 192 (Table 5.1) showed two ortho-coupled 
doublets in the aromatic region at  7.40 (1H, J = 8.5 Hz) and 6.43 (1H, J 
= 8.5 Hz), which were attributed to a tetra-substituted benzene ring. It 
also displayed two methines at  5.62 (s) and 3.42 (s), two doublets for a 
methylene at  3.44 (1H, J = 15.5 Hz) and 3.39 (1H, d, J = 15.5 Hz) and 
methoxyl proton resonance at  3.66. The upfield region of the same 
spectrum displayed displayed two singlet methyls at  1.70 and 1.60. The 
most downfield signals at  14.12 (1H, s) and 11.78 (1H, s) were attributed 
to amide hydrogen and chelated hydroxyl functions, respectively. The 
relatively downfield shift of amide hydrogen could be due to an anisotropic 
effect of carbonylic oxygen of the chromone moiety.  
The 13C NMR spectrum of 192 (Table 5.1) displayed altogether 19 
carbon signals which were identified as three methyls ( 52.5, 28.4, 18.0), 
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one methylene ( 41.1), four methines ( 140.4, 108.4, 73.1, 55.8) and 
eleven quaternary carbons ( 187.7, 169.8, 166.5, 165.3, 158.9, 157.1, 
117.1, 105.9, 104.2, 78.8, 58.6). The positions of various functionalities 
were fixed based on the HSQC, COSY and HMBC (Figure 5.1) information. 
The methyl carboxylate function was placed at C-6 due to HMBC 
correlation of H-7 ( 7.40) with the carbons at  117.1 (C-6) and  166.5 
(C-11). The same hydrogen was further correlated with C-5 ( 158.9) and 
C-9 ( 157.1). The chelated hydroxyl proton ( 11.78) showed long-range 
interaction with the carbons C-5 ( 158.9), C-6 ( 117.1) and C-10 ( 
105.9), the proton H-8 ( 6.43) was found to interact with the carbons C-6 
( 117.1), C-9 ( 157.1), C-10 ( 105.9) and have a weak correlation with 
C-4 ( 187.7). The proton resonating at  3.42 (H-3) exhibited HMBC 
coupling with C-2 ( 104.2), C-10 ( 105.9), C-12 ( 78.8), C-13 ( 73.1), C-
14 ( 58.6) and C-15 ( 18.0), whereas, the acylated methine H-13 ( 5.62) 
showed HMBC correlation with C-17 ( 165.3), C-2 ( 104.2), C-3 ( 55.8), 
C-12 ( 78.8), C-14 ( 58.6), C-16 ( 28.4) and C-15 ( 18.0). The above 
data indicated the presence of a chromone nucleus merged with a 5-
membered ring in cryptosporioptide (192) which covers eight DBE, 
whereas, the remaining three DBE could be attributed to a malonate 
moiety  165.3 (C-17), 41.1 (C-18) and 169.8 (C-19), which was acylated at 
C-2 and 13 to form a bridged 8-membered ring. The amide hydrogen ( 
14.12) that exhibited HMBC correlation with carbon at  169.8 (C-19), 
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104.2 (C-2), and 55.8 (C-3) also confirmed this 8-memberd bridged ring 
formation. The important HMBC correlations were shown in figure 5.1 to 
join various fragments of cryptosporioptide. 
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Figure. 5.1: Joining of various fragments of cryptosporioptide identified 
through HMBC correlation. 
The relative stereochemistry at the chiral centers was confirmed by 
NOESY correlations and molecular model. In NOESY spectrum, the 
correlations between Me-15 ( 1.60) and Me-16 ( 1.70) with H-3 ( 3.42) 
and H-13 ( 5.62) indicated that these groups or atoms were on the same 
side of the 5-membered ring, and that the malonate moiety is attached at 
C-2 and C-13 with cis- junctions. The absence of NOESY interaction of 
amide proton and on C-18 methylene protons with any other hydrogen 
also supported the assigned structure. The above discussed data led to 
structure 192 as a novel polyketide and is named cryptosporioptide 
(Saleem et al., 2013). 
The unique structure of cryptosporioptide precludes the use of 
reference compound to assign its absolute configuration. Therefore, the 
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electronic circular dichroism (CD) spectrum of cryptosporioptide (192) was 
recorded in solution (Figure 5.2, solid lines) and compared with that 
calculated using time-dependent density functional theory (TDDFT) after a 
computational procedure (described in the Computational Section 5.7.2) 
was employed to generate input structures (having initially arbitrary 
(2R,3S,12R,13R,14R) configuration) (Pescitelli et al., 2011; Autschbach et 
al., 2012). Nine low-energy conformers were found with relative internal 
energies within 2 kcal/mol computed at B3LYP/6-311G+(d,p) level. The 
lowest-energy structure is shown in Figure 5.3 and, together with a very 
similar one differing only of the rotation of 14-OH group, accounted for 
52% Boltzmann population at 300K. This structure is in keeping with 
NOESY results discussed above. All low-energy conformers were subdued 
to CD calculations with B3LYP/TZVP (CAM-B3LYP functional gave a 
consistent result), and the resultant calculated CD spectra were 
Boltzmann-averaged at 300K. The calculated average CD spectrum is 
shown in Figure 5.2 (dotted line). The good agreement with the 
experimental ones, apart from a systematic wavelength shift, allowed us to 
assign the absolute configuration of cryptosporioptide as (+)-
(2R,3S,12R,13R,14R).  
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Figure. 5.2: Solid lines: experimental UV-vis (top), CD spectra (bottom) of (+)-
cryptosporioptide (CH3CN, 6.28 mM, 0.01 cm cell). Dotted line: 
calculated CD spectrum of (2R,3S,12R,13R,14R)-cryptosporioptide 
with B3LYP/TZVP//B3LYP-6-311G+(d,p) method, as Boltzmann 
average of 9 low-energy structures at 300K. The calculated spectrum 
was obtained as sum of Gaussian bands with 0.38 eV exponential 
half-width, and red-shifted by 50 nm. 
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Figure. 5.3: Lowest-energy structure calculated for (2R,3S,12R,13R,14R)-
Cryptosporioptide with B3LYP-6-311G+(d,p) method. 
 
5.7.1.2. Characterization of cryptosporioptide A (193) 
 Cryptosporioptide A (193) was also obtained as yellow amorphous 
powder, which exhibited a pseudo-
molecular ion at m/z 430.0721 [M+Na]+ 
in (+ve) HR-FABMS, corresponding to 
the molecular formula C18H17NO10 with 
eleven DBE. The IR spectrum was 
indicative of the presence of carboxylic acid function as it exhibited a 
broad absorption band at 2420-3410 cm-1. The spectrum also displayed a 
shoulder band at 3405 cm-1 due to secondary amide with other prominent 
absorption bands at 1715, 1685, 1590 and 1565 cm-1 for carbonyl 
function and aromatic moiety.  
 The 1H NMR spectral (Table 5.1) of 193 was nearly identical to that 
of 192 as it showed two doublets at δ 7.39 (1H, J = 8.3 Hz) and 6.50 (1H, 
J = 8.3 Hz), two singlet methine at δ 3.57 and δ 5.67, methylene protons 
at δ 3.43 (1H, J = 15.6 Hz) and δ 3.40 (1H, J = 15.6 Hz) and two singlet 
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methyl at δ 1.62 and δ 1.53. The main difference was that the spectrum of 
193 was missing the signal for methoxyl group, and thus afforded a 
carboxylic acid function instead of methyl carboxylate as was observed in 
the data of compound 192.  
 The 13C-NMR spectrum (Table 5.1) substantiated the above 
deduction as it displayed 18 carbon signals, which were identified as two 
methyl (δ 28.4, 18.7), one methylene (δ 42.0), four methine (δ 141.4, 
109.7, 74.1, 56.7) and eleven quaternary carbons (δ 185.0, 169.1, 168.0, 
167.2, 160.1, 158.0, 117.6, 106.0, 105.0, 80.0, 60.0) due to (DEPT, BB) 
experiment. The structure was further confirmed through HMBC spectral 
analysis (Figure 5.1) in which H-7 (δ 7.39) showed HMBC correlation with 
carbonyl carbon at δ 169.1 to fix carboxylic function at C-6. The HMBC 
interaction of H-13 (δ 5.67) with C-17 (δ 168.0) confirmed the location of 
malonate moiety. Other diagnostic HMBC correlations are similar as 
shown in figure 5.1. Stereochemistry at various chiral centers could be 
defined through NOESY spectral information (Figure 5.4), deriding model 
and due to comparable optical rotation value with that of 192. 
Combination of the whole spectroscopic data and comparison with the 
data (Table 5.1) of 192, compound 193 was identified as de-methyl 
derivative of 192 and is named as cryptosporioptide A (193) (Tousif et al., 
2014). 
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Figure. 5.4: NOESY correlation observed in compound 193. 
5.7.1.3. Characterization of cryptosporioptide B (194)  
 Compound 194 was also obtained as yellow amorphous powder. 
The molecular formula C16H18O9 with 
eight DBE was established through HR-
FABMS (m/z 377.0841, [M+Na]+. The 1H 
and 13C-NMR spectrum displayed almost 
similar signals to that of 192 and 193 
that revealed the same skeleton of 194. The 1H-NMR spectrum of 194 was 
missing the signals for a methylene group (Table 5.1), whereas, H-13 
shifted upfiled (δ 4.09) by more than 1.0 ppm when compared to that of 
194. This data indicated that compound 194 must be missing malonate 
moiety. Molecular formula and 13C-NMR spectrum (Table 5.1) confirmed 
this deduction. The 13C-NMR spectrum of 194 displayed total 16 signals, 
which were attested for three methyl, four methine and nine quaternary 
carbons. The above discussed data revealed that compound 194 is 
missing malonate moiety and amide function, instead an additional 
O
OOHO
H3CO
HO Me
OH
OH
OH
Me
194
2
3 14
16
15
13
12
H
1
4
5
6
7
8
9
10
11
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
135 
 
hydroxyl group was found at C-2. This deduction was substantiated 
through IR spectral analysis, which showed the presence of hydroxyl 
(3470 cm-1), methine (3107, 2946 cm-1), carboxylate (1734 cm-1), ketonic 
(1682 cm-1) and aromatic (1591, 1563 cm-1) systems, whereas, the 
absorption band for amide function was missing (Tousif et al., 2014). 
Table. 5.1: 1H and 13C-NMR data of 192 (CDCl3; 500 and 125 MHz) 193 and 194 
(CD3OD; 500 and 125 MHz). 
 Compound 192 Compound 193 Compound 194 
Position δH (J in Hz) δc δH (J in Hz) δc δH (J in Hz) δc 
2 - 104.2 - 106.0 - 105.6 
3 3.42 (s) 55.8 3.57(s) 56.7 3.54 (s) 56.7 
4 - 187.7 - 185.0 - 182.3 
5 - 158.9 - 160.1 - 160.3 
6 - 117.1 - 117.6 - 118.0 
7 7.40 (d, J = 8.5) 140.4 7.39 (d, J = 8.3) 141.4 7.40 (d, J = 8.5) 141.8 
8 6.43 (d, J = 8.5) 108.4 6.50 (d, J = 8.3) 109.7 6.41 (d, J = 8.5) 109.0 
9 - 157.1 - 158.0 - 164.0 
10 - 105.9 - 105.0 - 104.0 
11 - 166.5 - 169.1 - 168.8 
12 - 78.8 - 80.0 - 82.1 
13 5.62 (s) 73.1 5.67 (s) 74.1 4.09 (s) 74.4 
14 - 58.6 - 60.0 - 62.2 
15 1.60 (s) 18.0 1.53 (s) 18.7 1.51(s) 18.0 
16 1.70 (s) 28.4 1.62 (s) 28.4 1.59 (s) 28.4 
17 - 165.3 - 168.0 - - 
18 3.44 (d, J = 15.5) 
3.39 (d, J = 15.5) 
41.1 3.43 (d, J = 15.6) 
3.40 (d, J = 15.6) 
42.0   
19 - 169.8 - 167.2 - - 
OMe 3.66 (s) 52.5 - - 3.54 (s) 53.0 
N-H 14.12 - - -   
5-OH 11.78 - - -   
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5.7.2. Computational Section for Compound 192 
Conformational searches and DFT geometry optimizations were run 
with Spartan’10 (Wave function, Inc., Irvine CA, 2010), using default 
parameters, grids and convergence criteria. TDDFT calculations were run 
with Gaussian’09 with default grids and convergence criteria. The 
conformational search was run using MMFF force field. All structures 
thus obtained within 10 kcal/mol were pre-optimized with B3LYP/6-
31G(d) and finally optimized with B3LYP/6-311+G(d,p). TDDFT 
calculations were run using CAM-B3LYP and B3LYP functionals and TZVP 
basis sets (www.gaussian.com/g_tech/g_ur/g09help.htm). ECD spectra 
were generated by applying a Gaussian band shape with 0.38 eV 
exponential half-width, using dipole-length rotational strengths; the 
difference with dipole-velocity values was checked to be minimal for all 
relevant transitions. 
5.7. 4. Biological Activities of Compounds 192-194  
Compounds 192-194 were tested against four enzymes 
acetylcholinesterase, butyrylcholinesterase, -Glucosidase and 
lipoxygenase and compound 192 was found significantly active against 
the enzyme lipoxygenase with an IC50 value of 49.15±0.17 M and enzyme 
-glucosidase with an IC50 value of 50.59±0.28 M, whereas it was 
inactive against other two enzymes. Compounds 193 and 194 showed 
moderate activity against -glucosidase (IC50 = 44.93±0.26 and 
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41.42±0.14 respectively) and lipoxygenase (IC50 = 134.38±1.65 and 
149.62±1.53 respectively), whereas, remained inactive against other two 
enzymes. Cryptosporioptide (192) was also tested in an agar diffusion 
assay against two bacterial test organimsms, Escherichia coli and Bacillus 
megaterium, two fungi, Microbotyrum violaceum and Botrytis cinerea, and 
the alga Chlorella fusca. At a concentration of 50 g per 9 mm paper disc, 
it inhibited the growth of Bacillus megaterium moderately with a 9 mm 
radius of the zone of inhibition. For comparison, the same concentration 
of penicillin and streptomycin resulted in radii of inhibition of 26 and 13 
mm, respectively. The metabolite was inactive against the other test 
organisms. The comparison of the lipoxygenase inhibitory activity of 
compounds 192-194, it is proposed that malonate moiety and 
methylcarboxylate functions could equally be responsible to inhibit the 
enzyme. 
Table. 5.2: Enzyme inhibitory activity of compounds 192-194. 
-Glucosidase activity Lipoxygenase activity 
Compound Inhibition (%) at 
0.25 mM 
IC50 (µM) % Inhibition at 0.25 
mM 
IC50 (µM) 
192 90.16±0.81 50.59±0.28 90.56 ± 1.19  49.15 ± 0.17 
193 90.23±0.73  44.93±0.26 62.37±2.34 134.38±1.65 
194 91.51±0.56 41.42±0.14 57.89±2.13 149.62±1.53 
Acarbosea - 38.25±0.12 - - 
Eserinea - - - 22.4 ± 1.3 
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5.8. EXPERIMENTAL 
5.8.1. General Experimental Procedures 
Column chromatography (CC) was performed with silica gel (230-
400 mesh, E-Merck, Darmstadt, Germany) eluting with various organic 
solvents, all commercial grades. Various fractions from CC were monitored 
on the aluminium sheets pre-coated with silica gel 60 F254 (20×20 cm, 0.2 
mm thick; E. Merck, Darmstadt, Germany), which were either visualized 
under UV lamp (254 and 366 nm) or heating with ceric sulpahte spray. 
The optical rotation was calculated on JASCO DIP-360 polarimeter. The 
UV spectra were recorded on Jasco V-650 spectrophotometer, whereas, IR 
spectra were recorded on Shimadzu 460 spectrometer (Duisburg, 
Germany). The 1H-NMR spectra were scanned on Bruker NMR 
spectrometer operating at 500 MHz, while 13C-NMR spectra were recorded 
on the same instrument operating at 125 MHz. The 2D NMR (HMQC, 
HMBC and COSY) spectra were also measured on the same machine 
operating at 500 MHz. NOESY spectra were recorded with a Varian INOVA 
600 (14.1 T) NMR spectrometer. FABMS and HR-FAB-MS were calculated 
on Finnigan (Varian MAT)JMS H×110 with a data system and JMSA 500 
mass spectrometers. CD spectra were measured on a J-715 
spectropolarimeter using a 0.01 cm quartz cell. 
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 5.8.2 Culture, Extraction and Isolation 
Cryptosporiopsis (internal strain no. 8999) endophytic fungal sp. 
was isolated from the shoot tissues of Viburnum tinus, collected from 
Gomera (Spain). The fungus strain was grown for four weeks at room 
temperature on biomalt solid agar medium. The culture media was 
repeatedly extracted with ethyl acetate. The extract was concentrated 
under reduced pressure to get 4.0 g of the crude extract, which was 
subjected to column chromatography over silica gel eluting with gradient 
of ethyl acetate:n-hexane. As a result 05 fractions (A-E) were obtained 
(Scheme 5.1).  
The fractions A-C mainly contain a mixture of lipids, whereas, 
fractions D and E with yellowish colored gummy mass showed several 
spots on TLC. Therefore, these fractions were further purified on a silica 
gel column eluting fraction D with 50% ethyl acetate in hexane that gave a 
sub-fraction D2 which showed a major spot with fewer minor bands on 
TLC. This sub-fraction on passing through sephadex LH-20 yielded 
cryptosporioptide (192, 25mg). The fraction E was also purified on a silica 
gel column eluting with an isocratic of 70% ethyl acetate in hexane to get 
four sub-fractions (E1-E4). The sub-fractions E2 and E3 were separately 
passed through sephadex LH-20 eluted with methanol that yielded 
cryptosporioptide A (193, 15 mg), from fraction E2 and cryptosporioptide 
B (194, 8 mg), from fraction E3. 
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Crude Extract from culture media
Silica gel CC
Various Frcations on the basis of TLC profiles
Sephadax LH-20
MeOH
Repeated Silica gel CC of Various Frcations on TLC 
basis Mostly free from Fats
EtOAc/ Hexane
192
D1-Fraction E2-Fraction
Sephadax LH-20
MeOH
193 194
A B C D E
50% ethyl acetate in hexane isocratic of 70% ethyl acetate in hexane
E3-Fraction
Sephadax LH-20
MeOH
 
Scheme 5.1: Extraction and isolation of secondary metabolites from 
Cryptosporiopsis (internal strain no. 8999) endophytic 
fungal sp. 
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5.8.3. Spectroscopic Data of Isolated Compounds 
5.8.3.1. Spectroscopic data of cryptosporioptide (192): Light yellow 
amorphous powder (25 mg). []D26  61.3 (c 
0.001, CHCl3); UV max (max, 6.28 mM in 
CH3CN) nm (104M–1cm–1): 374 (1.72), 269 
(0.60), 243 (0.69), 195 (1.60); CD ext (ext, 
6.28 mM in CH3CN) nm (M–1cm–1): 386.3 
(+2.56), 341.0 (+5.0), 283.8 (0), 243.0 (–6.3), 
192.5 (–7.3); IR max (KBr) cm-1: 3404, 2926, 1724, 1630; 1H-NMR (CDCl3, 
500): δ 7.40 (1H, d, J = 8.5 Hz, H-7), 6.43 (1H, d, J = 8.5 Hz, H-8), 5.62 
(1H, s, H-13), 3.42 (1H, s, H-3), 3.44 (1H, d, J =15.5 Hz, H-18), 3.39 (1H, 
d, J =15.5 Hz, H-18), 3.66 (3H, s, OMe), 1.70 (1H, s, Me-16), 1.60 (1H, s, 
Me-15), 14.12 (1H, s, N-H), 11.78 (1H, s, 5-OH); 13C-NMR (CDCl3, 125 
MHz): δ 187.7 (C-4), 169.8 (C-19), 166.5 (C-11), 165.3 (C-17), 158.9 (C-5), 
157.1 (C-9), 140.4 (C-7), 117.1 (C-6), 108.4 (C-8), 105.9 (C-10), 104.2 (C-
2), 78.8 (C-12), 73.1 (C-13), 58.6 (C-14), 55.8 (C-3), 41.1 (C-18), 28.4 (C-
16), 18.0 (C-15), 52.5 (OMe); HR-FAB-MS: m/z 444.0781 [M+Na]+ (calcd. 
444.0907 for C19H19NNaO10, corresponding to the formula C19H19NO10). 
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5.8.3.2. Spectroscopic data of cryptosporioptide A (193): Light yellow 
amorphous powder (15 mg). []D26 +81.1 
(CH3OH, c 0.001); UV λmax (CH3OH) nm (): 
372 (1.70), 268 (0.62), 242 (0.70), 194 
(1.59); IR max (KBr) cm-1: 3402, 2924, 
1722, 1629; 1H-NMR (CD3OD; 500 MHz): δ 
7.39 (1H, d, J = 8.3 Hz, H-7), 6.50 (1H, d, J 
= 8.3 Hz, H-8), 5.67 (1H, s, H-13), 3.57 (1H, s, H-3), 3.43 (1H, d, J =15.5 
Hz, H-18), 3.40 (1H, d, J =15.5 Hz, H-18), 1.62 (1H, s, Me), 1.53 (1H, s, 
Me); 13C-NMR (CD3OD, 125 MHz): δ 185.0 (C-4), 169.1 (C-11), 168.0 (C-
17), 167.2 (C-19), 160.0 (C-5), 158.0 (C-9), 141.4 (C-7), 117.6 (C-6), 109.7 
(C-8), 105.0 (C-10), 106.0 (C-2), 80.0 (C-12), 74.1 (C-13), 60.0 (C-14), 56.7 
(C-3), 42.0 (C-18), 28.4 (C-16), 18.7 (C-15); HR-FAB-MS: m/z 430.0721 
[M+Na]+ (calcd. 430.0908 for C18H17NNaO10, corresponding to the formula 
C18H17NO10). 
5.8.3.3. Spectroscopic data of cryptosporioptide B (194): Light yellow 
amorphous powder (8 mg). []D26 +22.1 
(CH3OH, c 0.0008); UV λmax (CH3OH) nm 
(): 376 (1.73), 270 (0.61), 244 (0.72), 196 
(1.62); IR max (KBr) cm-1: 3405, 2928, 
1720, 1628; 1H-NMR (CD3OD, 500 MHz): δ 7.40 (1H, d, J = 8.5 Hz, H-7), 
6.41 (1H, d, J = 8.5 Hz, H-8), 4.09 (1H, s, H-13), 3.54 (1H, s, H-3), 3.54 
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(3H, s, OMe), 1.59 (1H, s, Me), 1.51 (1H, s, Me); 13C-NMR (CD3OD, 125 
MHz): δ 182.3 (C-4), 168.8 (C-11), 160.3 (C-5), 164.0 (C-9), 141.8 (C-7), 
118.0 (C-6), 109.0 (C-8), 104.0 (C-10), 105.6 (C-2), 82.1 (C-12), 74.4 (C-
13), 62.2 (C-14), 56.7 (C-3), 28.4 (C-16), 18.0 (C-15), 53.0 (OMe); HR-FAB-
MS: m/z 377.0841 [M+Na]+ (calcd. 377.3201 for C16H19NaO8, 
corresponding to the formula C16H19O8). 
5.8.4. Enzyme Inhibitory Assays 
 The four enzyme inhibitory assays were performed according to the 
pre-established protocols (Tappel 1953; Baylac and Racine 2003; Ellman 
et al., 1961) with slight modifications, as described below.  
5.8.4.1.-Glucosidase inhibition assay 
 The -glucosidase inhibition activity was performed according to the 
method Reported by Pierre et al., (Pierre et al., 1978) with some 
modification. Total volume of the reaction mixture of 100 µl contained 70 
µl 50 mM phosphate buffer saline with pH 6.8, 10 µl (0.5 mM) test 
compound, followed by the addition of 10 µl (0.057 units) enzyme. The 
contents were mixed, preincubated for 10 min at 37ºC and pre-read at 
400 nm. The reaction was initiated by the addition of 10 µl of 0.5 mM 
substrate (p-nitrophenyl glucopyranoside). Acarbose was used as positive 
control. After 30 min of incubation at 37ºC, absorbance was measured at 
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400 nm using Synergy HT microplate reader. All experiments were carried 
out in triplicates.  
 The percentage inhibition (%) of the enzyme was calculated using 
the following formula: 
 Inhibition (%) = Control – Test × 100 
    Control 
5.8.4.2. Acetylcholinesterase assay  
 The Acetylcholinesterase (AChE) inhibition activity was performed 
according to the method described by Ellman et al., (Ellman et al., 1961) 
with slight modifications. The 100 µL reaction mixture which contain 60 
µL of buffer Na2H PO4 with pH 7.7, 10 µL (0.5 mM) test compound and 10 
µL (0.005 unit well) enzyme was added and then pre-read at 405 nm. After 
that it was incubated for 10 minutes at 37°C. The reaction was initiated 
by the addition of 10 µL of 0.5 mM substrate (acetylthiocholine iodide), 
followed by the addition of 10 µL DTNB (0.5 mM). Eserine (0.5 mM) was 
used as a positive control. Then absorbance was measure at 405 nm on 
Synergy HT (BioTek, USA) microplate reader. 
The percentage inhibition (%) of the enzyme was calculated using the 
following formula: 
 Inhibition (%) = Control – Test × 100 
    Control 
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5.8.4.3. Butyrylcholinesterase assay 
 The butyrylcholinesterase inhibition activity was performed 
according to same method as reported for Acetylchoinesterse with small 
difference as butyrylcholinesterase enzyme was used here. 
5.8.4.4. Lipoxygenase assay  
 The lipoxygenase (LOX)activity was perfirmed by same method as 
dercribed for Acetylchoinesterse with small difference as lepoxygenase 
enzyme used here (Evans et al., 1987; Baylac 2003) Baicalein (0.5 mM) 
was used as a positive control.  
The percentage inhibition (%) of the enzyme was calculated using the 
following formula: 
 Inhibition (%) = Control – Test × 100 
    Control 
Where Control = Total enzyme activity without inhibitor 
Test=  Activity in the presence of test compound  
 In all enzyme inhibitory assays, the IC50 values were calculated 
using EZ–Fit Enzyme Kinetics software (Perrella Scientific Inc. Amherst, 
USA). All the measurements were done in triplicate and statistical analysis 
was performed by Microsoft Excel 2003. Results are presented as mean ± 
sem. 
  
Chapter 5                                                                                                                      Endophytic Fungi                                                                                  
 
146 
 
5.8.5. Agar Diffusion Test for Antimicrobial Activity 
Cryptosporioptide (192) was dissolved in acetone at a concentration 
of 2 mg/mL. 25 μL of the solution (50 μg) were pipetted onto a sterile filter 
disc, which was placed onto an appropriate agar growth medium for the 
respective test organism and subsequently sprayed with a suspension of 
the test organism. The test organisms were the gram-negative bacterium 
Escherichia coli, the Gram-positive bacterium Bacillus megaterium (both 
grown on NB medium), the fungi Microbotryum violaceum and Botrytis 
cinerea, and the alga Chlorella fusca (fungi and alga were grown on MPY 
medium). Reference substances were ketoconazole, penicillin and 
streptomycin. Commencing at the outer edge of the filter disc, the radius 
of zone of inhibition was measured in mm. These microorganisms were 
chosen because they are non-pathogenic and had in the past proved to be 
accurate initial test organisms for antibacterial, antifungal and 
antialgal/herbicidal activities (Holler et al., 2000; Schulz et al., 1995). 
compound 193 and 194 were not evaluated for antibacterial activity due 
low amount. 
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